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ABSTRACT  
The unique reactivity that hard/soft-acid/base mismatched metal hydroxide 
complexes are capable of makes this elusive class of highly reactive organometallic 
complexes very interesting. The stabilisation of rhodium and iridium hydroxide bonds 
using electron rich N-heterocyclic carbene (NHC) ligands has enabled us to examine 
their rich chemistry and proved to be very rewarding. A general method was established 
for the preparation of a family of Rh(I)-NHC hydroxide complexes (four members), 
which proved to be highly active promoters of the conjugate addition of arylboronic 
acids to α,β-unsaturated ketones, achieving TONs and TOFs of 100,000 and 6,600 h-1 
respectively. In addition, we have studied the activity of Rh(I)-NHC hydroxides in 
catalysing the hydrosilylation and dehydrogenative silylation of terminal alkenes. The 
two competing reactions were studied under the same conditions and a scope for each 
transformation with good selectivity is presented. 
The scope of metal hydroxides was extended to include Ir(I)-NHC hydroxides (six 
members). Reactivity of this motif towards a wide range of organic substrates has been 
explored, undergoing reaction with arylboronic acids to form Ir(I)-aryl complexes and 
reacting with silanes to form Ir(I)-siloxides. The Ir(I)-hydroxide is able to deprotonate 
an array of O-H and N-H bonds to give new Ir(I)-alkoxides and Ir(I)-amides. In 
addition, C-H activation of a range of sp-, sp
2
- and sp
3
-hybridised carbon centres has 
been explored, delivering Ir(I)-alkyl complexes under very mild conditions, with the 
generation of H2O as the sole by-product. Subsequently, we have examined the insertion 
of CO2 into a number of Ir(I)-O and Ir(I)-N bonds, leading to Ir(I)-carbonates and Ir(I)-
carbamates, respectively. In the case of reaction between CO2 and Ir(I)-hydroxide, a 
fascinating [{Ir(I)}2-(µ-κ
1
O:κ2O,O-CO3)] complex was obtained under extremely mild 
conditions. This reaction has been studied in detail using kinetic and theoretical 
methods to calculate activation parameters and elucidate the insertion and concomitant 
dimerisation mechanism. 
In addition, we have utilised a series of methods for the preparation of a range of 
interesting fluorinated Rh(I)-NHC and Ir(I)-NHC complexes; bearing fluoride, 
bifluoride and trifluoromethyl groups. We disclose the first iridium bifluoride 
complexes and briefly discuss the relationship between these and the fluoride species in 
solution. We also report the first Ir(I)-NHC and Rh(I)-NHC trifluoromethyl complexes.  
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Chapter 1: Introduction 
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1. GENERAL INTRODUCTION 
1.1. TRANSITION METAL ORGANOMETALLIC CHEMISTRY 
The development of new transition metal catalysed processes continues to drive 
advances in the important fields of organic synthesis, materials chemistry and small-
molecule activation. Many crucial technologies, such as olefin metathesis
1
 and 
palladium-catalysed cross couplings,
2
 have relied on the exploration of new structural 
motifs. For example, the use of N-heterocyclic carbene (NHC) ligands led to a 
remarkable change in the reactivity of olefin metathesis catalysts,
3
 while ligand choice 
in Pd-mediated processes influenced reaction outcomes such as regio-, chemo- and 
stereoselectivity.
4
 Catalysis is of growing importance in industry, where highly efficient 
processes are necessary in order to perform cost-effective chemical procedures on a 
large scale. In the past, catalyst research and development focused on activity and 
optimisation of turnover rates. However, the focus is shifting towards the development 
of reactions with greater selectivity and the elimination of by-products in order to 
enable cleaner transformations, eliminate the need for waste disposal and ultimately 
deliver green chemistry.
5,6
 The underlying principle of green chemistry is the design of 
environmentally benign processes and products. Catalysis plays a vital role, being 
identified as one of the twelve green chemistry principles,
7
 which can be summarised 
into a working definition as the efficient utilisation of raw materials (preferably 
renewable), the elimination of waste and the avoidance of toxic reagents and solvents in 
the manufacture and utilisation of chemical products.
8
  
 Advancements in combinatorial chemistry, molecular modelling, high-
performance analytical techniques and more efficient data collection and correlation are 
all driving catalyst development, while the replacement of fossil fuels by alternative 
energy sources calls for crucial scientific breakthroughs.
9
 In the fine chemicals sector, 
enantioselective catalysis by supported metals is a major challenge,
10
 while soluble 
transition metal catalysts have important applications in the manufacture of bulk 
commodities and specialty products. Industrial competition and the demand for 
selective, efficient and environmentally friendly processes continue to drive catalyst 
research.
11
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It is therefore of paramount importance to fully explore new structural motifs in 
order to understand and implement them in the development of next generation catalytic 
systems. While efficient chemistry can often be performed by active catalyst species 
made in situ, the careful preparation and study of well-defined complexes provides a 
solid foundation from which to study reactivity and fundamental steps in organometallic 
chemistry. 
1.1.1. Transition metal hydroxides 
Organometallic complexes are most often prepared in organic solvents and the 
presence of adventitious water in reaction media containing sensitive organometallic 
compounds can result in the (detrimental) formation of oxide, hydroxide, 
(oxo)hydroxide and aqua complexes, which may also precede organometallic 
decomposition. The demand for ‘green’ processes has meant that more environmentally 
friendly reaction media are sought after, particularly with respect to solvents. Most 
organic processes are not compatible with aqueous solvents due to poor solubility and in 
the case of organometallic compounds, instability in water. However, the development 
of organometallic complexes that are insensitive to water and the exploration of their 
potential as catalysts may lead to more environmentally friendly processes that can be 
carried out in aqueous media.
12
  
Hydroxide complexes of the transition metals (TMs), and in particular, the late-
transition metals (LTMs) are rare due primarily to the inherent weakness of metal 
hydroxide (M-OH) bonds.
12
 Metal ions of LTMs usually adopt low oxidation states and 
their large size and loosely held (easily excited) outer d-orbital electrons make them 
highly polarisable. By the Pearson system,
13
 LTMs in low-oxidation states are classified 
as soft Lewis acids, with ‘hardness’ increasing with increasing oxidation state. 
Hydroxide ions are classified by hard/soft-acid/base (HSAB) theory as hard Lewis 
bases, and by Pearson’s acid-base concept,13 soft acids will form more stable complexes 
in solution with soft bases. Therefore, the interaction of a hard base (OH)
-
 with a soft 
acid (LTM) is disfavoured, and is predicted to result in a weak metal-hydroxide bond.
12, 
14
 By the same logic, the HSAB mismatch should lead to very reactive complexes, with 
labile OH groups and this is the fundamental reason for our interest in LTM 
hydroxides.
12
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Another reason for our interest in LTM hydroxides is due to numerous reports 
where metal hydroxides are implicated as important intermediates in catalytic 
transformations, particularly where water is involved as a substrate. Examples include 
the 1,4-addition of aryl boronic acids to α,β-unsaturated ketones,15 nitrile16 and olefin 
hydrations,
17
 hydrogen − deuterium exchange18 and water oxidation.11, 21 Interactions 
between transition metals and hydroxide moieties are also considered to be critical in 
reactions such as the Wacker oxidation,
19
 water-gas shift reaction,
20
 olefin 
hydrocarbonylation,
36
 methoxycarbonylation,
21
 carbonyl hydrogenation,
19
 and alcohol 
dehydrogenation.
19
 In addition, hydroxide and aqua complexes have been studied due to 
their biological significance. Several metalloenzymes, such as carbonic anhydrase 
consist of a Zn-H2O active site. The major activation step in the catalytic cycle of 
carbonic anhydrase involves a base assisted deprotonation of the Zn-H2O to generate a 
Zn-OH moiety. Nucleophilic attack by the Zn-OH at CO2 forms a zinc hydrogen 
carbonate and subsequent hydrolysis releases the hydrogen carbonate anion and 
regenerates the Zn-H2O (Scheme 1.1).
22
  
 
Scheme 1.1. Simplified mechanism of carbonic anhydrase (B = base, His = histidine)
22
 
Hydroxide complexes of most of the d-block metals of the periodic table have been 
prepared, ranging from hydroxide complexes of yttrium
23
 to those of zinc,
24
 cadmium
25
 
and mercury,
26
 either serendipitously in the presence of adventitious moisture,
12
 or by 
synthetic methods involving processes such as ligand or salt metathesis, oxidative 
addition or protonation reactions.
19
 The various preparative methods for LTM 
hydroxides will be discussed briefly in the next section. Most of the procedures 
described are general for metal alkoxides and amides but for the sake of this study, 
discussions will be focussed on metal hydroxides. 
1.1.1.1. Metal hydroxide synthesis 
1.1.1.1.1. Ligand metathesis 
TM hydroxide (and alkoxide) complexes have been prepared mostly by metal 
exchange or ligand (salt) metathesis reactions. The earliest reports of synthetic routes to 
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Rh and Ir hydroxides were reported in the late 1960s and early 1970s via metathesis 
reactions. For example, in 1969 Ugo prepared Rh(I) hydroxide 2 from 
[RhCl(CO)(PPh3)2] (1) and sodium methoxyethoxide in the presence of H2O (Scheme 
1.2).
27
 Roper reported the Ir(I) analogue from trans-[Ir(CO)(MeCN)(PR3)2]ClO4 (3) and 
NaOH
28
 and Vaska prepared hydroxides of both Ir (5a) and Rh (5b) via metathesis with 
corresponding fluoride complexes 4.
29
 Vaska’s complex trans-[IrCl(CO)(PPh3)2] (6) 
also reacts with NaOMe, followed by hydrolysis to give the Ir(I) hydroxide 7.
30
  
 
Scheme 1.2. Preparation of Rh and Ir hydroxides by metathesis reactions
27, 29
 
Several bridged hydroxide complexes of Rh and Ir have been prepared by salt 
metathesis. For example, [MCp*(µ-Cl)2]2 (M = Rh 8a, Ir 8b, Cp* = 
pentamethylcyclopentadiene) complexes react with NaOH and Ag2O in the presence of 
moisture to give [(MCp*)2(µ-OH)3]OH
 
(M = Rh 9a, Ir 9b).
31
 9a can easily be converted 
to [(RhCp*)2(µ-OH)3]PF6 (10), which reacts with PhOH to give the corresponding 
phenoxide-bridged dimer 11 (Scheme 1.3),
31b
  
 
Scheme 1.3. Preparation of Rh and Ir bridged hydroxide complexes by salt metathesis.
31
 
[M(cod)(OH)]2 (M = Rh 13a, Ir 13b) can be prepared easily from the commercially 
available chloride complexes [M(cod)Cl]2 (12) and KOH, providing valuable synthons. 
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For example, reaction of [Ir(cod)(OH)]2 (13b) with chelating phosphines leads to 
cleavage of the dimer to give four co-ordinate Ir-hydroxide complexes.
32
 Complex 13b 
can also react with aqueous HF to give [Ir(cod)(F)]n, which in turn can be isolated as 
monomeric [Ir(cod)(F)(PPh3)] upon treatment with triphenyl phosphine (PPh3).
33
 
[M(cod)(OH)]2 (13) has found application as a catalyst in a large number of 
transformations. For example, Mori and co-workers have shown the superior activity of 
the hydroxide complex 13a over the chloride complex 12a in 1,4-hydrosilylation
34
 and 
Mizoroki-Heck type coupling
35
 with α,β-unsaturated carbonyls. The same group have 
also reported 13a as an efficient promoter of hydroarylation and alkenylation of 
alkynes
36
 and aldehydes
37
 using silanediols. The catalytic efficiency of 13a has also 
been shown in combination with phosphine ligands, particularly chiral biphosphines to 
enable asymmetric transformations. A particular case in point was reported by Hayashi 
and co-workers who showed that 13a/L (L = chiral biphosphine) provided more active 
catalysts for the conjugate addition of arylboronic acids to α,β-unsaturated ketones, than 
the corresponding chloride systems generated from 12a/L.
38, 39
 
1.1.1.1.2. Oxidative syntheses 
The second method for preparing metal hydroxides is through oxidative addition, 
particularly of H2O, to give hydrido-hydroxo complexes. For example, Milstein and co-
workers have described oxidative addition of water across several Ir complexes
40
 such 
as [Ir(PMe3)4]PF6 (14) to give [Ir(H)(OH)(PMe3)4]PF6 (15) (Scheme 1.4).
40b
 The Ir(III)-
hydroxide 15 is stable to air and will not reductively eliminate water, even at high 
temperatures, but is able to deprotonate methanol to give an Ir(III)-methoxide complex 
16.  
 
Scheme 1.4. Oxidative addition of H2O to give an Ir(III) hydroxide
40b
 
Jensen
41
 reported that the 16-electron Ir-dihydride complex 17 reacts under 
dehydrogenation with tert-butyl ethylene (
t
be) to form the hydrido-hydroxide complex 
18, presumably via the oxidative addition of adventitious H2O. This was confirmed by 
adding excess H2O to the reaction mixture to deliver 18 in high yield (Scheme 1.5), and 
the transformation can be reversed by addition of H2. 
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Scheme 1.5 Oxidative addition of H2O to an Ir pincer complex
41
 
Less common is the addition of molecular oxygen to form metal hydroxide bonds 
such as the conversion of a five-coordinate Ir hydride 19 to an Ir hydroxide 20 as shown 
in Scheme 1.6. The exact mechanism has not been described but was postulated to 
involve the formation of a di-oxygen adduct, which is unstable and consequently 
releases OPPh3 to give complex 20.
42
 
 
Scheme 1.6. O2 adition to an Ir hydride to give an Ir hydroxide
42
 
1.1.1.1.3. Protonation and σ-ligand metathesis 
σ-Ligand metathesis differs from the salt metathesis described above in that only 
hydrogen atoms are transferred between σ-ligands. The transformation is normally 
preceded by oxidative addition and can either be reversible or irreversible, with 
reversible σ-ligand metathesis being driven to completion by excess reagent.19 Bennet 
and co-workers developed an irreversible σ-ligand metathesis route to access platinum 
cyclohexenyl hydroxides 22 as shown in Scheme 1.7. The oxidative addition of H2O is 
followed by hydrogen transfer to the coordinated cyclohexyne. Reactions are 
thermodynamically favourable, and the products are stable towards β-hydride 
elimination and the reformation of metal hydrides.
16a, 43
 Similar results have been 
reported by Keim upon heating [Rh(PMe3)3Me] in the presence of PhOH to give 
[Rh(PMe3)3(OPh)] and methane.
44
  
 
Scheme 1.7. σ-Ligand metathesis on Platinum16a, 43 
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1.1.1.2. Metal hydroxides and reactivity  
Several terminal Ir(I) and Ir(III)-hydroxide complexes have been reported. Of note, 
Woerpel and Bergman reported the synthesis of [Ir(Cp*)(OH)(Ph)(PMe3)] (24) from the 
corresponding iridium trifluoromethanesulfonate (OTf) complex 23 and CsOH or 
KO
t
Bu (Scheme 1.8).
45
 In their report, the authors studied the activation of a number of 
nucleophilic and electrophilic reagents. Reactivity was restricted to the hydroxyl 
moiety, for example 24 is able to activate X-H bonds (X = PhO, NH(p-MeC6H4)) by 
deprotonation with complete conversion to the corresponding Ir-X complex.
45
 The 
authors also reported the unprecedented insertion of alkenes and alkynes into the Ir-OH 
bond, for example ethylene reacts with 24 to give complex 25, which rearranges over 
time to give the formylmethyl complex 26. In a later communication, Ritter and 
Bergman reported that the apparent insertion of an inactivated alkene into the Ir-OH 
bond is catalysed by trace amounts of 23 present in the reaction mixture, which effects 
the initial alkene activation, followed by attack of the Ir-hydroxide to form a bimetallic 
intermediate.
46
  
 
Scheme 1.8. Preparation of Ir(III)-hydroxide and its reactivity towards organic substrates. 
45
 
In a similar study to that conducted by Woerpel and Bergman, Alper and Grushin
47
 
reported the preparation of [Rh(PPh3)2(µ-OH)]2 (28) from Wilkinson’s catalyst (27) and 
aqueous KOH in biphasic media (Scheme 1.9). Complex 28 performed C-H or O-H 
activation on a number of substrates including cyclopentadiene, methylmalonate and 
benzoic acid to give the corresponding monomeric Rh complexes and H2O. Complex 28 
also reacts with [M(CO)3CpH] (M = Cr, Mo, W) to generate heterobimetallic 
complexes. 
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Scheme 1.9. Preparation of [Rh(PPh3)2(µ-OH)]2 from Wilkinson’s catalyst (27)
47
 
Several interesting hydroxide complexes of ruthenium have been prepared, a 
number of them via the oxidative addition of H2O to form hydrido-hydroxo complexes 
such as [Ru(OH)(PMe3)4(R)] (R = H or Ph).
48
 [Ru(Cp*)(NHC)(OH)] (29, Scheme 1.10) 
was prepared by our group from the corresponding chloride complex and CsOH and 
proved to be an effective catalyst for the racemisation of aliphatic and aromatic 
secondary alcohols. Although the parent chloride complex was more active, the 
inclusion of an on-board base on 29 meant that reactions could be performed without 
the need to add a stoichiometric amount of base.
49
  
 
Scheme 1.10 Ru-NHC hydroxide and its use in base free alcohol racemisation
49
 
Whittlesey et al.
50
 have reported the preparation of a monomeric ruthenium aqua 
complex 31 somewhat serendipitously via adventitious water during the attempted 
recrystallisation of a Ru-dihydride complex 30 in hexane (Scheme 1.11). The 
corresponding ethanol complex 32 was isolated in the same way in ethanol and both 31 
and 32 reacted with CO. Complex 32 inserts CO into the Ru-O bond to give Ru-
(C(O)OEt), while the aqua complex 31 eliminates H2 in the presence of CO, leading to 
the hydrido-hydroxide adduct 33. Furthermore, CO2 can be inserted into the Ru-(H2O) 
bond on 31 to give a monomeric Ru bicarbonate complex 34. When placed under CO, 
the Ru(κ2O,O-CO3H) 34 rearranges to give Ru(η
1
-OCO2H) 35. The authors described 
the presence of the two bulky 1,3-dimethylimidazol-2-ylidene (IMes) ligands to play a 
vital role in stabilising bonds between Ru and oxygen and enabling isolation of these 
interesting compounds.  
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Scheme 1.11. Studies on Ru-IMes2 complexes by Whittlesey
50
 
Kaplan and Bergman described the interesting preparation of a ruthenium 
hydrido-hydroxide complex 37 via oxygen atom insertion into the metal-hydride bond, 
mediated by N2O (1 equiv., Scheme 1.12).
51
 Reaction with a second equivalent of N2O 
leads to isolation of the dihydroxide complex 38, albeit in low yields. The Ru-hydroxide 
moiety of 37 was reactive to a number of substrates, generating Ru thiolates, siloxides 
and alkoxides as shown, in yields between 25% and 40% (39). Complex 37 could also 
be reacted with silica to provide a silica supported system in the same way as Bergman 
has previously reported for the Ir-complex 24.
52
 Both Ru-hydroxides 37 and 38 reacted 
with phenylacetylene to form either the Ru-acetylide or Ru-di(acetylide) 40 
respectively. The authors indicate that the first step in the mechanism of bond activation 
is likely the reversible dissociation of the hydroxide to give a metal
+
/OH
-
 ion pair. In the 
case of addition of a weak acid (X-H), the initial ion pair formation is followed by 
oxidative addition of X-H and concomitant removal of a hydride by the (OH)
-
 to give 
M-X.
53
  
 
Scheme 1.12. Preparation of Ru-hydroxides by O-insertion of N2O
53
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 Group 10 metal hydroxides have been proposed as intermediates in several 
catalytic cycles and a number of these have been prepared synthetically. Nickel tends to 
form bridged complexes very easily and hence, most of the hydroxide complexes of Ni 
tend to be multi-metallic in nature.
12
 Pd(II) complexes have been isolated as bridged 
dimers, such as [Pd(Ar)(L)(µ-OH)]2 (L = tertiary phosphine)
54
 and the NHC-bearing 
[Pd(η3-allyl)(NHC)(µ-OH)]2 42 reported by our group (Scheme 1.13).
55
 Complex 42 
was used as a precatalyst in Buchwald-Hartwig aryl amination and Suzuki-Miyaura 
coupling, providing evidence that Pd-OH complexes may act as intermediates in the 
generation of catalytically active Pd(0) species from Pd(II)-Cl precatalysts.
55
 This report 
supported the mechanistic study by Carrow and Hartwig,
56
 on the transmetalation step 
of the Suzuki-Miyaura reaction which identified Pd-OH as the active species that 
undergoes transmetalation with arylboronic acids and not the Pd-halide precatalyst. In 
contrast to the lighter members of the group, platinum is able to form monomeric 
hydroxides of Pt(II) or Pt(IV) by oxidative addition reactions with H2O.
57
 
 
Scheme 1.13 Preparation of Pd(II)(NHC) hydroxide by salt metathesis
55
 
Takemoto and Grushin
58
 have isolated a monomeric Pd(II)-hydroxide in the form 
of [Pd(dppp)(OH)(Ph)] 44 by reaction of the Pd dimer 43 with 2 equivalents of the 
bisphosphine ligand (bis(diphenylphosphino)propane, dppp, Scheme 1.14). Using 
complex 44, the authors reported the first palladation of fluoroform (HCF3) to give Pd-
CF3 complex 45. The reaction is driven by Lewis base assisted H-bonding between the 
HCF3 and the hydroxyl moiety, with the most effective Lewis base being 
n
Bu3P. 
Fluoroform is a side product of the fluoropolymer industry, which generates more than 
20 ktonnes annually.
59
 Although it is non-toxic, the large scale release of HCF3 into the 
atmosphere has raised environmental concerns due to its green-house effect. HCF3 has a 
long atmospheric lifetime (>250 years)
60
 and it has a global warming potential 
calculated at >10,000 times higher than that of CO2.
59
 As a result, waste streams cannot 
be released into the atmosphere and must be destroyed. The incineration of HCF3 is very 
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energy inefficient since it acts as a flame retardant and hence, the use of HCF3 as a 
feedstock is a much more desirable approach than its destruction.
58
 Palladium 
complexes dominate the field of trifluoromethylation catalysis
61
 and therefore, the 
activation of HCF3 by Pd(II)-OH was a very important break-through for the field. The 
preparation of CF3 complexes will be dealt with in more detail in Chapter 6.  
 
Scheme 1.14. C-H activation of HCF3 by Pd(II)-hydroxide
58
 
Monomeric linear hydroxide complexes of the coinage metals were the first metal 
hydroxides to be developed in our group.
62
 Mechanistic investigations into gold-
mediated transformations in the presence of water implicated [Au(IPr)(OH)] 48 (IPr = 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene) as an important intermediate and 
furthermore, described 48 as being very stable. Treatment of [Au(IPr)Cl] (46) with 
KOH led to the isolation of [Au(IPr)(OH)] (48) as a stable complex (Scheme 1.15) and 
[Cu(IPr)(OH)] (49) was later prepared in the same way from the corresponding Cu-
chloride 47. Both 48 and 49 proved to be valuable synthons for selective X-H bond 
activation via deprotonation of a wide range of organic substrates, including sp, sp
2
 and 
sp
3
-hybridised C-H bonds to give a plethora of new Au(I) and Cu(I) species (Scheme 
1.15).
 34a, 34d, 35 
The Cu(I)-hydroxide 49 was also able to cleave Si-N and Si-C bonds to 
give cyano- and silyl-copper complexes. Complex 49 is able to deprotonate a Mo 
complex in the form of [Mo(CO)3Cp(H)] to give a heterobimetallic Cu-Mo complex. A 
number of alcohols, HNTf2, p-thiocresol, fluorinated arenes and even HPPh2 were all 
activated by Cu(I)-hydroxide 49 (Scheme 1.15). These reports demonstrated the breadth 
of appreciable reactivity that can be achieved by metal hydroxides, stabilised by suitable 
supporting ligands.
63
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Scheme 1.15. Preparation of Cu(I) and Au(I)-hydroxides and representative examples of bond 
activation (deprotonation) reactions by these complexes.
62a, 62d
 
The gold hydroxide 48 reacts with a wide range of acetylene compounds, both 
terminal and internal to give Au(I)-acetylide complexes and in the case of 
triethynylbenzene, a (Au)3-acetylide species was generated.
64
 The hydroxide moiety on 
48 was found to facilitate transmetalation with boronic acids, giving swift access to an 
array of Au(I)-aryl complexes 50 (Scheme 1.16).
65
 The Au(I)-aryl complexes 50 can 
also be accessed via the decarboxylation of carboxylic acids in the presence of 48.
66
  
 
Scheme 1.16. Preparation of Au(I)-aryl complexes from Au(I)-hydroxide
65-66
 
[Au(IPr)(OH)] (48) has been used as a catalyst for the solvent-free polymerisation 
of rac-β-butyrolactone to biodegradable polymers,67 and in 2010 Boogaerts and Nolan 
reported that 48 promoted the regioselective carboxylation of aromatic C-H bonds under 
CO2 (1.5 bar).
62b
 [Cu(IPr)(OH)] (49) was later shown to catalyse the same reaction, as 
well as the N-H carboxylation of various nitrogen heterocycles (Scheme 1.17).
62e
  
 
Scheme 1.17. Regioselective carboxylation of C-H and N-H bonds using Au(I) and Cu(I) 
hydroxides
62b, 62e
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 The Nolan group has also reported the synthesis of a di-gold complex bearing a 
bridging hydroxide [{Au(IPr)}2(µ-OH)]BF4 (51) via several routes from either the Au 
chloride 46 and AgBF4 or the Au hydroxide 48 in the presence of HBF4.
68
 For example, 
an aqueous based methodology allowed preparation of a number of the diaurated 
species, bearing different NHCs (scheme 1.18).
69
 These interesting complexes have 
provided rich chemistry and proven to be highly active as catalysts in a number of 
water-inclusive transformations, including alkyne and nitrile hydration and Meyer-
Schuster rearrangement
69
 and have even provided access to aryl vinyl ethers by 
hydrophenoxylation of alkynes under very mild conditions.
70
  
 
Scheme 1.18. Preparation of digold hydroxides from the Au chloride
69
 
There is a common theme to all of the work described on LTM hydroxides by the 
Nolan group. In all of these reports, the metal hydroxides have been isolated with the 
assistance of NHC groups as ancillary ligands. As mentioned, the stabilisation of the 
HSAB mismatching metal hydroxide pair by attachment of an NHC is counter intuitive, 
yet the enhanced stability of metal NHC complexes has provided access to a number of 
stable LTM-hydroxides and allowed our group to pursue some very fascinating 
chemistry. 
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1.2. N-HETEROCYCLIC CARBENES (NHCS) 
The supporting or ancillary ligands bound to an organometallic complex have a 
direct effect on the stability and reactivity of the complex. Therefore, it is important that 
the ancillary ligands can be tailored to some extent to suit the function of a particular 
organometallic complex. Three classes of ligands exist that can be tailored both 
sterically and electronically for broad use on late transition-metals. The traditional 
phosphines (PR3) and cyclopentadienyls (C5R5) have been used extensively in 
organometallic chemistry and modification of their substituents allows for adjustment of 
both steric and electronic characteristics. However, in most cases the two characteristics 
cannot be altered independently.
71
  
The third class of ‘tuneable’ spectator ligands are the carbenes, compounds 
containing a 6-electron divalent carbon centre.
72
 More specifically, N-heterocyclic 
carbenes (NHCs) are cyclic carbenes containing at least one α-amino substituent.72-73 
The α-amino substituents play an important role in stabilising the ground state 
multiplicity of the carbene via cooperative inductive and mesomeric roles. Their σ-
withdrawing character stabilises the formally sp
2
-hybridised non-bonding lone pair, 
while π-donation of the α-amino lone pairs into the vacant p-orbitals destabilises them. 
The result is a polarised four-electron three-centre π-system with some multiple bond 
character at the carbene carbon and hence the existence of a zwitterionic type structure 
with the negative charge localised at the carbon. This ensures that electronuetrality at 
the carbene centre is maintained and renders the singlet state dominant.
74
 Although 
NHCs are very different to phosphines in terms of electronics and spatial arrangement 
(and hence steric impact), they both contain a non-bonding singlet lone pair and act as 
two electron donors.
74
 As a result, the two ligand classes are comparable as supporting 
ligands and in the early years of NHC explorations, they were often termed as 
phosphine mimics. 
NHCs may consist of three-, four-, five- or even seven-membered heterocycles. 
The most commonly utilised NHCs are the five-membered imidazol-2-ylidenes NHC-1, 
imidazolin-2-ylidines NHC-2, benzimidazol-2-ylidines NHC-3 and triazol-2-ylidines 
NHC-4 (Figure 1.1).  
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Figure 1.1. Common five-membered NHCs.
75
  
Early fundamental work on NHCs was reported by Wanzlick
76
 and Öfele
77
 in the 
1960s, who independently isolated the first metal-NHC complexes. Both procedures 
involved the deprotonation of an imidazolium salt (52 and 53) to afford the imidazol-2-
ylidine complexes of chromium 54 and mercury 55 as shown in Scheme 1.19. This 
methodology was later extended by Lappert to include complexes of the saturated 
imidazolin-2-ylidines (of the type NHC-2).
78
  
 
Scheme 1.19. Preparation of the first metal-NHC complexes by Öfele
77
 and Wanzlick
76
 
 Arguably the most important breakthrough in NHC investigations came in 1991, 
when Arduengo
79
 isolated the first free carbene, 1,3-bisadamantylimidazol-2-ylidene 
(IAd) via deprotonation of the corresponding imidazolium chloride salt. This was later 
followed by isolation of the p-tolyl and mesityl analogues (ITol and IMes, Figure 1.2).
80
 
The isolation of ‘free’ carbenes and the discovery that they could be handled and stored 
under inert atmospheres enabled the direct preparation of metal-NHC complexes, and 
triggered explorations into NHC coordination chemistry and their utility as ancillary 
ligands.
73
 The potential of NHC compounds as supporting ligands was realised by 
Herrmann,
81
 Enders,
82
 and Dixneuf,
83
 who capitalised on their unique properties, 
transforming them from ‘mere laboratory curiosities’ into a class of highly versatile 
supporting ligands for homogeneous catalysis, with a range of applications, comparable 
to the established cyclopentadienyl and phosphine ligands.
71, 73
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Figure 1.2. First reported free NHCs: Arduengo’s imidazol-2-ylidenes.79-80  
The application of NHCs as supporting ligands has led to improved reactivity in a 
wide range of reactions, with the impact being perhaps most prolific in the fields of 
ruthenium catalysed olefin metathesis
1
 and palladium catalysed cross couplings.
2
 More 
recently, gold chemistry has flourished; and its growth has a lot to do with the 
employment of NHC ligands in stabilising Au complexes and the elucidation of 
straight-forward synthetic routes to Au(I)-NHC complexes.
84
 The success of NHCs as 
ligands in catalysis is often attributed to their powerful σ-electron donating ability, 
enabling the formation of strong metal-carbene bonds.
85
 In comparisons between NHCs 
and phosphines, the superior σ-donation of NHCs is often noted.71, 81a, 81c, 86 NHCs are 
powerful σ-donor nucleophiles with comparatively low π-acidity, typically forming 
strong metal-carbon bonds with high dissociation energies that are chemically and 
thermodynamically more inert to cleavage than metal-phosphine bonds.
87
 This concept 
was proven by Huang and Nolan, who performed calorimetric studies on a series of 
[RuClCp*(L)] complexes (L = PR3 or NHC). The authors reported that, with the 
exception of IAd, ligand substitution reactions on the Ru complexes were more 
exothermic (higher bond dissociation enthalpies) for NHC ligands (5 entries) than for 
PCy3 or P
i
Pr3,
88
 It was originally thought that strong metal-NHC bonds were a result of 
essentially pure σ-bonds between the metal and the NHC,81a, 87 however, studies have 
provided evidence to the contrary. In particular, a study by Cavallo and co-workers on a 
series of NHC complexes showed that the M-carbene bond cannot be considered as 
purely σ in nature. Even in the case of d0 systems, there is a considerable amount of π-
bonding (ca. 10%) that contributes to the overall orbital interaction. In systems with a 
low d-electron count, both π-bonding and π-back bonding have a significant 
contribution to the overall π-bond. However, as the d-electron count increases across a 
series, π-back bonding becomes more dominant, ranging from ca. 65% of the total π-
bond in d
0
 systems to as high as 90% for d
10
 systems.
89
 
The difference in shape and connectivity of NHC ligands compared to phosphines 
and cyclopentadienyls has a direct impact on steric and electronic characteristics. For 
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example, in the latter two classes, the ligands can be thought of as ‘cone shaped,’ 
particularly the phosphines, with their substituents bonded directly to the donor atoms 
and generally pointing away from the metal (B and C, Figure 1.3). NHC ligands on the 
other hand are ‘fan shaped,’ with the N-substituents pointing towards the metal and 
separated from the donor atom by two bonds (C, Figure 1.3). This has the implication 
that substituent alterations on phosphines or cyclopentadienyls normally affects both the 
steric and electronic characteristics of the ligand, which often cannot be varied 
independently. Alterations to the N-substituents on NHCs, on the other hand have a 
much larger effect on the steric nature of the ligand than the electronic character. 
Significant electronic alterations are often effected by making structural changes within 
the azole ring itself, particularly on the carbon backbone.
71, 90
  
 
Figure 1.3. Spatial representation of typical cyclopentadienyl (A), phosphine (B) and NHC (C) 
ligands.
71
 
The ability to alter the steric and electronic properties of NHC ligands 
independently makes them very versatile as supporting ligands and the ease with which 
specific properties can be tailored to fit particular catalytic applications has been 
documented in several articles.
3b, 90b, 90c, 91
 The electronic character of NHCs varies 
much less than for example, a series of phosphines; however, the establishment of a 
reliable method for the quantification of ligand electron-donation, via calculation of the 
Tolman electronic parameter (TEP)
92
 has enabled targeted ligand architecture, leading 
to an expansion of the NHC library with significantly divergent electronic 
characteristics.
86a
  
The TEP method was originally designed to quantify the electronic properties of 
tertiary phosphine ligands but is useful for most two electron donor ligands and has 
become a widely accepted method of electronic quantification.
86a, 93
 When a ligand (L) 
is coordinated to Ni in [Ni(CO)3L], σ-electron donation from L increases electron 
density at the metal and hence strengthens the π-back donation from Ni into the π*CO 
anti-bonding orbital. The stronger the π-donation is from the metal, the weaker the triple 
bond between C and O will be in the carbonyl ligand. Hence, the electronic character of 
the ligand L can be inferred from the A1 vibrational frequency of CO in an IR spectrum 
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of [Ni(CO)3L]. The TEP is the frequency of A1 and is directly proportional to the σ-
donating character of L, hence, the more σ-donating L is, the lower the TEP will be.93a  
Although this method was established using Ni, the precursor [Ni(CO)4] is 
extremely toxic. Complexes of the type [MCl(CO)2L] (M = Rh/Ir) are much easier and 
safer to access. The corresponding [MCl(cod)L] complexes are reacted with CO to give 
[MCl(CO)2L], with the two CO ligands arranged cis to each other. Hence, the average 
of the two carbonyl stretching vibrations is used to calculate TEP and several 
researchers have worked to develop equations to correlate the values obtained from Rh 
or Ir systems to TEP values calculated for the parent [Ni(CO3)L] system.
86a, 93a, 94
  
As previously mentioned, the steric bulk of the NHC can have a profound effect 
on the stability and activity of a metal complex to which it is bound. For example, Maj 
and co-workers reported that catalysts bearing various alkyl substituted NHCs were 
inactive in the polymerisation of cyclooctene, whereas those bearing aryl-substituted 
NHCs were active as long as the ortho positions were blocked by alkyl groups, avoiding 
ortho-metalation.
95
 In order to compare the steric bulk of different NHCs, the well-
established Tolman cone angle
92
 was inadequate since the NHC is not cone-shaped. In 
order to provide a method of quantifying steric demand within the metal sphere, Nolan, 
Cavallo and their co-workers developed the concept of buried volume (%VBur) which is 
suitable for calculating the steric influence of a wide array of ligands. Buried volume 
relies on the ability to generate a well-defined sphere around the metal, either by 
obtaining a crystal structure of the complex or by theoretical calculations. The %VBur 
refers to the percentage of a sphere (with a radius r) that is occupied by atoms of a 
ligand of interest.
96
 The %VBur is strongly dependent on the nature of the complex and 
the parameters used.
97
 It also does not account for ligand flexibility in solution
98
 and 
hence, it provides only a semi-quantitative comparison of the steric demand of the 
ligand. However, comparison of bond dissociation energies (BDE’s) have clearly 
illustrated a correlation between M-L bond distances and %VBur.
99
 More recently, this 
concept has been elaborated to include a method of mapping the steric bulk within the 
coordination sphere in 3 dimensions, giving further insight into the spatial arrangement 
of a ligand.
98
 
There are a variety of synthetic routes for the preparation of NHCs and their 
precursors. The most commonly employed methods target the deprotonation of azolium 
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salts, while alternatives often involve reductive desulfurisation of thioureas or α-
elimination of small molecules.
100
 NHC precursors are made up of three distinct 
subunits: the backbone functionality, the pre-carbenic unit and the amino unit (Figure 
1.4). Whichever route is used to access the NHC precursor, whether via an azolium salt 
or a thiourea, the critical step in the synthesis is most often the cyclisation event, either 
by introduction of the precarbenic unit, linkage of the backbone to the preassembled 
precarbenic and amino units, or ring closure by introduction of the amino moiety.
100
 The 
high demand for NHC precursors has meant that many of the imidazolium salts have 
become commercially available and their syntheses are scalable to kilogram batches. 
 
Figure 1.4. Simplified imidazolium unit 
NHC complexes of almost every metal in the periodic table are now known. Most 
synthetic protocols can be divided into three main categories: (i) in situ deprotonation of 
ligand precursors; (ii) complexation of free carbenes; and (iii) cleavage of electron rich 
olefins. The main complexation methods will be discussed in the next section, with 
particular attention being paid to examples of rhodium and iridium wherever possible. 
1.2.1. NHC complexation 
1.2.1.1. In situ deprotonation of ligand precursors 
These routes are particularly useful when the corresponding carbenes are unstable 
or difficult to handle, since the free NHC does not need to be isolated.
87
 
1.2.1.1.1. Deprotonation by basic metalates 
Although this route is limited by the nature and oxidation state of the metal, 
azolium cations can be deprotonated by Brønsted basic metalate anions upon heating, 
with the metal of the base acting as the ligand acceptor. This method was the first NHC 
coordination method described by Öfele
77
 to prepare [Cr(CO)5(NHC)] 54 (Scheme 
1.19). 
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1.2.1.1.2. Deprotonation by basic anions 
 Brønsted basic anions of the azolium salt or attached to the metal precursor can 
deprotonate the azolium salt in situ to give the desired NHC. Wanzlick used this 
strategy to prepare his mercury bis-NHC complex 55 (Scheme 1.19) and the method 
was utilised extensively before the isolation of free carbenes was first reported.
76
 This 
method is still valuable in some cases, for example, Rh and Ir(µ-alkoxo) complexes 56 
can be easily prepared by adding [M(cod)Cl]2 (M = Rh 12a, Ir 12b) to an alcohol 
solution of a metal alkoxide. The µ-alkoxo ligand then acts as an internal base, 
deprotonating the imidazolium salt at room temperature to generate either monomeric 
metal-NHCs [M(cod)(NHC)X] (57), or bis-NHC complexes [M(cod)(NHC)2]X (58) 
depending on the NHC and the conditions employed (Scheme 1.20).
81d, 101
  
 
Scheme 1.20. Deprotonation by basic anions
81d, 101
 
Silver(I) oxide is also a good precursor for this route, deprotonating imidazolium 
salts to give bis-NHC Ag(I) complexes which provide valuable transmetallation 
reagents, see section 1.2.1.4 (Scheme 1.21).
102
 
 
Scheme 1.21. Deprotonation of imidaxolium salts using Ag2O
103
 
1.2.1.1.3. Deprotonation by an external base 
External bases can be added to deprotonate azolium salts and will often lead to 
different products compared to the use of metal salts with basic anions. For example, 
lithium alkoxides or a combination of a potassium alkoxide and sodium hydride can 
deprotonate imidazolium salts in situ.
104
 Triethylamine (NEt3) in THF can also be used 
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as an external base for in situ deprotonation of triazolium salts, as shown in Scheme 
1.22. The perchlorate salt 60 is deprotonated to give the corresponding free carbene, 
coordination to Rh and concomitant ortho-metalation on the phenyl group leads to 
[RhCl(Cp*)(NHC)] (62).
105
 
 
Scheme 1.22. Preparation of ortho-metalated Rh(III)-complexes via in-situ deprotonation
105
 
1.2.1.1.4. Small molecule elimination from neutral ligand 
precursors 
Imidazolium salts, when reacted with a metal alcoholate such as KO
t
Bu will either 
be deprotonated or transformed into an alkoxy imidazolidine 63 as in Scheme 1.23.
82a, 
101b, 106
 The alcoholate 63 is able to release the alcohol thermally to give the free NHC in 
situ.  
 
Scheme 1.23. Small molecule activation route via alcoholate precursor
101b, 106
 
NHC-CO2 adducts can be prepared by bubbling CO2 through a solution of the 
imidazolium salt in the presence of a base such as potassium hexamethyldisilizane 
(KHMDS) or KO
t
Bu (Scheme 1.24). The resultant CO2 adducts (65) are stable 
zwitterions that can be stored under air for long periods of time but will release CO2 
when heated with metal precursors such as [RuCl2(p-cymene)]2 or [Rh(cod)Cl]2 12a to 
generate the corresponding metal-NHC complexes.
107
 
 
Scheme 1.24. Preparation of CO2-imidazolium adducts
107
 
  
Chapter 1: Introduction 
 
22 
 
1.2.1.2. The free NHC route 
Isolation of stable free NHCs by Arduengo
79
 (Figure 1.2) meant that they could be 
directly coordinated to metal complexes. The advantage of this approach is that metal 
precursors with varying oxidation states and ligand spheres can be utilised. Imidazolium 
salts can be deprotonated to form free NHCs by bases such as NaH or KO
t
Bu in THF
79-
80
 or by NaH in liquid ammonia (Scheme 1.25).
81d, 108
 Methylene bridged bis-
imidazolium salts can be deprotonated by KHMDS and coordination gives complexes 
such as 64,
109
 while cyclic thioureas such as 1,3,4,5-tetramethylimidazole-2(3H)-thione 
can be converted to free NHCs by elemental Na or K.
110
 The isolation of free NHCs has 
provided access to a wide range of metal-NHC complexes. The disadvantage of 
isolating free carbenes is that they are sensitive to air and moisture and need to be 
handled under an inert atmosphere and are often thermally unstable.
87
  
1.2.1.2.1. Dimer cleavage 
 Dimeric complexes with bridging halides, acetonitrile groups or CO ligands can 
be fragmented by nucleophilic NHCs. For example, Scheme 1.25 shows the dimer 
cleavage of [M(cod)Cl]2 (12) to give monomeric metal-NHC complexes of the type (57-
Cl).
101b
 NHCs with a small steric demand (for example when R = Me, Cy or 
i
Pr) may 
form bis-NHC complexes (66).
81d
 
 
Scheme 1.25. Free NHC route with metal dimer cleavage
81d, 87
 
1.2.1.2.2. Ligand exchange 
 Phosphines have relatively low dissociation energies and can be exchanged 
easily on metal complexes. In many cases this route leads to mixed NHC-phosphine 
systems.
87
 For example, a phosphine on Wilkinson’s catalyst (27) can be replaced by 
reaction with a free NHC such as IMes to give [RhCl(IMes)(PPh3)2] 66 (Scheme 
1.26).
111
 Other ligands, such as CO or cod can be substituted by NHCs on homoleptic 
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complexes such as [Cr(CO)6], [W(CO)6], [Fe(CO)5], [Ni(CO)4],
87, 108
 [Ni(cod)2] or 
[Pt(cod)2].
112
  
  
Scheme 1.26. Phosphine substitution on Wilkinson’s catalyst 27 to give a mixed NHC-
phosphine system
111
 
1.2.1.3. Olefin Cleavage 
Electron-rich olefins are nucleophilic and can be cleaved thermally by transition-
metal complexes. There are various methods for the dimerisation of non-stable NHCs to 
form tetraaminoethylenes (or enetetramines).
87
 For example, the benzimidazolin-2-
ylidene complex 69 can be prepared from the corresponding enetetramine 68 and 
[Rh(cod)Cl]2 (12a) in refluxing toluene (Scheme 1.27).
113
 
 
Scheme 1.27. Olefin cleavage of an enetramine by [Rh(cod)(Cl]2 (12a)
113
 
1.2.1.4. Ligand transfer reactions 
NHC ligands can be transferred intermolecularly from one metal to another. For 
example, NHC complexes of Cr, Mo, and W have been reported to transfer NHCs to 
Rh(I), Pd(II), Pt(II), Cu(I), Ag(I) and Au(I).
114
 Ag(I)-NHC or Cu(I)-NHC complexes 
prepared from Ag(I) or Cu(I) via basic anion deprotonation act as excellent ligand 
transfer agents as they are prepared directly from the imidazolium salts. This method is 
useful for the transfer of NHCs to a number of metal complexes. For example, in the 
case of Ir, the unwanted dicoordination of small NHCs can be avoided by 
transmetallation with Ag (Scheme 1.21),
102-103
 while Cazin and co-workers have shown 
that [Cu(NHC)Cl] (47) efficiently transfers NHC ligands to Pd or Au.
115
 
1.2.2. Rhodium and iridium NHC complexes 
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 Rhodium and iridium are two of the rarest elements on earth. This combined 
with their widespread use makes them very expensive transition metals. However, the 
chemistry of these metals is unique and worthy of investigation. Rh- and Ir-NHC 
investigations have experienced an exponential growth over the last three decades and 
the complexes described in this section and their uses in catalysis and organometallic 
synthesis by no means constitute a thorough account. This section will merely provide 
representative examples of the rich and diverse chemistry that these motifs have grown 
to encompass.  
1.2.2.1. Rhodium NHC complexes 
Rhodium, along with palladium and nickel dominates the field of LTM-NHC 
catalysis in terms of the number of published reports. The number of isolated Rh-NHC 
complexes is large and continues to grow. Their uses outside of catalysis are numerous, 
and even include a limited number of biochemical applications.
116
 The coordination of 
NHC ligands to Rh has been documented extensively for the quantification of electronic 
ligand parameters by the TEP method.
86a, 93a
  
 In addition to showing complementary reactivity to other metals, rhodium has 
delivered new reactivity and holds the potential for development of more 
environmentally friendly processes due to its insensitivity to water. This has enabled the 
utilisation of H2O as either a proton
 
source or as a solvent, for example, where 
hydrolysis is important in preparing new organic compounds.
117
 Rh typically adopts the 
+1 or +3 oxidation state within a catalytic cycle and there is unique chemistry 
associated with each oxidation state.
117
 For the purpose of this investigation, focus will 
be concentrated more heavily on Rh(I) complexes. 
The first report of an LTM-NHC complex as an efficient catalyst was with rhodium 
in the form of [Rh(cod)(IMe)Cl] 70 (IMe = dimethyl(imidazolin-2-ylidene), which was 
used as an efficient hydrosilylation catalyst.
118
 Since the mid 1990’s, Rh-NHC 
complexes have featured extensively as homogeneous catalysts, promoting several 
transformations including but not limited to arylation, hydrosilylation, conjugate 
addition, hydroformylation and a number of cyclisations.
84, 119
  
1.2.2.1.1. Arylation with organoboron reagents  
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The addition of organoboron reagents to carbonyl compounds or α,β-unsaturated 
ketones is typically catalysed by rhodium complexes bearing phosphine or diene based 
ligands. As such, these transformations, along with hydrosilylation and hydrogenation 
reactions have been some of the most heavily investigated transformations promoted by 
Rh-NHC catalysts.
119
 The Rh-catalysed addition of boronic acids to aldehydes to give 
diarylmethanol compounds was first discovered by Miyaura in 1998.
120
 Fürstner 
improved the method by using monodentate imidazolium salts with Rh, the best results 
being obtained with IPr·HCl and RhCl3·3H2O (1.0 mol% each). This allowed for the 
arylation of a range of aryl and alkyl aldehydes, while vinyl boronic acids were used to 
give allylic alcohols.
121
 Following this report, a number of Rh-NHC complexes were 
reported in addition reactions. Particularly, complexes of the type [Rh(cod)(NHC)Cl] 
have proven to be active precatalysts in the addition of arylboronic acids to 
benzaldehydes (Eq. 1, Figure 1.5). These complexes (71) have varied from those 
bearing five membered imidazol-2-ylidenes (NHC-1) such as 57a-Cl,
122
 imidazolin-2-
ylidines (NHC-2),
123
 benzimidazol-2-ylidenes 
124
 and the perhydrobenzimidazol-2-
ylidenes 
125
 (Figure 1.5); one of the most active catalysts to date for this transformation 
is that bearing the 6-membered tetrahydropyrimidin-2-ylidene on 73, Figure 1.5.
126
  
 
Figure 1.5. Arylation of aldehydes using [Rh(cod)(NHC)X] complexes 
 Although Rh complexes have been very successful in the conjugate addition of 
boronic acids to α,β-unsaturated ketones, there are relatively few reports of Rh-NHC 
complexes catalysing this reaction, which will be dealt with in detail in Chapter 2.  
1.2.2.1.2. Hydrosilylation 
Hydrosilylation reactions as a whole, constitute one of the most extensively 
studied transformations using Rh-NHC complexes.
84
 The hydrosilylation of alkenes, 
alkynes, carbonyls and imines have all been catalysed by Rh-NHC complexes in both 
racemic and asymmetric fashions. The first report of an NHC complex performing 
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asymmetric catalysis was the hydrosilylation of acetophenone by diphenylsilane, in the 
presence of a napthyl-derived NHC complex 74 (Scheme 1.28). 
127
  
 
Scheme 1.28. Assymetric hydrosilylation of acetophenone
127
 
Polydentate NHC ligands have been used extensively in the hydrosilylation of 
carbonyl compounds. In particular, Gade and co-workers have reported using oxazoline-
based NHCs to reduce aryl and alkyl ketones.
128
 There are many variations, particularly 
of the [Rh(cod)(NHC)Cl] scaffold reported in the literature that have been used in 
carbonyl hydrosilylation.
84
 Alkene and alkyne hydrosilylation by comparison have been 
investigated much less using NHC complexes and these complexes will be discussed in 
Chapter 3. Recently, Oro et al.
129
 developed a method for the preparation of dimeric 
[Rh(NHC)(coe)(µ-OH)]2 (75, NHC = IPr or IMes, coe = cis-cyclooctene). The authors 
showed that the complexes were very efficient in the hydrothiolation of alkynes to give 
α-vinyl sulphides with high selectivity.  
1.2.2.1.3. Hydroformylation 
The hydroformylation of alkenes (Eq. 2) is one of the largest homogeneous 
industrial processes by volume.
130
 Reactions have historically been dominated by 
phosphine based systems such as Wilkinson’s catalyst (27) and therefore, a number of 
Rh-NHC complexes have been tested in hydroformylation, particularly variants of the 
[Rh(cod)(NHC)X] (57a) framework.
119,11184
 Crudden and co-workers reported the first 
Rh-NHC catalysed hydroformylation of various styrene derivatives in high yield and 
selectivity towards branched products using Wilkinson analogues [RhCl(IMes)(PPh3)L] 
(67: L = PPh3, 76: L = CO, Figure 1.6).
111a, 131
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Figure 1.6. Rh(I)-NHC complexes tested in hydroformylation reactions
119
 
Bimetallic complexes (77) were tested by Peris and Fernandez
132
 in the 
hydroformylation of alkyl and aryl alkenes, showing high selectivity for the branched 
products. Buchmeiser
133
 has investigated the use of tetrahydropyrimidinylidene systems 
such as 73 and Weberskich has tested several tetrazole-based systems, with one of the 
most active catalysts to date being 78, boasting TOFs of up to 3540 h
-1
.
134
 The halide- 
and cod-free complexes such as 79 and 80, coordinated to the bulky IPr ligand, also 
showed high activity in hydroformylation reactions. The steric bulk of IPr was reported 
to hinder detrimental isomerisation reactions on the product.
135
 Danopoulos and co-
workers have also reported hydroformylation using NHC-indenyl chelate ligands which 
showed weak activity in both the hydroformylation of 1-octene and in the carbonylation 
of methanol.
136
 
1.2.2.1.4. Hydrogenation 
Hydrogenation of unsaturated organic compounds is an important transformation, 
demonstrating ideal atom-economy. The first homogeneous catalyst to be developed for 
hydrogenation was Wilkinson’s catalyst (27).137 Wilkinson’s catalyst is active at room 
temperature under 1 atm of H2 and easily reduces monosubstituted and cis-disubstituted 
alkenes (e.g. cyclohexene).
138
 Previously mentioned [RhCl(IMes)(PPh3)2] (66) was 
designed as an analogue of Wilkinson’s catalyst (27) and hence, 66 and its analogues, 
with various phosphines have been tested extensively in hydrogenation reactions, 
particularly of olefins.
111a
 Although Nolan
139
 and Lebel
140
 have independently shown 66 
to be active in a number of hydrogenation and methenylation reactions, 66 and 
analogous complexes are often found to be less active than 27,
141
 requiring high 
temperatures and the addition of phosphine scavengers such as CuCl. The low activity 
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of 66 compared to Wilkinson’s catalyst (27) has been rationalised by comparing the 
phosphine dissociation rates between 66 and 27. For example, phosphine dissociation 
on 66 is 10 – 15 times slower than on Wilkinson’s catalyst. Since phosphine 
dissociation constitutes the essential activation step, slow dissociation has a detrimental 
effect on catalyst activity.
141-142
  
A number of monodentate and bidentate NHC ligands have been successfully 
deployed as supporting ligands for hydrogenation catalysts. The monodentate NHC 
complexes, particularly of the [Rh(cod)(NHC)Cl] (57a-Cl) type, tend to be sensitive to 
decomposition in the presence of H2 and phosphines can be added to avoid 
decomposition of the active species. For example, Herrmann and co-workers
111b
 have 
used 1,3-dicyclohexylimidazol-2-ylidene (ICy) derivatives (57a, 81 to 83, Figure 1.7) in 
the hydrogenation of aliphatic alkenes (Eq. 3, Figure 1.7). In their study, the phosphine-
free catalyst [Rh(cod)(ICy)Cl] 57a-Cl
ICy
 was prone to decomposition and only showed 
activity comparable to Wilkinson’s catalyst (27) when tertiary phosphines were added 
to the reaction mixture to provide a stabilising effect, presumably via formation of a 3-
coordinate [Rh(Cl)(ICy)(PR3)] species in situ. The best results were obtained using 
PPh3 (2 equiv.) in EtOH at 60 °C, H2 (20 bar). Phosphine dissociation plays an 
important role in this reaction and among the well-defined mixed NHC-phosphine 
systems, 82 was less active than 81 due to poor dissociation of the phosphite and further 
phosphine substitution by NHC as in 83 led to even lower catalytic activity.
111b
 
 
Figure 1.7. Rh-ICy complexes used in hydrogenation reactions
111b
 
1.2.2.2. Iridium NHC complexes  
Ir-NHC complexes display reactivity comparable to the analogous Rh complexes, 
favouring the +1 and +3 oxidation states. A large amount of catalysis with Ir has 
focused on reduction reactions, with Ir-hydrides as key intermediates.
84
 As with 
rhodium, many carbonyl-Ir-NHC complexes have been prepared in order to quantify 
Chapter 1: Introduction 
 
29 
 
electronic characteristics of various NHCs
103
 by the TEP method.
92
 The highly electron 
donating character of NHCs favours oxidative addition of C-H bonds involving the N-
substituents. Since the N-substituents typically point towards the metal, coordination of 
NHCs to iridium and rhodium has produced interesting cyclometalated complexes.
143
  
The most extensively studied process on iridium is C-H activation (both aromatic 
and aliphatic).
84
 For example, our group has described the cyclometalation process by 
intramolecular C-H activation when 1,3-di(tert-butyl)imidazol-2-ylidene (I
t
Bu) is 
coordinated to [M(coe)2(µ-Cl)]2 (M = Rh 84a, Ir 84b, Scheme 1.29).
144
 Halide 
abstraction using AgPF6 afforded isolation of the unusual 14 electron complexes 86a-b 
and the unusual stability of these electron deficient species was attributed to the high 
electron donor strength of the NHC. Furthermore, 86a and 86b could be reacted with H2 
to give the dihydride complexes 87a-b, which are stabilised by agostic interactions with 
the metal centre.
145
 Huang and Nolan have also shown that C-H activation of an ortho 
methyl group on IMes is possible on [RhCl(H)(IMes)(IMes’)].146  
 
Scheme 1.29. Cyclometalation processes resulting from bulky NHC ligands
144-145
 
Several intramolecular C-H activation processes on Ir(III) have also been studied, 
such as the cyclometalation events that take place on [Ir(Cp*)(NHC)] complexes 
reported by the groups of Peris and Yamaguchi (Scheme 1.30).
147
 The C-H activations 
were found to be very facile in each case and the selectivity towards aromatic or 
aliphatic C-H activation was highly dependent on the steric nature of the NHC ligand. 
For example, in a report by Peris, on complexes of the type 88, if R on the N-substituent 
(Scheme 1.30) is a proton then aromatic C-H activation occurs, leading to complex 89. 
If R is an alkyl group such as a methyl, then the resultant 
t
Bu group will be in closer 
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proximity to the metal centre and alkyl C-H activation will be favoured, giving 90.
147a
 
There are a number of different variations of intramolecular C-H activation involving 
these types of complexes and even examples where a basic functionality on the Cp 
ligand can act as a proton acceptor. For example, when 91 is reacted with AgOTf in 
acetonitrile, the cyclometalated carbene complex 92 is obtained. A proton on the 
ammonium moiety can be removed by reacting with KOMe to give the cationic tethered 
complex 93.
147d
 
 
Scheme 1.30. C-H activation of Ir(III)(NHC) complexes  
Polydentate NHC ligands have featured extensively on iridium, providing several 
different complexes where the topological properties of the ligand may be altered.
143
 
For example, chelate NHCs reported by Crabtree possess a methylene linker between 
the two imidazole units. The N-substituents in this case act as ‘wingtips’ and the steric 
bulk of the substituents may be tailored to switch the chelation on (94) or off (95, 
Scheme 1.31).
148
  
 
Scheme 1.31. Chelating NHCs and tailoring of steric bulk
148
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The chelate effect can also favour oxidative addition, for example, in a report by 
Mas-Marzá et al.,
149
 the authors showed how pyridine imidazolium salts (96) could be 
reacted with Rh or Ir dimers (12) and the chelate nature of the NHC lent itself towards 
C-H oxidative addition, leading in each case to a metal(III)-NHC hydride complex (97, 
Scheme 1.32). The C-H oxidative addition can be supressed by transferring the NHC 
via Ag(I), leading instead to Rh(I) or Ir(I) complexes (98). If the metal precursor is 
changed for [MCl(coe)2]2 (84) and reacted with the Ag-NHC in only 0.25 equiv. then 
metal(III)-bisNHC complexes are generated as shown (99).
149
 The broad versatility 
shown by this chelating NHC compound is very interesting and complexes 97 - 99 were 
tested in benchmark catalytic transformations, with the complexes of 98 both showing 
decent activity in the hydrosilylation of phenylacetylene but with poor selectivity. The 
cyclisation of acetylenic carboxylic acids was successful and the authors reported the 
first cyclisation of 4-pentynoic acid by an Ir complex, 98b.
149
 
 
Scheme 1.32. Coordination of pyridine imidazolium salts
149
 
1.2.2.3. Catalysis with Iridium NHC complexes 
1.2.2.3.1. Hydrogenation 
Following the development of Wilkinson’s catalyst, Osborn and Schrock 
investigated the use of cationic Rh complexes, with the aim of eliminating the 
phosphine dissociation step involved in the activation of Wilkinson’s catalyst (27). The 
cationic dihydride complexes proved to be very active in the reduction of alkynes to cis 
olefins and the reduction of dienes to monoenes.
150
 Following thorough investigation of 
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cationic Rh complexes, Osborn and co-workers investigated cationic Ir complexes as 
hydrogenation catalysts but apparent low activity meant that they were disfavoured over 
their Rh analogues. However, in 1977, Crabtree and co-workers
151
 reported that the use 
of non-coordinating solvents with [Ir(cod)(py)(PR3)]PF6 complexes enabled the 
dehydrogenation of highly substituted alkenes. The most active catalyst in this series 
became known as Crabtree’s catalyst, [Ir(cod)(py)(PCy3)]PF6 (100, Figure 1.8). 
Crabtree’s catalyst soon became the benchmark in hydrogenation reactions, able to 
dehydrogenate a range of substrates with varying degrees of substitution and 
unchallenged in the hydrogenation of tri- and tetra-substituted olefins. However, the 
Achilles’ heel of Crabtree’s catalyst is its stability under catalytic conditions, 100 
rapidly decomposes to irreversibly form inactive Ir-hydride clusters.
152
 In the hope of 
developing more thermally stable hydrogenation catalysts, Buriak
153
 and Nolan
154
 
investigated the use of NHC ligands to stabilise Crabtree’s catalyst. Lee and Nolan 
prepared the NHC (SIMes) analogue 101a (Figure 1.8) of Crabtree’s catalyst from 
[Ir(cod)py2]PF6.  
 
Figure 1.8. The development of Ir hydrogenation catalysts
153-154
  
Although 101a was less active than Crabtree’s catalyst (100) in the hydrogenation 
of simple olefins at room temperature under H2 (1 atm), 101a proved to have higher 
thermal stability than 100 and was still catalytically active under mild H2 pressure (60 
psi) at 50 °C.
154
 Buriak and co-workers investigated the effect of replacing the pyridine 
ligand with NHC ligands, rather than the phosphine (102, Figure 1.8). The authors 
reported that the mixed phosphine-NHC complexes showed comparable reactivity to 
100 in the hydrogenation of primary (1-octene) and secondary (cyclohexene) olefins 
and that 102 showed enhanced stability compared to 100. Hydrogenation reactions 
could be carried out in air, using reagent grade solvents.
153a
 Furthermore, the phosphine 
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complexes (102) out-performed the pyridine analogue 101 and the most active complex 
among them was that containing the IMe ligand and P(
n
Bu)3 (102d). The high steric 
bulk of IMes limited its coordination to complexes with smaller phosphine groups and 
102a showed high catalytic activity in the hydrogenation of unhindered alkenes but 
activity decreased with tertiary (1-methylcyclohexene) and quaternary (2,3-dimethyl-2-
butene) alkenes. Overall, catalytic activity of 102 was comparable to 100 at 1 mol% 
catalyst loading but with enhanced stability towards air and un-purified reagents. These 
catalyst systems were further developed by Buriak’s group, who in 2006 reported a 
highly active catalyst with reactivity surpassing even the state of the art, Crabtree’s 
catalyst (100). By replacing the NHC with a saturated version (SIMes) as Nolan and 
Lee
154
 had reported, and replacing the PF6
-
 counter ion with the non-coordinating 
tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (BARF), the resultant complex 103 
showed high reactivity in hydrogenation reactions, even with tri- and tetra substituted 
alkenes and remarkable longevity under catalytic conditions.
153b
  
Nilsson and co-workers have further proven the utility of this scaffold and shown 
that analogues of complex 103, bearing unsaturated NHCs are effective in a range of 
hydrogenation reactions, including the reduction of alkynes to alkenes.
155
 In the same 
year as Lee and Nolan published their investigations of 101a, Burgess and co-
workers
156
 reported the use of chiral chelating NHC ligands to prepare complexes of the 
type 104, which were able to hydrogenate aryl alkenes (Eq. 5, Figure 1.9) giving 
enantioselectivities up to 98%. 
 
Figure 1.9. Enantioselective hydrogenation using chiral NHC ligands
156
 
Transfer hydrogenation refers to hydrogenation by a hydrogen source other than 
molecular H2 and has typically been catalysed by Ru complexes,
157
 by Wilkinson’s 
catalyst (27) or by Crabtree’s catalyst (100). More recently, there have been several 
reports using NHC complexes of Rh and Ir, particularly in the reduction of imides, 
carbonyls and alkenes with isopropanol as the hydrogen donor (Eq. 6, Figure 1.10).
158
 
Our group
158
 reported the first active Ir-NHC catalysts in transfer hydrogenation. The 
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ICy analogue of Crabtree’s catalyst (101b, Figure 1.10) was very reactive in the 
reduction of ketones, and showed moderate activity in the transfer hydrogenation of 
olefins but was inactive in the reduction of imines or nitriles.
158
 The SIMes derivative 
101a (Figure 1.9) was also tested in transfer hydrogenation with simple olefins and was 
found to be comparable in activity to 100.
154
 The chelating Ir(III) complexes 94 
(particularly the neo-pentyl analogue, Scheme 1.31) were also active promoters of 
transfer hydrogenation, especially on ketones and to a lesser extent, aldehydes and 
imines.
159
  
 
Figure 1.10. Transfer hydrogenation 
1.2.2.3.2. C-H borylation 
The selective functionalisation of un-activated aryl C-H bonds constitutes one of 
the greatest challenges in C-H activation and much attention has been devoted to this 
problem. Aryl boronic esters provide valuable substrates for a number of reactions such 
as Suzuki-Miyaura cross-coupling, 1-2 and 1,4-addition to carbonyl compounds and 
oxidative aminations.
160
 Aryl boronates are widely available but their preparation is 
dependent on the availability of aryl halide starting materials. The direct borylation of 
arenes provides access to a wide array of aryl boronates via the reaction shown in Eq. 7, 
Figure 1.11. This reaction has been the subject of at least two decades of extensive 
research and there are several metals that are capable of catalysing the transformation, 
including Rh and Ir. The first Ir complexes to perform aryl borylation were Ir-Cp* 
complexes, but with low turn-over numbers. The introduction of phosphines and NHC 
ligands have led to successively higher activities and Herrmann and co-workers have 
studied various complexes of Ir(I) and Rh(I) for aryl borylation.
101b,101b, 160a
 For 
example, the authors prepared a large array of Rh and Ir complexes bearing different 
mono and bis NHC ligands, but in particular they tested varients of the three systems 
shown in Figure 1.11 in the C-H borylation of a number of arenes (including toluene 
and aryl halides). Under the conditions shown in Eq. 7, all five Ir catalysts gave between 
92% and 100% conversion for each arene, showing high chemo-selectivity with C-X 
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bonds not being attacked and high regio-selectivity with only one product in each case, 
while the analogous Rh-catalysts showed no activity at all. Cataltic activity, particularly 
of the most active species, 58b-TFA
Me
 was comparable to some of the most active 
catalysts previously reported such as the [Ir(cod)(µ-OMe)]2-dtpy system reported by 
Hartwig and Miyaura (dtpy = 4,4′-di-tert-butyl-2,2′-bipyridine).161 
 
Figure 1.11. Aryl C-H borylation with metal-NHC complexes
101b
 
Following this report, Herrmann and co-workers published a more exhaustive 
scope, testing the complexes shown in Figure 1.12 in the C-H borylation of arenes under 
microwave irradiation and several trends in reactivity were established. The mono-NHC 
complexes 57b-Cl showed lower stability under reaction conditions and as a result were 
much less active than the bis-NHC complexes (58b). The authors reported that catalytic 
activity increased with σ-donor strength and that the chelating NHCs delivered more 
active catalysts (105 and 107) than the non-chelating NHCs (57, 58 and 106) .
160a
 The 
length of the bridge between the two NHC fragments on 105 was important with the 
propylene bridge giving the best results, whereas a longer bridge led to steric hindrance 
at the coordination site and decreased catalytic activity. Furthermore, activity increased 
with growing basicity of the counter ion, with TFA giving the highest activity.
160a
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Figure 1.12. C-H borylation of arenes
160a
 
The catalytic application of Ir(III)(NHC) complexes has not been discussed here 
but is vast and in particular, complexes of the type [Ir(NHC)(Cp
*
)X2] have proven to be 
potent catalysts in several applications, including but not limited to deuteration of 
organic substrates,
147b
 dynamic kinetic resolution (DKR) of alcohols,
162
 and Oppenauer-
type oxidation of alcohols, where acetone is used as the oxidant.
163
 
Success within our group in the preparation of LTM-hydroxides, particularly on 
gold and copper led us to examine whether the scope could be extended to include 
hydroxide complexes of rhodium and iridium. The use of NHCs as supporting ligands is 
a fundamental strategy in our group and their employment was essential in the isolation 
of Au- and Cu-hydroxides. Hence, the fundamental aim of this project was to develop 
general synthetic methods for the preparation of Rh(I)- and Ir(I)-NHC hydroxides. Once 
a general synthesis for Rh(I)-NHC hydroxides was established we intended to test the 
catalytic capabilities of these new complexes in established organic transformations, 
particularly where Rh-hydroxides have been identified as key intermediates such as the 
conjugate addition of boronic acids to activated alkenes.  
Once the preparation of Rh(I)-hydroxides had been established, we endeavoured to 
extend the methodology to include Ir(I)-NHC hydroxides. Having accessed these 
complexes, our focus was to shift from catalysis to bond activation and small molecule 
activation. We aimed to explore the reactivity of Ir(I)-hydroxides towards a range of 
substrates in order to explore the benefit of using a metal-hydroxide motif. Furthermore, 
we aimed to explore reactivity with important molecules such as CO2. 
Chapter 1: Introduction 
 
37 
 
Finally we sought the development of general methods for the preparation of 
fluorinated Ir(I) and Rh(I)-NHC complexes. We aimed to prepare a range of complexes 
bearing fluoride, bifluoride and trifluoromethyl groups that may be useful in 
fluorination and trifluoromethylation chemistry. 
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2. WELL-DEFINED RHODIUM(I) HYDROXIDES AND THEIR 
ACTIVITY IN THE CONJUGATE ADDITION OF 
ARYLBORONIC ACIDS TO ACTIVATED ALKENES
2.1. INTRODUCTION 
An organic transformation that has benefited largely from rhodium catalysis is the 
conjugate addition of organometallic compounds to activated alkenes. Various metals, 
including copper and nickel have been used in combination with organometallic 
reagents such as Grignard’s, diorganozincs and organolithiums to prepare β-substituted 
carbonyls.
117
 However, these reagents are very sensitive to moisture and high 
temperatures and therefore require the employment of strictly anhydrous conditions at 
low temperatures.  
In 1997, Miyaura and co-workers provided an alternative method for the 
preparation of β-substituted carbonyls 3 by the addition of alkyl- and arylboronic acids 
2 to α,β-unsaturated ketones 1 in the presence of a rhodium catalyst (Scheme 2.1).164 
They reported that [Rh(acac)(CO)2] 4 with a variety of ligands, particularly 
biphosphines with large bite angles such as 1,3-Bis(diphenylphosphino)propane (dppp 
L1) could successfully catalyse conjugate addition in an aqueous medium.
164
 
 
Scheme 2.1. 1,4-Addition of aryl and alkenyl boronic acids to activated alkenes.
117, 164
 
Miyaura’s new method (Scheme 2.1) showed several advantages over previous 
techniques: (1) organoboronic acids are stable to oxygen and moisture as compared to 
other organometallic reagents employed, enabling the utilisation of protic and even 
aqueous solvent systems; (2) organoboronic acids are less reactive towards ketones in 
the absence of a catalyst than the organomagnesiums or organolithiums used thus far, 
eliminating unwanted 1,2-additions; (3) various alkenyl and aryl substituents can be 
introduced at the β-position. In contrast, there had not been any reports so far of 
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successful enantioselective introduction of sp
2
-hybridised
 
carbons, using copper-
catalysed methods.
165
  
In 1998, Hayashi reported the first asymmetric 1,4-adition of boronic acids 2 to 
activated alkenes 1 using [Rh(acac)(C2H4)] (5) and enantiopure (S)-BINAP ligand L2 
(Scheme 2.2).
166
 Hydrolytic deboronation was found to be a problematic side reaction 
under these conditions, overcome by the addition of a large excess of boronic acid 2. 
Hayashi’s method enabled the coupling of arylboronic acids substituted with both 
electron-withdrawing and electron-donating groups to both linear and cyclic α,β-
unsaturated ketones with very high ee (91-99%) . 
 
Scheme 2.2. Asymmetric 1,4-addition of aryl- and alkenylboronic acids to activated alkenes.
166
 
The development of catalytic methods for 1,4-addition was accelerated by the 
elucidation of the reaction mechanism by Hayashi and co-workers.
15
 By performing a 
series of stoichiometric reactions, they gained access to postulated reaction 
intermediates (Scheme 2.3).
15
 Hence, the square-planar Rh(I)-phenyl complex 8 was 
obtained by phenylation of the Rh-Cl bond in [RhCl(PPh3)((S)-BINAP] (7) and 
characterised by 
31
P NMR (Eq. 1, Scheme 2.3). Complex 8 was reacted with an excess 
of cyclohexen-2-one (1a) to give 3a (Eq. 2, Scheme 2.3)and when used as a catalyst, in 
the reaction between 1a and 2a, led to 3a in 94% yield and 98.6% ee (Eq. 3, Scheme 
2.3). The reactivity of 8 was comparable to that of [Rh(acac)(C2H4)2]/(S)-BINAP] 
(5/L2), implicating the Rh-phenyl complex 8 as a likely intermediate in the catalytic 
cycle.  
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Scheme 2.3. Reactions performed to elucidate the catalytic cycle by Hayashi.
15
 
In a stoichiometric reaction, 8 was reacted with tert-butyl vinyl ketone, and the 
transformation was monitored by 
31
P NMR. A new complex was observed and assigned 
as the oxa-π-allylrhodium intermediate 9 (Scheme 2.4). This assignment was supported 
by comparison of the 
31
P NMR spectrum with that of an independent allyl complex 
prepared from [RhCl(BINAP)]2 and a potassium enolate.
167
 In the last step, H2O was 
added to a solution containing the transient allyl species 9. A new rhodium complex was 
observed upon hydrolysis and assigned as the Rh-hydroxide dimer 10 (Scheme 2.4).
15
 
 
Scheme 2.4. Preparation of transient oxa-π-allyl complex and subsequent hydrolysis to the Rh-
hydroxide.
15
 
Upon addition of phenylboronic acid 2a to 10, a very fast transmetalation at room 
temperature afforded the Rh-phenyl compound 8. This was an important observation 
and upon further investigation, the authors reported that transmetalation with 10 was 
faster than with the analogous [Rh(acac)(BINAP)]2 (11). Furthermore, that reaction of 
10 with acetylacetone quickly afforded 11.  
To explain these results, Hayashi reported that the Rh(acac) complex (i) (Scheme 
2.5) in aqueous media would be converted to a Rh-hydroxide (ii) complex and that 
transmetalation with ii to give the Rh-phenyl complex (iii) is faster than with i (Scheme 
2.5). However, formation of ii is reversible, with reformation of Rh(acac) (i) having a 
detrimental effect on catalyst activity.  
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Scheme 2.5. Reversible in situ conversion of Rh(acac) (i) to Rh(OH) (ii) and comparative 
transmetalation to Rh-Ph (iii).
15
  
Based on these findings, the same group presented a new catalyst in the form of 
[Rh(BINAP)(OH)]2 (10), which was more active than the previously reported 
catalysts.
15
 The catalytic cycle, with the three key intermediates and the processes that 
lead to them are shown in Scheme 2.6. Hence, transmetalation between a Rh-hydroxide 
(ii) and phenylboronic acid 2a affords the Rh-phenyl intermediate (iii). Once iii has 
been formed, it may react with H2O to reform the Rh-hydroxide (ii) and benzene. 
Alternatively, an enone insertion into the Rh-phenyl bond will afford an oxa-π-allyl-
rhodium intermediate (iv). The cycle is completed by hydrolysis to give the conjugated 
product 3a and regenerate the Rh-hydroxide (ii), propagating the cycle.
15
  
 
Scheme 2.6. Catalytic cycle for 1,4-addition of arylboronic acids to α,β-unsaturated carbonyls.15 
The rate enhancement in the transmetalation shown by Rh-hydroxide complexes 
has been explained by considering the high oxophilicity of boron.
117
 In analysing the 
transmetalation studies between organoboranes and palladium(II) or platinum(II) by 
Suzuki
168
 and Venanzi
169
 respectively, Lautens extrapolated their findings to propose a 
mechanism for an isoelectronic Rh(I) system (Scheme 2.7).
117
 Loss of a coordinated 
solvent moiety from the Rh-hydroxide (v) is followed by coordination of the 
phenylboronic acid (2a) to the hydroxyl moiety, potentially assisted by η6-binding to the 
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rhodium metal to give organoboronate intermediate (vi). Transmetalation then occurs 
via the transition state complex (vii) to give the phenylrhodium (viii) and the dissociated 
B(OH)3 (ix). 
 
Scheme 2.7. Mechanism of transmetalation between boronic acid 2a and representative Rh-
hydroxide (v)
117
  
Much effort has been focused on tailoring rhodium complexes to improve both 
activity and selectivity for 1,4-adition, with particular attention being paid to ancillary 
ligands.
39a, 39c-g
 The recurring trend in the literature is that activity is enhanced by the 
use of electron-poor ligands.
170
 Examples of electron-poor ligands employed on 
particularly active catalyst systems are shown in Figure 2.1 and include the chiral dienes 
L3,
39d, 39f, 171
 phosphoramidites L4 and L5,
39b, 39c, 170c
diphosphines L6 , L7 and L8,
170, 172
 
and the BINAP-type ligands L2 discussed vide supra.
15, 166, 173
 For example, a Rh-
complex bearing an electron-poor chiral diphosphine, MeO-F12–BIPHEP L6 was 
reported by Sakai,
170a
 showing very high activity (TON and TOF of 320,000 and 53,000 
h
-1
 respectively at 2.5 x 10
-4
 mol% loading) in 1,4-addition. The extraordinary activity 
was attributed to the superior π-accepting capability of the ligand; inducing favourable 
conditions for transmetalation between boron and rhodium.
170b
  
 
Figure 2.1. Commonly used electron-poor ligands in 1,4-addition.
39
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Due to the success of electron-poor ligands, the use of NHCs as ligands for 1,4-
addition is very underdeveloped. To our knowledge, there are only a handful of reports 
where NHCs have been used as supporting ligands in the conjugate addition of 
arylboronic acids to activated alkenes to date. Two reports make use of chiral NHC 
ligands to perform 1,4-addition reactions asymmetrically (Figure 2.2). Andrus et al.
39g
 
described the use of dicyclophane imidazolium salts L9 (3.0 mol%) with 
[Rh(acac)(C2H4)2] (5, 2 mol%) to deliver a range of conjugate addition products in high 
yields (89-97%) with high ee (87-93%). Jeletic and co-workers
174
 showed that a number 
of κ2-bis-NHCs on well-defined rhodium complexes 12 and 13 could catalyse the 
reaction between 1a and 2a in dioxane/MeOH to deliver the product in up to 98% 
isolated yield and up to 82% ee with a catalyst loading of 1.5 mol%.  
 
Figure 2.2. Rhodium NHC systems for catalytic conjugate addition of arylboronic acids to 
enones.
39g, 174
 
A third report, making use of Rh-NHC complexes in conjugate addition was 
reported after the work in this chapter was published. In the report by Esteruelas et al.
175
 
[Rh(cod)(NHC)Cl] (14, NHC = 3-benzyl-1-(2-hydroxy-2-phenylethyl)imidazol-2-
ylidene, Figure 2.2) catalysed the conjugate addition of 2a to 1a at 1 mol% under 
anhydrous conditions. This is an interesting result since the authors showed that by 
attaching a hydroxide to the terminus of the alkyl N-substituent, the pendant alkoxide 
could perform the role of H2O. In particular, the hydroxide is able to cleave the product 
from the Rh complex by nucleophilic substitution at the metal, negating the need for 
aqueous solvent.  
Our main aim in this study was firstly to develop a synthesis for the preparation of 
Rh(I)-hydroxides since we were primarily interested in extending the chemistry of 
LTM-NHC hydroxides to include rhodium. Previous success in our group had indicated 
that NHC ligands were able to stabilise metal-hydroxide bonds on Au
62a
 and Cu
62d
 and 
we hoped to employ the same strategy to deliver Rh(I)-hydroxides. Due to the 
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implications of Rh-hydroxides as important intermediates in conjugate addition 
reactions, we hoped to test the Rh(I)-hydroxides in conjugate addition reactions.  
2.2. COMPLEX SYNTHESIS 
In order to prepare Rh(I)-NHC hydroxide complexes, we chose to utilise the 
commercially available [Rh(cod)Cl]2 (15) as starting material. As described in Chapter 
1, the preparation of [Rh(cod)(NHC)Cl] complexes has been well documented by 
reacting 15 with free NHCs Ll0 − L11.81c, 87 Gratifyingly, we were able to modify the 
reported methods, and by adding an excess of CsOH to the reaction mixture, the 
chloride was replaced in a one pot procedure to give Rh(I)-NHC hydroxides 16a-c 
(Scheme 2.8). 
 
Scheme 2.8. Preparation of [Rh(cod)(NHC)(OH)] complexes 16a–c. 
Complexes 16a-c were stable under inert conditions and were characterised by 
multinuclear NMR techniques and their purity was confirmed by elemental analysis. 
Single crystals of 16a and 16b were grown by slow evaporation of saturated hexane 
solutions. X-ray analysis unambiguously confirmed the identity of monomeric, 16-
electron complexes, adopting square planar geometries around the metal centre (Figure 
2.3).
68
 Of note, the Rh-carbene bond on 16b (2.022(3) Å) is considerably shorter than 
that on 16a (2.046(6) Å). This may be due to the added steric bulk of IPr on 16a, 
causing the Rh-carbene bond to lengthen. It could be a result of increased electron 
donation from ICy (TEP = 2049.6 cm
-1
)
176
 compared to IPr (TEP = 2051.5 cm
-1
),
94a
 or a 
combination of decreased steric bulk and increased electron donation togaether. The Rh-
OH bonds on 16a and 16b were very similar in length (2.030(4) Å, 16a and 2.036(2) Å, 
16b) and considerably longer than the Ir-OH bond length reported for 
[Ir(cod)(IMes)(OH)] (2.007(5) Å), the closest reported relative of these complexes.
177
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Figure 2.3. Thermal ellipsoid representations of [Rh(cod)(IPr)(OH)] 16a and 
[Rh(cod)(ICy)(OH)] 16b, showing 50% thermal ellipsoid probability. Selected distances (Å) for 
16a: Rh1-C1 2.046(6), Rh1-O1 2.030(4) and 16b: Rh1-C1 2.022(3), Rh1-O1 2.036(2). 
2.3. CATALYSIS 
With complexes 16a-c in hand, we turned our attention to the conjugate addition 
of arylboronic acids to α,β-unsaturated carbonyls. The addition of phenylboronic acid 
(2a) to cyclohexenone (1a) was selected as the benchmark reaction. In a trial reaction 
conducted at room temperature, the desired product 3a was obtained in 54% isolated 
yield after 1 h with a catalyst loading of 0.2 mol% using [Rh(cod)(ICy)(OH)] (16b). 
To rapidly afford optimised conditions and simultaneously test the thermal 
stability of our complexes under catalytic conditions, transformations were examined 
under microwave irradiation. Testing the well-defined complexes 16a-c at 0.05 mol% in 
a THF/H2O (10:1) solvent mixture at 100 °C for 30 min under the conditions illustrated 
in Scheme 2.9, the desired product, 3a was obtained in 59% (using 16a), 86% (using 
16b) and 74% (using 16c) isolated yields (Table 2.1).  
 
Scheme 2.9. Comparison between Rh-hydroxides in 1,4-addition under microwave irradiation. 
  
Rh1 
Rh1 
C1 
C1 
O1 
O1 
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Table 2.1. Comparison between catalysts 16a-c in 1,4-addition of 2a to 1a
a
. 
Entry Catalyst Yield 3a (%)
b
 
3a 1 [Rh(cod)(IPr)(OH)] 16a 59 
2 [Rh(cod)(ICy)(OH)] 16b 86 
3 [Rh(cod)(IDD)(OH)] 16c 74 
4 nil 0 
a 
Reaction conditions: [Rh(cod)(NHC)(OH)] (0.05 mol%), KOH (0.5 equiv.),  
mw, 100 °C, 200W, 30 min, THF/H2O (10:1); 
b 
Isolated Yield. 
 
The cycloalkyl-substituted NHC complexes 16b and 16c were found to 
outperform the aryl-substituted analogue 16a. Among the cycloalkyl-NHCs, the 
complex containing the smaller
 
ICy ligand L10 resulted in the highest yields. Under 
these reaction conditions, the catalysts appeared to be tolerant of elevated reaction 
temperatures. Having identified [Rh(cod)(ICy)(OH)] (16b) as the most active catalyst, it 
was tested at homeopathic quantities, achieving full conversion after 12 h under 
conventional heating (100 
o
C) at 0.001 mol%, with a TON of 100,000 and TOF of 6,600 
h
-1
.  
In the interest of performing rapid transformations, the reaction of phenylboronic 
acid (2a) and cyclohexenone (1a) was optimised under microwave irradiation after 30 
min (Table 2.2). From the results obtained, we determined that the presence of an 
inorganic base (KOH) was essential for the reaction (Entry 5, Table 2.2) and that a 
catalyst loading of 0.2 mol% could be used to obtain almost complete conversions after 
only 30 min under microwave irradiation (Entry 2, Table 2.2).  
Table 2.2. Optimisation of reaction conditions for the 1,4-addition of 2a to 1a
a 
Entry 16b (mol%) Base 
(0.5 equiv.) 
Yield (%)
b
 
3a 1 1.00 KOH 99
 
2 0.20 KOH 99 
3 0.05 KOH 86 
4 0.025 KOH 84
 
5 0.20 - <10
 
6 0.20 KOH 85
b 
a 
Reaction conditions: mw, 100 °C, 200W, 30 min, THF/H2O (10:1); 
b 
Isolated yields by column chromatography ;
 b 
Thermal, 100 °C, 1 h, PhMe/H2O (10:1). 
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A scope for the transformation was next examined to demonstrate the versatility 
and the limitations of 16b. We examined the coupling of four arylboronic acids: the 
parent system 2a, two para-deactivated substrates (2b and 2c) and the sterically 
demanding ortho-methylphenyl boronic acid (2d). The boronic acids were coupled to 
three cyclic enones 1a-c of differing ring size under the optimised conditions (Scheme 
2.10, Table 2.3). Cyclohexenone (1a) was very reactive towards the four arylboronic 
acids (2a–d), giving high yields in all cases (Entries 1-4, Table 2.3). Both 
cyclopentenone (1b) and cycloheptenone (1c) proved more difficult substrates, 
particularly when reacted with the deactivated 4-chlorophenylboronic acid (2b) and 4-
(trifluoromethyl)phenylboronic acid (2c). These reactions were much slower under the 
conditions reported and reaction times had to be increased to 90 min in each case in 
order to achieve better yields (Entries 6, 7, 10 and 11, Table 2.3). Interestingly, the more 
sterically demanding, 2-methylphenylbonic acid (2d) was found to give high yields with 
the three enones examined (Entries 4, 8 and 12, Table 2.3). 
 
Scheme 2.10 1,4-Addition of Arylboronic Acids to Cyclic Enones under optimised conditions. 
To further test the versatility and applicability of the Rh-ICy hydroxide motif, we 
explored alternative aryl delivery systems, successfully coupling potassium 
phenyltrifluoroborate (17a) and phenylboronic acid pinacol ester (17b) to 
cyclohexenone (1a) (Scheme 2.11), yielding phenylcyclohexanone (3a) in high 
conversions.  
 
Scheme 2.11. Conjugate addition using alternative aryl delivery sources. 
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Table 2.3. Scope and limitations of 1,4-Addition of Arylboronic Acids 2 to Cyclic Enones 1
a
 
Entry Enone 
1 
ArB(OH)2 
2 
Product 
3 
Yield (%)
b
 
 
1 
 
  
99 
2 
  
93 
3 
  
94 
4 
  
96 
     
5 
 
  
90 
6 
  
77
c
 
7 
  
70
c
 
8 
  
92 
     
9 
 
  
80 
10 
  
68
c
 
11 
  
53
c
 
12 
  
92 
a Reaction conditions: [Rh(cod)(ICy)(OH)] (16b, 0.2 mol%), THF/H20 (10:1), mw, 100 °C, 200 W, 30 min. 
b Isolated yields are average of two runs and obtained after purification by flash chromatography. c 
Irradiation time was 90 min. 
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2.4. MECHANISTIC STUDIES 
Having demonstrated the high activity of 16b in conjugate addition we conducted 
a series of stoichiometric reactions to shed light on the mechanism at play. 
[Rh(cod)(ICy)Ph] (18) was prepared from 16b and phenylboronic acid (2a) in C6D6 in a 
very rapid transformation as shown in Scheme 2.12. 
1
H NMR analysis confirmed 
complete conversion of 16b into 18 after only 15 min at room temperature.  
 
Scheme 2.12. Stoichiometric reaction to prepare phenyl rhodium intermediate 18. 
When the reaction was repeated with [Rh(cod)(IPr)(OH)] (16a) only 50% 
conversion (by 
1
H NMR) was noted after 16 h. This difference in the rate of 
transmetalation between 16a and 16b may well account for the lower activity of 16a 
observed during catalyst screening, the principal effect being a result of the steric bulk 
imposed by the NHC. The Rh(I)-phenyl complex 18 was isolated (87%) and fully 
characterised, with single crystal X-ray analysis unambiguously confirming the square 
planar geometry about the Rh centre (Figure 2.4). The phenyl ring is positioned 
orthogonal to the Rh-carbene plane, thereby minimising steric strain. 
 
Figure 2.4. Thermal ellipsoid representation of [Rh(cod)(ICy)(Ph)] 18, showing 50% 
thermal ellipsoid probability. Selected distances (Å): Rh1-C1 2.036(3), Rh1-C31 
2.058(4). 
Hartwig
178
 has shown that transmetalation of an aryl moiety from boron to 
rhodium occurs via formation of a rhodium arylboronate (RhOB(OH)Ar) species, 
followed by β-aryl elimination to give the Rh-aryl complex. Complex 18 was used to 
catalyse the conjugate addition of phenylboronic acid 2a to cyclohexenone 1a under 
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microwave irradiation and resulted in nearly identical activity to that of 16b (98% 
isolated yield). Additionally, the reaction of 18 with 2 equivalents of cyclohexenone 
(1a) in THF/H2O resulted in the formation of 3a in a yield of 72% under catalytic 
conditions (Scheme 2.13). These experiments strongly suggest that 18 is an important 
intermediate along the catalytic pathway.  
 
Scheme 2.13. Reactions performed in the presence of Rh(I)-Ph 18 to prepare (3a). 
Our next step was to try to isolate the postulated oxa-π-allyl intermediate. 
Reaction between 18 and cyclohexenone (1a) in various solvents was very slow and 
unfortunately did not yield the desired product. Various reaction conditions were 
employed using different solvents, at temperatures ranging from -24 to 80 °C with 
reaction times up to 10 days, but to no avail (Table 2.4, experimental section). In a last 
effort, we attempted to react 18 with a pre-formed enolate Na
+
 salt of cyclohexanone as 
reported in a similar transformation by Slough.
167
 Again this approach was unsuccessful 
and we can only postulate as to the exact structure of the allyl intermediate.  
The last step to consider in the catalytic cycle is the hydrolytic cleavage of the 
conjugated product 3a from the postulated allyl intermediate and simultaneous 
regeneration of the rhodium hydroxide 16b to propagate the cycle. In order to 
understand the role of H2O in the process, a reaction was performed under catalytic 
conditions with H2O being replaced by D2O (Scheme 2.14). 
1
H NMR analysis of the 
final product showed deuterium incorporation (85%) into the conjugated product 3a-D, 
α- to the carbonyl. This experiment confirmed hydrolytic cleavage of the addition 
product 3a by H2O from the rhodium centre.  
 
Scheme 2.14. Deuterium incorporation studies of the hydrolysis step. 
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The role played by the base in the reaction is still somewhat obscure. Several 
reports have indicated that base is essential for the in situ preparation of the 
hydroxorhodium species,
39a, 170b, 179 
where precatalysts such as [Rh(cod)Cl]2 (23) or 
[Rh(acac)(C2H4)2] (6) are used. Inorganic bases have been shown to accelerate 
transmetalation between organoborons and metal complexes,
117
 via quaternisation of the 
boronic acid to form an anionic organoboronate, which subsequently coordinates the 
metal centre. This concept has been explored by Suzuki
168
 in Pd-catalysed cross-
coupling and supported by DFT studies.
180
 The theory has been extended to Rh-
systems
117
 but has not yet been supported experimentally. Miyaura and co-workers
39a
 
suggested that the base might play a further role in facilitating hydrolysis of the enolate 
intermediate.  
There are several observations that we have highlighted, concerning the role of the 
base. Firstly, the Rh-hydroxide 16b bears an internal base; secondly the transmetalation 
observed between 16b and 2a (Scheme 2.12) is so swift in the absence of a base that 
this kind of quaternisation would be unlikely to affect the reaction rate. However, 
catalysis in the absence of a base produces the conjugated product 3a in less than 10% 
yield under optimised microwave conditions (Entry 5, Table 2.2). Studies on the allyl-
formation step and subsequent hydrolytic cleavage of 3a have drawn our attention to the 
possibility that KOH may play a role in facilitating enone insertion. A possible 
explanation is that a side reaction occurs with the enone to yield a potassium enolate, 
which reacts more favourably with the Rh-phenyl complex but our investigations into 
this hypothesis were inconclusive. A further role played by the base may be in the H2O 
assisted regeneration of the catalyst, providing the hydroxyl group to reform the Rh(I)-
hydroxide complex. 
A proposed mechanism is presented in Scheme 2.15 which is consistent with the 
one proposed by Hayashi (vide supra).
15
 Activation of the arylboronic acid by the Rh-
hydroxide 16b forms the Rh-phenyl complex 18, followed by enone insertion to most 
likely give the unobserved transient oxa-π-allyl Rh intermediate. Hydrolysis by H2O, in 
the presence of KOH completes the cycle with release of the 1,4-addition product 3a 
and reformation of the Rh(I)-hydroxide 16b. 
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Scheme 2.15. Proposed catalytic cycle for Rh-catalysed 1,4-addition. 
2.5. CONCLUSIONS 
In summary, we have reported that Rh(I)-hydroxides may be prepared via a 
general one-pot procedure. Strongly electron-donating NHC ligands are able to stabilise 
the Rh-OH bond and we have isolated three complexes of the type 
[Rh(cod)(NHC)(OH)] (16a-c, NHC = IPr, ICy and IDD). Complexes 16a-c were fully 
characterised by multinuclear NMR techniques and elemental analysis, with X-ray 
crystal structures being reported for 16a and 16b.  
[Rh(cod)(ICy)(OH)] (16b) was found to be a very efficient catalyst in the 
conjugate addition of arylboronic acids (2) to cyclic enones (1), promoting full 
conversion at 0.001 mol% catalyst loading under thermal heating, with TON’s and 
TOF’s of 100,000 and 6,600 h-1 respectively. This is in contrast to previous reports in 
which ancillary ligands with weaker electron donating properties were found to lead to 
optimal reactivity and catalytic conversions.
170
 Furthermore, aryl molander salts 17a 
and arylboronic esters 17b were also found to serve as viable substrates in conjugate 
addition, leading to high conversions. Stoichiometric reactions were performed to 
isolate possible reaction intermediates and to discover the source of the high activity 
displayed by the Rh(I)-hydroxide 16b. A very fast transmetalation between boronic acid 
2a and Rh(I)-hydroxide 16b provided a plausible explanation for the high activity of 
16b, since transmetalation has been identified as the rate-limiting step in systems 
involving electron deficient ligands.
181
 Isolation and full characterisation, including X-
 Chapter 2: Conjugate Addition 
 
54 
 
ray structural analysis of the Rh(I)-phenyl intermediate 18 was also achieved. 
Unfortunately, efforts towards the isolation of the second key intermediate, the 
proposed oxa-π-allyl species were unsuccessful and we suspect that insertion of the 
ketone may constitute the rate-limiting step. Deuterium labelling studies confirmed the 
role of H2O in the hydrolysis of the rhodium enolate to release the conjugated product, 
with an 85% deuterium-incorporation on the α-carbon of product 3a-D. The exact role 
that the base plays in the reaction is still somewhat obscure. We have shown 
experimentally that the base is not essential for transmetalation between Rh(I)-
hydroxide and an arylboronic acid for this system. We propose two possible roles of the 
base, firstly that it may facilitate the enone insertion step and secondly, that the base is 
essential in regeneration of the active Rh(I)-hydroxide complex. 
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2.6. EXPERIMENTAL DETAILS 
2.6.1. General considerations 
Unless stated otherwise all reactions were carried out inside an MBraun Glovebox 
under inert conditions. All reagents were supplied by Aldrich and used without further 
purification and solvents were distilled and dried as required. Normal phase thin layer 
chromatography (TLC) was performed on Polygram 0.20 mm silica gel plates, Flash 
chromatography was performed using Silicycle Silia Flash silica gel 60 (particle size 
0.040 – 0.063 mm). Visualisation on silica was achieved using either iodine vapour or 
UV light at 254 nm. NMR data was obtained using either a Bruker 400 MHz or 300 
MHz spectrometer at 303 K in the specified deuterated solvent. All chemical shifts are 
given in ppm and coupling constants in Hz. Signals on the 
13
C{
1
H} spectra are singlets 
unless otherwise stated. Spectra were referenced to residual protonated solvent signals 
(for 
1
H) or solvent signals (for 
13
C): (CDCl3: 
1H δ 7.26 ppm, 13C δ 77.00 ppm; C6D6: 
1
H 
δ 7.16 ppm, 13C δ 128.06 ppm). Reactions under microwave irradiation were performed 
in a CEM Discover single-mode microwave apparatus, producing controlled irradiation 
at 2450 MHz. Reaction times refer to hold times at the indicated temperature and not 
total irradiation times with constant cooling via propelled air flow at a set power of 200 
W. Elemental analyses were performed at the London Metropolitan University. CCDC-
823666 (16a), CCDC-823667 (16b) and CCDC-823668 (18) contain the supplementary 
crystallographic data for these complexes. These data can be obtained free of charge 
from The Cambridge Cryatallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
2.6.2. Synthesis and Characterisation data 
 
[Rh(cod)(IPr)(OH)] 16a 
A 25 mL Schlenk tube was charged with [Rh(cod)Cl]2 15 (100 mg, 0.2 mmol), IPr 
L9 (158 mg, 0.4 mmol) and CsOH (122 mg, 0.8 mmol) in THF (5 mL). The resultant 
mixture was stirred overnight then filtered on celite and concentrated in vacuo. The 
resultant solid was washed with hexane (3 x 10 mL) and dried in vacuo to give 
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[Rh(cod)(IPr)(OH)] 16a (190.0 mg, 75.8%) as a yellow solid; 
1
H NMR (300 MHz, 
C6D6): δ 7.27 − 7.35 (m, 2H, ArH), 7.20 − 7.26 (m, 4H, ArH), 6.59 (s, 2H, NCH), 4.29 
− 4.42 (m, 2H, cod-CH), 3.35 (m, 4H, (CH(CH3)2), 2.99 (m, 2H, cod-CH), 1.83 − 2.02 
(m, 4H, cod-CH2), 1.59 − 1.72 (m, 2H, CH), 1.49 (d, 14H, 
3
JHH = 6.6, CH3, m, 2H, cod-
CH2), 1.46 – 1.54 (m, 2H, CH), 1.06 (d, 12H, 
3
JHH = 6.9, CH3); 
13
C{
1
H} NMR (75 
MHz, C6D6): δ 191.8 (d, 
1
JRhC = 56, Rh-NHC ), 147.0 (ArC), 137.3 (ArC), 129.9 
(ArCH), 123.9 (NCH), 92.5 (d, 
1
JRhC = 9, cod-CH), 63.5 (d, 
1
JRhC = 12, cod-CH), 33.7 
(CH(CH3)2), 29.0 (cod-CH2), 28.9 (cod-CH2), 26.5 (CH3), 23.2 (CH3); Anal. Calcd for 
C35H49N2ORh (MW 621.08): C, 68.17, H, 8.01, N, 4.54. Found: C, 68.26; H, 7.87; N, 
4.38. 
  
[Rh(cod)(ICy)(OH)] 16b 
A 25 mL Schlenk tube was charged with [Rh(cod)Cl]2 15 (100 mg, 0.2 mmol), 
ICy L10 (94 mg, 0.4 mmol) and CsOH (122 mg, 0.8 mmol) in THF (5 mL). The 
resultant mixture was stirred overnight then filtered on celite and concentrated in vacuo. 
The resultant solid was washed with hexane (3 x 10 mL) and dried in vacuo to give 
[Rh(cod)(ICy)(OH)] 16b (163 mg, 84.4%) as a yellow solid; 
1
H NMR (300 MHz, 
C6D6) δ 6.42 (s, 2H, N(CH)2N), 5.73 (tt, 2H, 
3
JHH = 12.1, 3.9, N-CH(CH2)2), 5.13 – 5.30 
(m, 2H, cod-CH), 3.08 (m, 2H, cod-CH), 2.47 – 2.63 (m, 4H, cod-CH2), 2.30 (d, 2H, 
3
JHH = 12.2, CH2), 2.12 (quint, 2H, 
3
JHH = 6.9, CH2), 1.84 – 2.00 (m, 4H, cod-CH2), 
1.34 – 1.73 (m, 10H, CH2), 1.27 (qd, 2H, 
3
JHH = 12.5, 3.6, CH2), 1.10 (qd, 2H, 
3
JHH = 
12.5, 3.8, CH2), 0.94 (qt, 2H, 
3
JHH = 12.8, 3.7, CH2); 
13
C{
1
H} NMR (75 MHz, C6D6) δ 
186.3 (d, 
1
JRhC = 57, Rh-NHC), 117.2 (N(CH)2N), 97.4 (d, 
1
JRhC = 8, cod-CH), 66.7 (d, 
1
JRhC = 13, cod-CH), 60.5 (N-CH(CH2)2), 34.9, 34.5, 34.4, 29.5, 26.4, 26.0, 25.7 (ICy-
CH2). Anal.Calcd for C23H37N2ORh (MW 460.46): C, 59.99; H, 8.10; N, 6.08. Found: 
C, 59.90, H, 8.02; N, 5.97. 
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[Rh(cod)(IDD)(OH)] 16c 
A 25 mL Schlenk tube was charged with [Rh(cod)Cl]2 15 (100 mg, 0.2 mmol), 
IDD L11 (162.5 mg, 0.4 mmol) and CsOH (123 mg, 0.8 mmol) in THF (5 mL). The 
resultant mixture was stirred overnight then filtered on celite and concentrated in vacuo. 
The resultant solid was washed with hexane (3 x 10 mL) and dried in vacuo to give 
[Rh(cod)(IDD)(OH)] 16c (180.0 mg, 70.9%) as a yellow solid; 
1
H NMR (300 MHz, 
C6D6) δ 6.45 (s, 2H, N(CH)2N), 5.83 – 5.98 (m, 2H, N-CH(CH2)2), 5.20 (m, 2H, cod-
CH), 3.04 – 3.15 (m, 2H, cod-CH), 2.53 – 2.72 (m, 4H, cod-CH2), 2.01 – 2.13 (m, 4H, 
CH2), 1.87 – 1.97 (m, 4H, cod-CH2), 1.68 – 1.84 (m, 10H, CH2), 1.15 – 1.54 (m, 30H, 
CH2); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 187.1 (d, 
1
JRhC = 57, Rh-NHC), 117.2 
(N(CH)2N), 96.0 (d, 
1
JRhC = 8, cod-CH), 62.4 (d, 
1
JRhC = 13, cod-CH), 57.4 (N-
CH(CH2)2), 34.4 (cod-CH2), 32.2 (cod-CH2), 31.7, 29.4, 25.0, 24.7, 24.3, 24.1, 24.0, 
23.7, 23.2, 22.7, 22.5 (IDD-CH2); Anal. Calcd for C35H61N2ORh (MW 628.78): C, 
66.86; H, 9.78; 4.46. Found: C, 66.88; H, 9.65; N, 4.46. 
  
[Rh(cod)(ICy)Ph] 18 
A 25 mL Schlenk tube was charged with [Rh(cod)(ICy)(OH)] 16b (500 mg, 1.08 
mmol) and phenylboronic acid 2a (130.0 mg, 1.08 mmol) in C6H6 (5 mL). The resultant 
solution was stirred for 1 h then filtered and reduced in vacuo to a yellow solid. The 
solid was dissolved in hexane (20 mL) and filtered before being reduced in vacuo to 
give [Rh(cod)(ICy)Ph] 18 (488.3 mg, 87.4%) as an orange solid; 
1
H NMR (400 MHz, 
C6D6): δ 7.81 (d, 2H, 
3
JHH = 7.7, o-ArH), 7.23 (t, 2H, 
3
JHH = 7.4, m-ArH), 6.99 (t, 1H, 
3
JHH = 7.3, p-ArH), 6.21 (s, 2H, NCH), 5.47 (tt, 2H, 
3
JHH = 12.1, 3.5, (N-(CH)2-N), 4.74 
(m, 2H, cod-CH), 4.08 (m, 2H, cod-CH, 2.45 (m, 4H, cod-CH2), 2.15 (d, 4H, 
3
JHH = 8.9, 
ICy-CH2), 1.99 – 1.92 (m, 4H, cod-CH2), 1.66 (t, 4H, 
3
JHH = 12.7, ICy-CH2), 1.55 (d, 
2H, 
3
JHH = 13.5, ICy-CH2), 1.41 – 1.52 (m, 4H, ICy-CH2), 1.22 (qd, 2H, 
3
JHH =12.5, 
3.6, ICy-CH2), 1.06 (qd, 2H, 
3
JHH = 12.5, 3.6, ICy-CH2), 0.90 – 0.99 (m, 2H, ICy-CH2); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 189.9 (d, 
1
JRhC = 60, Rh-NHC), 177.4 (d, 
1
JRhC = 36, 
Rh-Ph), 138.2 (ArC), 126.2 (ArCH), 121.0 (ArCH), 116.5 (N(CH)2N), 87.5 (d, 
1
JRhC = 
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9, cod-CH), 81.7 (d, 
1
JRhC = 7, cod-CH), 60.4 (N(CH)2N), 35.2 (cod-CH2), 34.7 (cod-
CH2), 32.0, 31.9, 26.4, 25.9, 25.7 (ICy-CH2); Anal. Calcd for C29H41N2Rh (MW 
521.56): C, 66.91; H, 7.94; N, 5.38. Found: C, 66.81, H, 7.99 N, 5.31. 
2.6.3. Catalysis 
Method 1. 3-Phenylboronic acid 2a (73.2 mg, 0.6 mmol), [Rh(cod)(ICy)(OH)] 
16b (0.46 mg, 1.0 µmol, 0.20 mol%) and KOH (14 mg, 0.25 mmol) were charged to a 
vial with THF (1 mL) inside a glove box. The vial was sealed and removed to air, where 
it was charged with cyclohexen-2-one 1a (48.1 mg, 48.0 µL, 0.50 mmol) and degassed 
H2O (100 µL) and allowed to stir at rt for 1 h. The product, 3-phenyl cyclohexanone 3a 
was determined by 
1
H NMR and
 
GC analysis (54% conversion).  
Method 2. A 10 mL Schlenk tube was charged with 3-phenylboronic acid 2a (73.2 
mg, 0.6 mmol), cyclohexen-2-one 1a (48.1 mg, 48.0 µL, 0.50 mmol), 
[Rh(cod)(ICy)(OH)] 16b (0.46 mg, 1.0 µmol, 0.20 mol%) and KOH (14 mg, 0.25 
mmol) in THF (2 mL) and H2O (200 µL) and refluxed under Ar for 1 h. The resultant 
mixture was chromatographed (flash chromatography, elution with hexane-ethyl acetate 
[4-1]) to give 3-phenyl cyclohexanone 3a (75.6 mg, 86.8%) as a clear oil. 
Method 3.General procedure for catalysis under microwave irradiation 
Arylboronic acid 2a-d (0.6 mmol), [Rh(cod)(ICy)(OH)] 16b (0.46 mg, 1.0 µmol, 
0.20 mol%) and KOH (14 mg, 0.25 mmol) were charged to a 10 mL microwave vial 
with THF (1 mL) inside a glove box. The vial was sealed and removed to air, where it 
was charged with cyclic enone 1a-c (0.50 mmol) and H2O (100 µL) before being 
irradiated in the microwave at 100 ºC, 200 W for 30 min. The resultant mixture was 
chromatographed (flash chromatography, elution with hexane-ethyl acetate [4:1]) to 
afford the addition product 3a-l. 
TON reaction 
A 25 mL Schlenk flask was charged with phenylboronic acid 2a (1.52 g, 12.4 
mmol), cyclohexen-2-one 1a (996 mg, 1.0 mL, 10.4 mmol), KOH (290 mg, 5.2 mmol) 
and [Rh(cod)(ICy)(OH)] 16b (4.80 x 10
-2 
mg, 1.04 x 10
-1 
µmol, 0.001 mol%) in toluene 
(5 mL) and H2O (500 µL). The resultant mixture was stirred at 100 ºC for 12 h. 3-
Phenyl cyclohexenone 3a (1.8 g, 99.7%) was isolated as a clear oil by flash 
chromatography (elution with hexane-ethyl acetate [4:1]). 
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3-phenyl cyclohexanone 3a from phenylboronic acid pinacol ester 
Catalytic preparation of 3-phenyl cyclohexenone 3a under microwave irradiation 
was followed, using [Rh(cod)(ICy)(OH)] 16b (0.46 mg, 1.0 µmol, 0.20%), 
phenylboronic acid pinacol ester (122.4 mg, 0.6 mmol), cyclohexen-2-one 1a (48.1 mg, 
48 µL, 0.50 mmol), KOH (14 mg, 0.25 mmol) in THF/D2O (1/0.1 mL) to give 3-phenyl 
cyclohexenone 3a (89% conversion by 
1
H NMR and GC). 
3-phenyl cyclohexanone 3a from potassium phenyltrifluoroborate  
Catalytic preparation of 3-phenyl cyclohexenone 3a under microwave irradiation 
was followed, using [Rh(cod)(ICy)(OH)] 16b (0.46 mg, 1.0 µmol, 0.20 mol%), 
potassium phenyltrifluoroborate (110.4 mg, 0.6 mmol), cyclohexen-2-one 1a (48.1 mg, 
48 µL, 0.50 mmol), KOH (14 mg, 0.25 mmol) in THF/D2O (1/0.1 mL) to give 3-phenyl 
cyclohexenone 3a (87% conversion by 
1
H NMR and GC). 
2.6.4. Characterisation data 
 
3-Phenyl cyclohexanone 3a
182
 
(86 mg, 99%) as a clear oil.
 1
H NMR (300 MHz, CDCl3) δ 7.32 - 7.39 (m, 2H), 
7.21 – 7.30 (m, 3H), 2.97 - 3.10 (m, 1H), 2.33 - 2.68 (m, 4H), 2.06 - 2.23 (m , 2H), 1.76 
- 1.96 (m, 2H); 
13
C{
1
H} NMR (75MHz, CDCl3): δ 211.0, 144.3, 128.6, 126.6, 126.5, 
48.9, 44.7, 41.1, 32.7, 25.5. 
 
3-(4-Chloro-phenyl)-cyclohexanone 3b
183
 
(97 mg, 93%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) δ 7.28 (d, 2H, 
3
JHH = 
8.4), 7.15 (d, 2H, 
3
JHH = 8.4), 2.09 – 3.05 (m, 1H,), 2.29 – 2.60 (m, 4H), 2.00 – 2.19 (m, 
2H), 1.71 – 1.89 (m, 2H); 13C{1H} NMR (100 MHz, CDCl3) δ 210.4, 142.7, 132.3, 
128.7, 127.9, 48.7, 44.0, 41.0, 32.6, 25.3. 
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3-(4-Trifluoromethyl-phenyl)-cyclohexanone 3c
182
 
(112.6 mg, 93.5%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) δ 7.58 (d, 2H, 
3
JHH 
= 8.4 Hz), 7.33 (d, 2H, 
3
JHH = 8.4 Hz), 3.01 – 3.14 (m, 1H), 2.48 – 2.64 (m, 2H), 2.32 – 
2.48 (m, 2H), 2.04 – 2.21 (m, 2H), 1.74 – 1.95 (m, 2H); 13C{1H} NMR (100 MHz, 
CDCl3) δ 210.1, 148.2, 129.3 (q, 
1
JFC= 24.3), 127.0, 125.6 (q, 
2
JFC= 2.5), 122.8, 48.8, 
44.5, 41.1, 32.5, 25.4.  
 
3-o-Tolyl-cyclohexanone 3d
184
 
(90.2 mg, 95.8%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) δ 7.21 – 7.27 (m, 
2H), 7.11 – 7.21 (m, 2H), 3.14 – 3.29 (m, 1H), 2.52 (d, 2H, 3JHH = 8.9), 2.35 – 2.49 (m, 
2H), 2.33 (s, 3H), 2.11 – 2.33 (m, 1H), 1.97 – 2.07 (m, 1H), 1.75 – 1.94 (m, 2H); 
13
C{
1
H} NMR (100 MHz, CDCl3) δ 211.3, 142.3, 135.1, 130.7, 126.5, 126.4, 125.1, 
48.4, 41.3, 40.3, 32.0, 25.8, 19.3. 
 
3-Phenyl cyclopentanone 3e
182
 
(72 mg, 90%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) δ 7.31 – 7.36 (m, 2H), 
7.22 – 7.27 (m 3H,), 3.41 (tt, 1H, 3JHH = 8.0, 3.2), 2.66 (dd, 1H, 
3
JHH = 6.2), 2.39 – 2.51 
(2H, m), 2.36 – 2.39 (2H, m), 1.92 – 2.05 (1H, m); 13C{1H} NMR (75 MHz, CDCl3) δ 
218.3, 143.0, 128.6, 126.6, 45.7, 42.1, 38.8, 31.1. 
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3-(4-Chloro-phenyl)-cyclopentanone 3f
39a
 
 
Irradiation time 90 min,(75 mg, 77%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) 
δ 7.31 – 7.36 (m , 2H,), 7.22 – 7.27 (m, 2H), 3.41 (tt, 1H, 3JHH = 10.8), 2.66 (dd, 1H, 
3
JHH = 7.2), 2.39 – 2.51 (m, 2H), 2.24 – 2.38 (m, 2H), 1.92 – 2.05 (m, 1H); 
13
C{
1
H} 
NMR (100 MHz, CDCl3) δ 218.3, 143.0, 132.0, 128.6, 126.7, 45.8, 42.2, 38.8, 31.1. 
 
3-(4-Triflouromethyphenyl)-cyclopentanone 3g
39a
 
Irradiation time 90 min,(76.0 mg, 63%) as a clear oil: 
1
H NMR (400 MHz, 
CDCl3) δ 7.60 (d, 2H, 
3
JHH = 8.0), 7.37 (d, 2H, 
3
JHH = 8.0), 3.48 (tt, 1H, 
3
JHH = 7.1, 5.7), 
2.70 (dd, 1H, 
3
JHH = 7.6), 2.43 – 2.54 (m, 2H,), 2.27 – 2.40 (m, 2H), 1.94 – 2.07 (m, 
1H); 
13
 C{
1
H} NMR (100 MHz, CDCl3) δ 217.4, 147.0, 129.0 (q, 
1
JFC= 32.3), 127.1, 
125.6 (q, 
2
JFC= 3.7), 122.7, 45.4, 42.0, 38.7, 31.0. 
 
3-o-Tolyl-cyclopentanone 3h
184
 
(79.9 mg, 91.7%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) δ 7.12 – 7.25 (m, 
4H), 3.55 – 3.68 (m, 1H), 2.64 (dd, 1H 3JHH = 7.6), 2.24 – 2.56 (m, 4H), 2.39 (s, 3H), 
1.95 – 2.09 (m, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 218.6, 140.9, 135.9, 130.6, 
126.5, 126.4, 124.7, 45.3, 38.5, 38.3, 30.0, 19.6. 
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3-Phenyl cycloheptanone 3i
182
  
(75 mg, 80%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) δ 7.30 (tt, 2H, 
3
JHH = 
7.4, 1.5), 7.16 – 7.23 (m, 3H), 2.86 – 2.98 (m, 2H), 2.64 (dd, 1H, 3JHH = 11.7, 1.6), 2.56 
– 2.62 (m, 2H), 1.93 – 2.13 (m, 3H), 1.65 – 1.80 (m, 2H), 1.43 – 1.56 (m, 1H); 13C{1H} 
NMR (75 MHz, CDCl3) δ 213.4, 146.9, 128.6, 126.4, 126.3, 51.2, 43.9, 42.7, 39.2, 
29.2, 24.1 
 
3-(4-Chloro-phenyl)-cycloheptanone 3j
185
 
Irradiation time 90 min,(76 mg, 68.3%) as a clear oil: 
1
H NMR (300 MHz, 
CDCl3) δ 7.28 (dt, 2H, 
3
JHH = 8.6, 2.3), 7.12 (dt, 2H, 
3
JHH = 8.5, 2.3), 2.83 – 2.98 (m 
2H), 2.56 – 2.68 (m, 3H), 1.95 – 2.32 (m, 3H), 1.64 – 1.81 (m, 2H), 1.41 – 1.59 (m, 
1H); 
13
C{
1
H} NMR (75 MHz, CDCl3) δ 213.0, 145.3, 131.9, 128.7, 127.7, 51.0, 43.9, 
42.1, 39.1, 29.1, 24.0. 
 
3-(4-Triflouromethyphenyl)-cycloheptanone 3k 
Irradiation time 90 min,(68 mg, 53%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) 
δ7.56 (d, 2H, 3JHH = 8.0), 7.29 (d, 2H, 
3
JHH = 8.1), 2.90 – 3.03 (m, 2H), 2.57 – 2.66 (m, 
3H), 1.96 – 2.15 (m, 3H), 1.64 – 1.83 (m, 2H), 1.42 – 1.60 (m, 1H); 13C{1H} NMR (75 
MHz, CDCl3 ) δ 213.4, 146.9, 128.6 (q, 
1
JF-C = 32.5), 126.4, 126.3, 125.9, 125.6 (q, 
2
JF-
C= 3.5), 122.3, 51.2, 43.9, 42.7, 39.2, 29.2, 24.1. 
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3-o-Tolyl-cycloheptanone 3l 
184
 
(92.6 mg, 91.5%) as a clear oil: 
1
H NMR (400 MHz, CDCl3) δ 7.07 – 7.22 (M, 
4H), 3.09 (tt, 1H, 
3
JHH = 11.4, 2.0), 2.93 (t, 1H,
 3
JHH = 12.8), 2.52 – 2.67 (m, 3H), 2.33 
(s, 3H), 1.96 – 2.15 (m, 3H), 1.63 – 1.83 (m, 2H), 1.49 (q, 1H, 3JHH = 11.9); 
13
C{
1
H} 
NMR (100 MHz, CDCl3) δ 213.7, 145.0, 134.4, 130.5, 126.4, 126.0, 125.0, 50.6, 43.9, 
38.4, 37.8, 29.5, 24.2, 19.4. 
 
2
H
 
-labelled 3-phenyl cyclohexanone 3a-d 
Catalytic preparation of 3-phenyl cyclohexenone 3a under microwave irradiation 
was followed, using [Rh(cod)(ICy)(OH)] 16b (0.46 mg, 1.0 µmol, 0.20 mol%), 
phenylboronic acid 2a (73.2 mg, 0.6 mmol), cyclohexen-2-one (48.1 mg, 48 µL, 0.50 
mmol), KOH (14 mg, 0.25 mmol) in THF/D2O (1.0/0.1 mL) to give 
2
H-labeled 3-
phenyl cyclohexenone 3a-d (~ 85% 
2
H –incorporation by 1H NMR) as a clear oil: 1H 
NMR (300 MHz, CDCl3) δ 7.31 - 7.41 (m, 2H), 7.21 – 7.32 (m, 3H), 2.97 - 3.10 (m, 
1H), 2.33 – 2.63 (m, 3H), 2.06 – 2.23 (m, 2H), 1.76 – 1.96 (m, 2H); 13C{1H} NMR 
(75MHz, CDCl3): δ 211.0, 144.3, 128.6, 126.6, 126.5, 48.6 (m), 44.6, 41.1, 32.7, 25.5. 
Catalysis using [Rh(cod)(ICy)Ph] 18 
Method 1. Catalytic preparation of 3-phenyl cyclohexenone 3a under microwave 
irradiation was followed, using [Rh(cod)(ICy)Ph] 18 (0.5 mg, 1.0
 
µmol, 0.20mol%), 
phenylboronic acid 2a (73.2 mg, 0.6 mmol), cyclohexen-2-one 1a (48.1 mg, 48 µL, 0.50 
mmol) and KOH (14 mg, 0.25 mmol) in THF/H2O (1/0.1 mL) to give 3-phenyl 
cyclohexenone 3a (85 mg, 98%). 
Method 2. A microwave vial was charged with [Rh(cod)(ICy)Ph] 18 (40 mg, 7.7 x 
10
-2
mmol), cyclohexen-2-one 1a (15 mg, 15 µL, 1.5 x 10
-1 
mmol) and KOH (4.3 mg, 
7.7 x 10
-2
mmol) in THF/H2O (600/60 µL) and irradiated at 100 ºC, 200 W, 30 min 
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before being concentrated in vacuo and purified on silica with CH2Cl2 as eluent to give 
3-phenyl cyclohexanone 3a (72% by 
1
H NMR and GC). 
Attempted Synthesis of Rh(cod)(ICy)-oxa-π-allyl complex  
Method 1. A round bottom flask/NMR tube was charged with [Rh(cod)(ICy)Ph] 
(18) (25 mg, 0.04 mmol), KOH (2.7 mg, 0.04 mmol) and cyclohexen-2-one (1a) (8.0 
mg, 0.08 mmol) and mixed in the various solvents, under the conditions described in 
Entries 1 – 7, Table 2.4. Reactions were followed by 1H NMR analysis, which did not 
reveal formation of the desired allyl complex. 
Method 2. An NMR tube was charged with [Rh(cod)(ICy)Ph] (18) (25 mg, 0.04 
mmol) and cyclohexen-2-one (1a) (8.0 mg, 0.08 mmol) in THF-d8/D2O (600/60 µL) and 
mixed for 3 days (Entry 8, Table 2.4). Reaction was followed by 
1
H NMR analysis 
which did not reveal formation of the desired allyl complex. 
Method 3. An NMR tube was charged with [Rh(cod)(ICy)Ph] (18) (25 mg, 0.04 
mmol), KOH (4.3 mg, 0.08 mmol) and cyclohexen-2-one (1a) (8.0 mg, 0.08 mmol) in 
THF-d8 (600 µL) and mixed for 3 days (Entry 9, Table 2.4). The reaction was followed 
by 
1
H NMR analysis, which revealed the disappearance of 
1
H NMR signals 
corresponding to cyclohexen-2-one (1a) after ~ 1 h. No further reaction was observed 
and the product could not be isolated. 
Method 4. A 10 mL round bottom flask was charged with cyclohexen-2-one (1a) 
(9.2 mg, 0.1 mmol) and NaH (2.3 mg, 0.1 mmol) in THF-d8 (1 mL). The suspension 
was allowed to stir for 1 h before being filtered and transferred to an nmr tube 
containing [Rh(cod)(ICy)Ph] (18) (25 mg, 0.04 mmol). The solution was mixed at rt for 
3 days (Entry 10, Table 2.4). 
1
H NMR analysis showed no change over 3 days, with 
only signals corresponding to [Rh(cod)(ICy)Ph] (18). 
Method 5. A 10 mL round bottom flask was charged with 3-phenylcyclohexan-2-
one (3a) (17.5 mg, 0.1 mmol) and NaH (2.3 mg, 0.1 mmol) in THF-d8 (1 mL). The 
suspension was allowed to stir for 1 h before being filtered and transferred to a nmr tube 
containing [Rh(cod)(ICy)(OH)] (16b) (20 mg, 0.04 mmol). The solution was mixed at rt 
for 3 days (Entry 11, Table 2.4). 
1
H NMR analysis showed no change over 3 days, with 
only signals corresponding to [Rh(cod)(ICy)(OH)] 16b. 
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Table 2.4. Reaction conditions for the attempted preparation of oxa-π-allyl intermediate 
Entry Rh S.M. Solvent Temp (°C) Time 
1 18 C6H6 rt 10 d 
2 18 C6H6 60 3 h 
3 18 nil rt 3 d 
4 18 PhMe 80 3 h 
5 18 THF rt 1 d 
6 18 THF -24 1 d 
7 18 THF 60 3 h 
8 18 THFd8 rt 3 d 
9 18 THFd8 rt 3 d 
10 18 THF rt 3 d 
11 16b THF rt 3 d 
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3. ALKENE HYDROSILYLATION AND DEHYDROGENATIVE 
SILYLATION CATALYSED BY RH(I)-HYDROXIDES 
3.1. INTRODUCTION 
Silicon-carbon bond creation by the addition of silicon hydrides to multiple bonds 
(hydrosilylation or hydrosilation), particularly C=C or C≡C bonds is a key process in 
the preparation of organosilicons (Eq. 1).
186
 Hydrosilylation reactions are typically 
employed in the preparation of industrially important organosilanes such as γ-
substituted propylsilanes, silicon polymers (particularly silicon oils), functional 
siloxanes and silicon resins. Hydrosilylation is also an important process used in the 
cross-linking of silicon polymers to make elastomers and silicon-based release coatings, 
among other applications.
186d
 The hydrosilylation of multiple bonds represents an 
industrially relevant process that has seen much development, particularly with regard 
to the LTM complexes that drive the reaction.
186d, 187
  
 
Hydrosilylation of C=C bonds was conducted as early as 1947 by Sommer, who 
reported the hydrosilylation of 1-octene with trichlorosilane via a free-radical 
mechanism.
188
 In the late 1950’s, a LTM catalysed hydrosilylation process was 
developed by Speier, using hexachloroplatinic acid [Cl6H2Pt] (4).
189
 This was an 
important milestone in the preparation of organosilicons, leading to wide industrial 
application, but suffered from long induction periods and poor selectivity. In 1973, 
Karstedt reported dramatic enhancements to Speier’s catalyst. Karstedt’s divinyl-
siloxane stabilised Pt(0) system (Pt2[Me2SiCH=CH2)2O]3) (5) was to become the 
benchmark of hydrosilylation catalysts, still widely employed in industrial applications 
today.
186d, 190
 In spite of its high activity and wide application, Pt-catalysed 
hydrosilylation is plagued by competing side-reactions such as oligomerisation, 
polymerisation, hydrogenation, redistribution, dehydrogenation and dehydrogenative 
silylation.
186d, 187
 Regio- and stereoselectivity is a major concern, most notably in the 
hydrosilylation of alkynes. Hence, there is great interest in the development of highly 
selective hydrosilylation catalysts.
186d
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Apart from advances made with Pt-catalysts,
186d, 191
 metal complexes of iridium, 
palladium, nickel, ruthenium
186d, 187, 192
 and more recently, non-noble metals
193
 have 
been employed as efficient hydrosilylation catalysts. Rhodium complexes have been 
investigated extensively in the last half century. In particular, Wilkinson’s catalyst and 
its analogues were the first Rh-complexes to be investigated ([Rh(PR3)3X], X = Cl, R = 
Ph for Wilkinson’s catalyst)194 or [Rh(CO)(PR3)2X])
192b
 and were found to be very 
efficient in the hydrosilylation of ketones and aldehydes. Variations of these catalysts 
include the highly active dimethylglyoximate Rh(I-III) complexes, active at catalyst 
loadings as low as 0.004 mol%.
195
 Rh-dimers containing π-acceptor ligands, e.g. 
[Rh2X2Y4] (X = Cl, alkyl groups, OSiOMe3, and Y = olefin, CO, cod, P(OR)3, Cp or 
Cp
*
)
187, 192b, 196
 and [Rh(cod)Cl]2/L (L = PR3) have all been successfully employed as 
hydrosilylation promoters.
187
 Of particular interest to us are carbene complexes, 
specifically those of the type [Rh(cod)(NHC)X] (X = Cl, Br) which have shown 
promising results in the selective hydrosilylation of simple and functionalised alkenes.
73, 
84, 186b, 186c, 187, 197
  
In comparison to other hydrosilylation reactions, particularly hydrosilylation of 
carbonyl compounds, the hydrosilylation of alkenes and alkynes, catalysed by Rh-NHC 
complexes is comparatively underdeveloped, with only limited examples in the 
literature. For example, Buchmeiser has reported the use of a tetrahydopyrimidene-
based NHC complex, [Rh(cod)(NHC)]BF4 (6) (Figure 3.1) which catalysed the 
hydrosilylation of ketones, alkenes and alkynes in only moderate yields but at low 
catalyst loading (0.05 mol%). Complex 6 was also active in the hydrosilylation of 
terminal and internal olefins, ketones and aldehydes.
198
 Oro showed that 
[Rh(cod)(NHC)Cl] complexes 7 and 8 could catalyse the hydrosilylation of terminal 
alkynes with good yields and decent selectivity, with the smaller Me-substituted ligand 
outperforming the bulkier Mes-substituted NHC ligand (Figure 3.1).
199
  
 
Figure 3.1. Rh-NHC complexes employed in hydrosilylation
186b, 198,199
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The use of ionic liquids and in some cases supercritical fluids has boosted the 
activity of Rh-NHC and phosphine functionalised Rh-NHC systems,
186b, 194b, 197a, 200
 
enabling hydrosilylation at loadings as low as 0.005 mol%, with TON’s of up to 
20,000.
200
 For example, [Rh(cod)(NHC)Cl] (9) promoted hydrosilylation of four 
aliphatic alkenes with HSi(OEt)3 (1b) at 0.02 mol% catalyst loading, but reactions 
needed to be conducted at 70 °C in ionic liquid such as 1-butyl-3-methylimidazolium 
hexafluorophosphate (BMimPF6).
186b
 Modifications to this system have included the 
use of phosphines functionalised with imidazolium salts such as those shown in Scheme 
3.1. The 2-phosphine imidazolium salts 10a were prepared and reacted with 
RhCl3·3H2O to give complexes of the type depicted by 11. Catalytic activity of 11 was 
very high in the hydrosilylation of alkenes by HSi(OEt)3 (1b) in ionic liquid medium as 
shown (Eq. 2, Scheme 3.1), giving full conversion of aliphatic alkenes at 0.005 mol% 
catalyst loading of 11a (R
1
 = Me, R
2
 = Et, X = PF6). The authors postulated that the 
electron rich heterocycle has a stabilising effect on the Rh-phosphine centre, leading to 
a highly active catalyst system that could be recycled in ionic liquid.
46
 In a sequential 
study, the same group used imidazolium functionalised phosphines of the type 10b, 
providing ambivalent P,C-donor ligands, in combination with RhCl3·3H2O to perform 
the same hydrosilylation reactions. Catalytic activity was comparable but overall was 
lower than with the well-defined system 11. Presumably, the imidazolyl moiety on 10b 
stabilises the Rh-phosphine interaction in solution, providing a suitable scaffold for 
hydrosilylation to take place.
43a
 
 
Scheme 3.1. Phosphine-NHC functionalised ligands used in hydrosilylation
197a, 200 
A mechanism for hydrosilylation of alkenes was derived in 1965 by Chalk and 
Harrod to describe hydrosilylation using Speier’s catalyst 4 and comprises a 
conventional oxidative addition/reductive elimination sequence.
201
 Hence, oxidative 
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addition of a silane (1) to a metal centre (d
8
 or d
10
) is followed by migratory insertion of 
the alkene into the M-H bond (rate determining step). The resulting metal-silyl-alkyl 
complex then undergoes reductive elimination by Si-C bond formation, releasing the 
alkyl silane product (3) and a metal-alkene complex, formed in the presence of excess 
alkene, propagating the cycle.
192b
 Hydrosilylation in the presence of a rhodium catalyst 
has been documented to proceed via different mechanisms. Rhodium complexes are 
very efficient catalysts in dehydrogenative silylation of multiple bonds, and hence 
dehydrogenative silylation constitutes the most competitive side reaction for Rh-
catalysed systems.
192b
 In the presence of an excess of alkene, the product determining 
step is a competitive β-H transfer from either the σ-alkyl or σ-silylalkyl fragments of 
intermediate (iii) (Scheme 3.2). In the case of dehydrogenative silylation, β-H transfer 
from the silylalkyl fragment releases the vinylsilane (v) and gives a Rh-alky-hydride 
complex. Reductive elimination will then generate the alkane (vi) and the [Rh] complex. 
Hence, dehydrogenative silylation is favoured by a high alkene : silane ratio.
202
 
 
Scheme 3.2 Competitive β-H transfer leading to either alkyl- or vinylsilanes202 
Complexes of Fe, Ni, Co, Pd and Rh have all provided active dehydrogenative 
silylation catalysts, particularly where alkenes with conjugated substituents are used, 
such as styrenes.
202
 Hydrosilylation, catalysed by a rhodium catalyst has been described 
by modified versions of the Chalk-Harrod mechanism (to account for competitive side 
reactions such as dehydrogenative silylation) such as that shown in Scheme 3.3.
192b, 202-
203
 The process is initiated by oxidative addition of a trisubstituted silane (viii) to the Rh 
complex (vii) to give a silyl-Rh(III)-hydride (ix). Alkene insertion into the Rh-silyl 
bond (x), followed by C-H reductive elimination then releases the organosilicon product 
(xiii) and regenerates the active species (vii), propagating the cycle.
192b
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Scheme 3.3. Modified Chalk-Harrod mechanism
192b
 
Following these reports, particularly of Rh-NHC halide complexes being 
employed in hydrosilylation reactions, we aimed to test the use of Rh-NHC hydroxides. 
We were encouraged by the reactivity that the Rh(I)-hydroxide motif had shown in 
catalysing the conjugate addition of arylboronic acids to activated alkenes (Chapter 2) 
and aimed to extend their utility to hydrosilylation. 
Historically, rhodium complexes have performed well as promoters of 
hydrosilylation and in particular, there is a precedent for the use of [Rh(cod)(NHC)Cl] 
complexes in hydrosilylation reactions.
84, 118, 127
 We wanted to examine the effect of 
having an internal base on the Rh-NHC scaffold, in the form of a hydroxide. It has 
previously been established by reports from our group that LTM hydroxides react very 
easily with silanes to form metal siloxides.
62d
 In Chapter 2, steric variations between 
three NHC ligands (IPr L1, ICy L2 and IDD L3) were implicated as being responsible 
for differences in catalytic activity, yet we did not fully explore this theory. In addition 
to the Rh-hydroxides reported in Chapter 1, we aimed to synthesise a novel complex, 
bearing the small 1,3-di(isopropyl)-4,5-dimethylimidazol-2-ylidine (I
i
Pr
Me
) ligand. We 
hoped that I
i
Pr
Me
 would impart even less steric bulk than ICy, yet still be stable enough 
that it would provide a very active catalyst. 
3.2. RESULTS AND DISCUSSION 
[Rh(cod)(I
i
Pr
Me
)(OH)] 13d was prepared from [Rh(cod)Cl]2 (12) and the free 
carbene L4 in the presence of CsOH (Scheme 3.4), according to the established 
procedure (Chapter 2) and fully characterised. 
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Scheme 3.4. Preparation of [Rh(cod)(I
i
Pr
Me
)(OH)] 3d 
In order to test the series of Rh-complexes 13a-d in alkene hydrosilylation, the 
reaction between triethylsilane (1a) and 1-hexene (2a) was selected as the model 
reaction (Scheme 3.5). Reaction conditions were optimised using [Rh(cod)(ICy)(OH)] 
(13b) (see experimental section). Hence, 1a was reacted with two equivalents of 2a in 
toluene at 60 °C in the presence of [Rh(cod)(NHC)(OH)] (13a-d, 0.02 mol%). Gas 
chromatography-mass spectrometry (GC-MS) and 
1
H NMR analysis of the reaction 
mixture indicated that two products were present: triethyl(hexyl)silane (3a) and (E)-
triethyl(hex-1-enyl)silane (14a) (Scheme 3.5). It became clear at this point that 
competitive dehydrogenative silylation was leading to formation of the vinylsilane 14a. 
Selectivity was to become a key issue in these reactions since dehydrogenative 
silylation often competes with hydrosilylation when catalysed by Rh complexes.
187
  
 
Scheme 3.5. Hydrosilylation of terminal alkenes 
Table 3.1. Reaction between 1a and 2a, catalysed by [Rh(cod)(NHC)(OH)] (13a-d)
a
  
Entry Catalyst NHC Conversion (%)
b 
3a (%)
b 
14a (%)
b
 
1 13a IPr L1 85 86 14 
2 13b ICy L2 94 83 17 
3 13c IDD L3 93 84 16 
4 13d I
i
Pr
Me
 L4 93 86 14 
a
Reaction conditions: HSiEt3 (1a) (0.3 mmol), 1-hexene (2a) (0.6 mmol), 13a-d  
(0.02 mol%), toluene (1 mL), 60 °C, 24 h. 
b
Product yields calculated from GC-MS  
(conversion relative to concentration of 1a) and confirmed by 
1
H NMR. 
 
At 60 °C, all four catalysts 13a-d showed high activity (Table 3.1), with 
conversions of 85% for 13a and 93 − 94% for 13b-d, with similar selectivity towards 
the alkylsilane 3a (83 – 86%). In order to obtain a clear comparison between the four 
catalysts, the reaction was repeated under milder conditions. Reaction profiles for each 
entry at room temperature showed considerable differences in performance (Figure 3.1). 
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Paying particular attention to the first 8 h, activity increased in the following order: 13a 
< 13c < 13b < 13d. Complex 13d displayed the highest catalytic activity, boasting full 
conversion after 8 h. Noteworthy is that while Rh-IDD hydroxide 13c was slow to 
initiate, over time the reaction progress surpassed that of Rh-ICy hydroxide 13b. The 
selectivity towards alkylsilane 3a decreased for all entries at lower temperature (71-
75%) except that of Rh-I
i
Pr
Me
 hydroxide 13d which showed only 7% vinylsilane 
production (Table 3.2, Entry 4). 
 
Figure 3.2. Catalytic activity of [Rh(cod)(NHC)(OH)] (13a-d) in the hydrosilylation of 1-
hexene (2a) by HSiEt3 (2a). Reaction conditions shown in Table 3.2 
Table 3.2. Hydrosilylation of 1-hexene (2a) by HSiEt3 (1a) using 13a-d at room temperature.
a 
Entry Catalyst NHC Conversion (%)
b 
3a (%)
b 
14a (%)
b 
1 13a IPr L1 42 72 28 
2 13b  ICy L2 82 75 25 
3 13c  IDD L3 89 71 29 
4 13d  I
i
Pr
Me
 L4 >99 93 7 
a
Reaction conditions: HSiEt3 1a (0.3 mmol), 1-hexene 2a (0.6 mmol),  
13a-d (1.0 mol%), toluene (1 mL), rt, 24 h. 
b
Product yields calculated from GC-MS  
(conversion relative to concentration of HSiEt3 ) and confirmed by 
1
H NMR.  
 
In order to rationalise the variation in catalyst activity between complexes 13a-d, 
the steric and electronic characteristics of the NHC ligands involved (L1-L4) were 
investigated. To compare the steric demand of each ligand, X-ray structures of 
complexes 13a-d were obtained from single crystals, grown by slow evaporation of 
saturated hexane solutions (13c and 13d shown in Figure 3.3, 13a and 13b reported in 
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Chapter 2). The %VBur was calculated for each ligand (L1-L4) using the SambVca 
software
98
 (Table 3.4).  
 
Figure 3.3. Thermal ellipsoid representations of [Rh(cod)(IDD)(OH)] (13c) and 
[Rh(cod)(I
i
Pr
Me
)(OH)] (13d), showing 50% thermal ellipsoid probability. H atoms have been 
omitted for clarity. Selected bond lengths (Å) and bond angles (°):13c Rh(1)-O(1): 2.024 (6), 
Rh(1)-C(1): 2.054 (8), C(1)-Rh(1)-O(1): 89.4 (3); 13d Rh(1)-O(1): 2.074 (3), Rh(1)-C(1): 2.044 
(3), C(1)-Rh(1)-O(1): 90.53 (13). 
Table 3.3. %VBur, TEP and selected bond lengths for complexes 13a-d  
Entry NHC %VBur
a 
TEP (cm
-1
) Rh-C
NHC
 (Å) Rh-OH (Å) 
1 IPr L1 35.1 2051.5
c 
2.046(6) 2.030(4) 
2 ICy L2 27.1 2049.6
b 
2.022(3) 2.036(2) 
3 IDD L3 47.9 2049.0
b 
2.054(8) 2.024(6) 
4 I
i
Pr
Me
 L4 28.0 2049.6
d 
2.044(3) 2.074(3) 
%VBur:
 a
Calculated using SambVca software (sphere radius = 3.5, distance from centre of sphere = 2.00, 
mesh spacing = 0.5, hydrogens omitted);
98
 TEP: calculated from νco([Ir(CO)2Cl(NHC)] in DCM. 
b
Calculations by Nolan et al. 2010.
176
 
c
Calculations by Nolan et al. 2008.
94a
  
d
DFT calculations from [Ni(CO)3(NHC)].
93b
 
As expected, the IDD ligand L3 displays the highest %VBur (47.9%), followed by 
IPr L1 (35.1%). To our surprise, I
i
Pr
Me
 L4 displayed a higher %VBur (28.0%) than ICy 
L2 (27.1%). The difference is only marginal and probably within experimental error, 
however we were surprised by the bulk that was displayed by I
i
Pr
Me
. There are two 
reasons for this: firstly, the methyl groups on the backbone of the NHC will exert a 
steric repulsion on the 
i
Pr substituents, pushing them towards the metal, thereby 
increasing the bulk of I
i
Pr
Me
 within the metal sphere. Secondly, the high degree of 
flexibility of the cyclohexyl rings on ICy means that they are able to adopt positions that 
impose minimal steric interference within the metal sphere, and hence a small %VBur. It 
should be noted that these measurements are calculated for solid state structures and do 
not describe behaviour in solution but do nevertheless give us an indication of the steric 
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environment at each metal centre. A comparison of the bond lengths in the solid state 
was measured from the X-ray structures (Figure 3.3) and showed that the Rh-carbene 
bond of Rh-ICy hydroxide 13b (Table 3.3, Entry 2) is considerably shorter (2.022(3) Å) 
than the other entries. The Rh-OH bond, on the other hand is longest on the Rh-I
i
Pr
Me
 
complex 13d ((2.074(3) Å, Table 3.3, Entry 4). 
To provide a comparison of the electronic character of each ligand, TEP values 
have been included in Table 3.3.
93b, 94a, 176
 The TEP values indicate that the four NHC 
ligands vary only slightly in electronic character. There is no difference in σ-donation 
between ICy L2 (2049.6 cm
-1
) and I
i
Pr
Me
 L4 (2049.6 cm
-1
), while IPr L1 shows the 
lowest σ-donation (2051.5 cm-1) and IDD L3 shows the highest electronic contribution 
(2049.0 cm
-1
). Our group has previously reported that in a series of cycloalkyl-
substituted NHCs, the size of cycloalkyl N-substituents had very little effect on the 
electronics of the ligand and that differences in performance are more likely to result 
from steric contributions.
176
  
In the reaction between 1-hexene (2a) and HSiEt3 (1a) at room temperature, Rh-
ICy hydroxide 13b showed considerably lower activity than Rh-I
i
Pr
Me 
hydroxide 13d 
(Results in Table 3.2, with reaction profiles in Figure 3.2). Catalysts 13b and 13d show 
comparable activity initially, but over time, the reaction with 13b slows down and 
finally plateaus after just six hours. This may be as a result of decomposition of the 
complex, leading to catalyst death, whereas 13d appears to be more robust. Rh-IDD 
hydroxide 13c was slow to initiate hydrosilylation at room temperature, but 
demonstrated high activity after 24 h. This would indicate that high stability and 
inherent flexibility of the ligand may be important in enabling a variable steric 
environment. Our group has shown that the cyclododecyl rings are able to flex in 
solution, providing fluctuating sterics and enabling lower energy barriers for the inter-
conversion between different conformations.
176
 It is interesting that the steric data 
gathered on 13c in the solid state (Table 3.3, Entry 3) indicated a sterically congested 
coordination sphere with a high %VBur (47.9%) for the IDD ligand, yet 13c showed 
great potential as a hydrosilylation catalyst, promoting high yield, particularly at 
elevated temperature (93% conversion for reaction between 1a and 2a (Table 3.1, Entry 
3); and 94% for the reaction between 1a and styrene (2b) (see experimental section) at 
0.02 mol%, 60 °C). Based on these results and those reported separately by our 
group,
176
 it is evident that the high flexibility of the cyclododecyl rings means that 
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structural data collected in the solid state does not necessarily reflect behaviour in 
solution or at elevated temperatures and by no means reflects the catalytic capabilities 
of a complex bearing the IDD ligand.  
Having identified Rh-I
i
Pr
Me
 hydroxide 13d as the most efficient catalyst, we 
investigated the scope and limitations (Scheme 3.6, Table 3.4) for the hydrosilylation of 
terminal alkenes, to demonstrate the versatility of the method and investigate the effect 
of varying the alkene and the silane on catalyst activity and selectivity. In each case, 
reactions were performed under optimised conditions at 60 °C with 0.02 mol% catalyst 
loading. For comparison, each reaction was repeated at room temperature with 1.0 
mol% catalyst loading. Reactions with triethylsilane (1a) showed high conversions, 
particularly at room temperature in the presence of 1.0 mol% of 13d. Reactions with 
aliphatic alkenes (Table 3.4, Entries 1 and 7) gave better selectivity towards the desired 
alkyl silanes under mild conditions (1.00 mol%, room temperature). Triethoxysilane 
(1b) was a very efficient hydrosilylation reagent, giving full conversion to the 
alkylsilane (3) selectively in each case, with the exception of chlorostyrene 2c (Table 
3.4, Entries 9-16). Methyl(diphenyl)silane (1c) also showed high conversions at room 
temperature with 1.00 mol% catalyst loading, delivering the hydrosilylated products (3) 
with pleasing selectivity, particularly when coupled to the aliphatic alkenes (Table 3.4, 
Entries 17 and 23). Triphenylsilane (1d) proved to be a relatively unreactive substrate, 
giving low yield when coupled with 2a and predominant selectivity towards the 
dehydrogenated product 14b when coupled with styrene 2b (Table 3.4, Entries 25-28). 
 
Scheme 3.6. Scope of hydrosilyation of terminal alkenes using Rh hydroxide 
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Table 3.4. Reaction between silanes 1 and terminal alkenes 2
a 
Entry Product 13d (mol%) T (
o
C) Conv
b
 (%) 3 (%)
b 
14 (%)
b,c 
1 
 
1.00 rt
 
>99 93 7 
2 0.02 60 93 86 14 
3 
 
0.50 rt 95 50 50 
4 0.02 60
 
94 67 33 
5 
 
1.00 rt 65 32 68 
6 0.05 60 91 21 79 
7 
 
1.00 rt 92 61 29
d 
8 0.02 60 76 76 16
e 
9 
 
0.50 rt
f
 >99 >99
 
- 
10 0.02 60
f 
>99 >99 - 
11 
 
0.50 rt
f
 >99 >99
 
- 
12 0.02 60 99 >99 - 
13 
 
1.00 rt >99 92 8 
14 0.02 60 99 93 7 
15 
 
0.50 rt >99 >99 - 
16 0.02 60 94 >99 - 
17 
 
1.00 rt 97 >99 - 
18 0.02 60 67 99 <1 
19 
 
1.00 rt >99 88 12 
20 0.02 60 95 60 40 
21 
 
1.00 rt >99 73 27 
22 0.02 60 38 57 43 
23 
 
1.00 rt 96 >99 - 
24 0.02 60 64 >99 - 
25 
 
1.00 rt 30 97 3 
26 0.05 60 32 >99 - 
27 
 
0.50 rt >99 35 65
 
28 0.02 60 >99 35 65
 
a
Reaction conditions: HSiR3 1 (0.3 mmol), alkene 2 (0.6 mmol), 13d, toluene (1 mL), 24 h (unless stated 
otherwise). 
b
Product yields calculated from GC-MS (conversion relative to concentration of HSiR3 ) and 
confirmed by 
1
H NMR. 
c
Stereochemistry determined as (E) for each entry by 
1
H NMR unless stated 
otherwise. Reaction also produces 2-(triethylsilyl)-1-octene 
d
(10%) and 
e
(7%). 
f
Reaction time = 18 h.  
Clearly, there is strong competition between hydrosilylation and dehydrogenative 
silylation in the reactions described (Table 3.4) and selectivity appears to be substrate 
specific. The alkylsilanes (1a, c and d) are more susceptible to dehydrogenative 
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silylation than the silyl ether 1b, while the conjugation in the styrene systems (2b and 
2c) makes them good substrates for dehydrogenative silylation. Selectivity towards 
dehydrogenative silylation ranges from almost non-existent when HSi(OEt)3 (1b) is 
used (Table 3.4, Entries 9-16) to being the dominant process when styrenes are coupled 
to triethyl- (1a) or triphenylsilane (1c) (Table 3.4, Entries 5,6 and 27,28). The selectivity 
in the reaction with methyl(diphenyl)silane 1c was interesting. When reacted with the 
aliphatic alkenes (2a and 2c), the reaction selectively produced the hydrosilylation 
product (3) (Table 3.4, Entries 17 – 18, 23 – 24). However, when coupled to one of the 
styrenes (2b and 2c), competitive dehydrogenative silylation ranged from 12% to 43% 
(Table 3.4, Entries 19 – 22). 
Intrigued by the competition between hydrosilylation and dehydrogenative 
silylation, we investigated the selective preparation of vinylsilanes by dehydrogenative 
silylation of alkenes using 13d, under similar conditions. The ability to prepare 
vinylsilanes directly from alkenes is a valuable process, particularly if stereocontrol is 
achieved, since hydrosilylation of alkynes is often accompanied by side reactions and 
can lead to isomers of the olefinic product.
204
 During reaction optimisation it was 
evident that increasing the alkene concentration favoured the dehydrogenative process. 
In particular, when the styrene (2b) concentration was increased in the reaction with 1a, 
the selectivity could be increased from 40% (Table 3.5, Entry 1) to 95% (Entry 4). 
Table 3.5. Reaction between HSiEt3 (1a) and varied concentrations of styrene (2b)
a 
Entry 2b (equiv.)
b
  Conversion
c
 (%) 3b
c
 (%) 14b
c
 (%) 
1 1  93 60 40 
2 4 >99 19 82 
3 7  >99 11 89 
4 10 >99 5 95 
a
Reaction conditions: 1a (0.3 mmol), 2b
b
(molar equivalence relative to 1a), 13b 1.0 mol%,  
toluene (1 mL), 60 °C, 2.5 h. 
c
Conversion and product ratio calculated by GC-MS  
and confirmed by 
1
H NMR. 
 
Under similar conditions as before, silanes 1a-d were reacted with alkenes 2a-d 
(10 equiv.) at 60 °C (Table 3.6). In eight of the fourteen entries, we observed 
preferential dehydrogenative silylation towards vinylsilane 14 as the major products 
(Table 3.6, Entries 1 − 4, 10, 11, 13 and 14), with seven of the entries showing a 
substantial shift in selectivity (Entries 1 − 4, 10, 11 and 13). Triethoxysilane (1b) only 
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underwent dehydrogenative silylation in the presence of 2c (10 equiv., Table 3.6, Entry 
7) with no dehydrogenative silylation for the other entries (Entries 5,6 and 8). 
1
H NMR 
analyses of products indicated the exclusive formation of the (E)-vinylsilane products 
(undetermined for 14n, Table 3.6, Entry 14).  
Table 3.6. Reaction between silanes and terminal alkenes (10 equiv.)
a
 
Entry Product Conv (%)
b 
3 (%)
b 
14 (%)
b,c 
1 
 
99 43 57 
2 
 
>99 5 95 
3 
 
>99 8 92
 
4 
 
92 35 60
d 
5 
 
>99 >99 - 
6 
 
>99 >99 - 
7 
 
>99 65 35 
8 
 
>99 >99 - 
9 
 
>99 85 15 
10 
 
96 38 62 
11 
 
93 38 62 
12 
 
>99 83 17 
13 
 
99 12 88 
14 
 
>99 8 92
e 
a
Reaction conditions: HSiR3 1 (0.3 mmol), alkene 2 (3.0 mmol), 13d (0.05 mol%), toluene (1 mL), 60 °C, 
24 h. 
b
Product yields calculated from GC-MS (conversion relative to concentration of HSiR3) and 
confirmed by 
1
H NMR analysis. 
c
Stereochemistry determined by 
1
H NMR. 
d
Reaction also produces 
branched product 15a (5%). 
e
Stereochemistry unclear.  
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3.3. CONCLUSIONS 
In summary we have investigated the catalytic potential of a series of four 
[Rh(cod)(NHC)(OH)] complexes in the hydrosilylation of terminal alkenes. The Rh(I)-
hydroxide motif proved to be an efficient catalytic system in hydrosilylation reactions 
with the alkyl-substituted NHCs proving to be better ligands than their aryl-substituted 
counterpart (IPr). Following the reaction profile for the reaction between HSiEt3 (1a) 
and 1-hexene (2a), we identified Rh-I
i
Pr
Me
 hydroxide 13d as the most active and robust 
catalyst. A scope of limitations was developed for the hydrosilylation reaction, 
catalysed by 13d. Reactions between terminal alkenes and silanes could be performed 
for a variety of substrates, with catalytic activity rivalling some of the most active 
catalysts reported.
186b, 197a, 200, 205
 However, selectivity proved to be a key issue, with 
dehydrogenative silylation competing with hydrosilylation to give vinylsilane products. 
Selectivity was very substrate specific, with dehydrogenative silylation ranging from 
non-existent when triethoxysilane (1b) was used, to being the dominant process when 
triphenylsilane (1d) was coupled to styrene (2b).  
We were able to exploit this competitive side reaction by simply increasing the 
quantity of alkene in relation to the silane. Hence, vinylsilanes were prepared from 
alkenes by dehydrogenative silylation in the presence of 13d (0.05 mol%). In several 
cases we observed a substantial shift in selectivity from hydrosilylation to 
dehydrogenative silylation, showing good regio- and stereocontrol at low catalyst 
loading, comparable to the most active catalysts reported in the literature.
202, 206,207
  
  
   Chapter 3: Hydrosilylation  
 
81 
 
3.4. EXPERIMENTAL DETAILS 
3.4.1. General considerations 
Synthesis of Rh-I
i
Pr
Me
 hydroxide was performed inside an MBraun Glovebox 
under inert conditions. All reagents were supplied by Aldrich and used without further 
purification and solvents were distilled and dried as required. NMR data was obtained 
using either a Bruker 400 MHz or 300 MHz spectrometer in the specified deuterated 
solvent. All chemical shifts are given in ppm and coupling constants in Hz. Signals on 
the 
13
C{
1
H} NMR spectra are singlets unless otherwise stated. Spectra were referenced 
to residual protonated solvent signals (for 
1
H) or solvent signals (for 
13
C): (C6D6: 
1H δ 
7.16 ppm, 
13C δ 128.0 ppm; CDCl3: 
1H δ 7.26 ppm). Elemental analyses were 
performed at the London Metropolitan University. Gas chromatography (GC) analyses 
were performed on an Agilent 7890A apparatus equipped with a flame ionisation 
detector and a (5%-Phenyl)-methylpolysiloxane column (30 m, 320 μm, film: 0.25 μm). 
Flow rate 1 mL min
-1
 constant flow, inlet temperature 260 °C, column temperature 50 
°C, 20 °C min
-1
 increase to 70 °C (held for 1 min), 50 °C min
-1
 increase to 300 °C (held 
for 1 min), total time 7.6 min. GC-MS measurements were performed on a Trace GC 
Ultra gas chromatograph equipped with a DSQ II mass selective detector and a RXI
®
-
1ms column (30 m, 0.25 mm, film: 0.25 μm). [Rh(cod)(NHC)(OH)] complexes 13a-d 
were prepared in the manner reported in Chapter 2. CCDC-867621 (13c) and CCDC-
867622 (13d). Crystallographic data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
3.4.2.  Synthesis and Characterisation 
 
[Rh(cod)(IPr)(OH)] (13d) 
A 25 mL Schlenk tube was charged with [Rh(cod)Cl]2 (12) (100 mg, 0.2 mmol), 
I
i
Pr
Me
 L4 (73 mg, 0.4 mmol) and CsOH (122 mg, 0.8 mmol) in THF (5 mL). The 
resultant mixture was stirred overnight then filtered on celite and concentrated in vacuo. 
The resultant solid was washed with hexane (3 x 10 mL) and dried in vacuo to give 
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[Rh(cod)(I
i
Pr
Me
)(OH)] (13d) (132.5 mg 80.0 %) as a yellow solid; 
1
H NMR (300 MHz, 
C6D6): δ 6.46 (quint, 2H, 
3
JHH = 7.1, NCH), 5.32 – 5.18 (m, 2H, cod-CH), 3.16 – 3.05 
(m, 2H, cod-CH), 2.65 – 2.36 (m, 4H, cod-CH2), 2.14 – 1.99 (m, 2H, cod-CH2), 1.96 – 
1.80 (m, 2H, cod-CH2), 1.60 (s, 6H, NC(CH3)), 1.32 (d, 6H, 
3
JHH = 7.0, CH(CH3)2), 
1.29 (d, 6H, 
3
JHH = 7.0, CH(CH3)2); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 184.9 (d, 
1
JRhC = 
56, Rh-NHC), 124.6 (NC(CH3)), 95.9 (d, 
1
JRhC = 8, cod-CH), 71.7 (d, 
1
JRhC = 14, cod-
CH), 53.8 (CH(CH3)2), 34.0 (cod-CH2), 29.2 (cod-CH2), 22.4 (CH3), 22.3 (CH3), 9.8 
(CH3); Anal. Calcd. for C19H33N2ORh (MW 408.38): C, 55.88, H, 8.14, N, 6.86. 
Found: C, 55.76; H, 8.24; N, 6.88. 
3.4.3. Catalysis 
3.4.4. General method for catalytic hydrosilylation 
[Rh(cod)(NHC)(OH)] (13a-d) was dissolved in toluene (1 mL) and removed from 
the glove-box. HSiR3 1a-d and alkene 2a-d were added and the reaction mixture was 
stirred at the stated temperature for 24 h. Conversion to products was determined by GC 
and GC-MS (conversion relative to concentration of HSiR3) and confirmed by 
1
H NMR 
after separation from starting materials by flash chromatography on silica gel with 
hexane as eluent. Stereochemistry of vinylsilanes was determined by 
1
H NMR. 
1
H NMR 
and MS were compared to literature values. 
 
3.4.5. Optimisation studies 
Table 3.7 Solvent optimisation for reaction: HSiEt3 (1a) and styrene (2b)
a 
  T = 5 h T = 24 h 
Entry Solvent Conversion  3b  
 
14b 
 
Conversion  3b  
 
14b 
 
1 Benzene 80 51 49 90 56 44 
2 Dioxane 60 61 39 80 65 35 
3 MeOH 7 32 68 8 40 60 
4 THF 62 50 50 88 56 44 
5 Toluene 70 53 47 92 58 42 
a
Reaction Conditions: 1a (0.3 mmol), 2b (0.3 mmol), [Rh(cod)(ICy)(OH)] (13b) (1.0 mol%), rt, solvent 
(1 mL). Conversions and relative product yields as %; calculated from GC-MS (relative to concentration 
of 1a) and confirmed by 
1
H NMR.  
 
 
 
   Chapter 3: Hydrosilylation  
 
83 
 
 
Table 3.8 Temperature optimisation for reaction: HSiEt3 (1a) and styrene (2b)
a 
  T = 2.5 h T = 5 h 
Entry Temp (°C) Conversion  3b  
 
14b  
 
Conversion  3b  
 
14b  
 
1 rt 32 53 47 70 55 45 
2 60 93 60 40 93 65 35 
3 80 93 65 35 94 67 33 
a
Reaction Conditions: 1a (0.3 mmol), 2b (0.3 mmol), [Rh(cod)(ICy)(OH)] (13b) (1.0 mol%), t, Toluene 
(1mL). Conversions and relative product yields as %; calculated from GC-MS (relative to concentration 
of 1a) and confirmed by 
1
H NMR.  
 
Table 3.9 Reaction of HSiEt3 (1a) with different concentrations of Styrene (2b)
a 
  T = 2.5 h T = 5 h 
Entry Styrene  
(equiv.) 
Conversion  3b  
 
14b  
 
Conversion  3b  
 
14b  
 
1 1 93 60 40 93 65 35 
2 4 >99 19 82 >99 18 82 
3 7 >99 11 89 >99 11 89 
4 10 >99 5 95 >99 5 95 
a
Reaction Conditions: 1a (0.3 mmol), 2b (molar equivalence relative to 1a), [Rh(cod)(ICy)(OH)] (13b) 
(1.0 mol%), 60 °C, Toluene (1mL). Conversions and relative product yields as %; calculated from GC-
MS (relative to concentration of 1a) and confirmed by 
1
H NMR.  
 
Table 3.10 Catalyst loading optimisation for reaction: HSiEt3 (1a) and styrene (2b)
a 
  T = 1 h T = 2.5 h T = 5 h 
Entry [Rh] 3b 
(mol%) 
Conversion 
 
3b  
 
14b  
 
Conversion  3b  
 
14b  
 
Conversion  3b  
 
14b  
 
1 1.000 77 54 44 88 51 49 96 53 47 
2 0.500 68 63 37 82 57 43 90 50 50 
3 0.100 32 70 30 47 69 31 86 65 35 
4 0.005 17 80 20 32 77 23 74 71 29 
5 0.001 1 50 50 4 50 50 12 60 40 
a
Reaction Conditions: 1a (0.3 mmol), 2b (0.6 mmol), [Rh(cod)(ICy)(OH)] (13b) ( mol% relative to 1a), 
60 °C, Toluene (1mL). Conversions and relative product yields as %; calculated from GC-MS (relative to 
concentration of 1a) and confirmed by 
1
H NMR.  
 
Table 3.11 Reaction of HSiEt3 (1a) with different concentrations of 1-hexene (2a)
a
 
  T = 1 h T = 2.5 h T = 5 h 
Entry 1-hexene 
2a (eq.) 
Conversion  3a 
 
14a  
 
Conversion  3a  
 
14a  Conversion  3a  
 
14a  
 
1 1 35 54 46 54 52 48 55 47 53 
2 2 53 85 15 88 94 6 >99 99 1 
3 3 92 82 18 97 85 15 >99 84 16 
4 5 >99 60 40 >99 77 23 >99 70 30 
a
Reaction Conditions: 1a (0.3 mmol), 2a (molar equivalence relative to 1a), [Rh(cod)(ICy)(OH)] (13b) 
(1.0 mol%), 60 °C, Toluene (1mL). Conversions and relative product yields as %; calculated from GC-
MS (relative to concentration of 1a) and confirmed by 
1
H NMR.  
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Table 3.12 Catalyst loading optimisation for reaction: HSiEt3 (1a) and 1-hexene (2a)
a 
  T = 4 h T = 24 h 
Entry [13b] 
(mol%) 
Conversion  
 
3a  
 
14a  
 
Conversion  
 
3a  
 
14a  
 
1 1.00 99 99 1 >99 99 1 
2 0.50 98 95 5 >99 98 2 
3 0.10 90 88 12 93 94 6 
4 0.05 90 85 15 92 88 12 
a
Reaction Conditions: 1a (0.3 mmol), 2a (0.6 mmol), [Rh(cod)(ICy)(OH)] (13b) ( mol% relative to 1a), 
60 °C, Toluene (1mL). Conversions and relative product yields as %; calculated from GC-MS (relative to 
concentration of 1a) and confirmed by 
1
H NMR.  
 
Table 3.13 Catalyst comparison for reaction: HSiEt3 (1a) and 1-hexene (2a) at rt
a
 
   Conversion to Products (3a +14a) (%)/ Time (h) 
Entry [Rh(cod)(NHC)(OH)] 
NHC = 
1 2 3 4 5 6 7 8 24 
1 13a IPr L1 3 6 9 17 20 24 27 28 42 
2 13b ICy L2 40 65 76 78 80 82 82 82 82 
3 13c IDD L3 30 45 54 65 74 76 77 78 89 
4 13d I
i
Pr
Me
 L4 43 75 88 92 96 97 98 98 >99 
a
Reaction Conditions: 1a (0.3 mmol), 2a (0.6 mmol), [Rh(cod)(NHC)(OH)] (13a-d) ( 1.0 mol%), rt, 
Toluene (1mL). Conversions and relative product yields as %; calculated from GC-MS (relative to 
concentration of 1a) and confirmed by 
1
H NMR.  
 
3.4.6. Characterisation data 
triethyl(hexyl)silane 3a 
1
H NMR (300 MHz, CDCl3) δ 1.37 – 1.20 (m, 8H), 0.89 – 0.85 
(m, 12H), 0.58 – 0.40 (m, 8H); GC-MS m/z = 171 (M-C2H5, 100), 163, 143, 115.
208
 
(E)-triethyl(hex-1-en-1-yl)silane 14a: 
1
H NMR (300 MHz, CDCl3, representative 
signals ) δ 6.08 (dt, 1H, 
3
JHH = 18.7, 6.3), 5.59 (dt, 1H, 
3
JHH = 18.7, 1.5), 2.04 – 1.94 (m, 
2H); GC-MS m/z = 198 (M
+
), 169 (M-C2H5, 100), 141, 113.
209
 
triethyl(phenethyl)silane 3b: 
1
H NMR (400MHz, C6D6, representative signals) δ 2.74 (t, 
3
JHH = 8.0, 2H), 1.02 (t, 2H, 
3
JHH = 8.0), 0.83 (q, 9H, 
3
JHH = 8.0), 0.66 (q, 6H, 
3
JHH = 
8.0); GC-MS m/z = 191 (M-C2H5, 100), 163, 135.
194b
 
(E)-triethyl(styryl)silane 14b: 
1
H NMR (400MHz, C6D6) δ 7.20 (d, 
3
JHH = 19.0, 1H), 
6.60 (d, 1H, 
3
JHH = 19.0), 1.19 (t, 9H, 
3
JHH = 7.9), 1.11 (t, 6H, 
3
JHH = 7.9); GC-MS m/z 
= 218 (M
+
), 189 (M-C2H5, 100), 161, 131.
209
 
(4-chlorophenethyl)triethylsilane 3c: 
1
H NMR (300 MHz, CDCl3, representative 
signals) δ 2.43 – 2.30 (m, 2H), 0.99 (t, 2H, 3JHH = 7.6); GC-MS m/z 225 (M-C2H5), 197, 
169, 141, 115, 87 (100).
210
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(E)-(4-chlorostyryl)triethylsilane 14c: 
1
H NMR (300 MHz, CDCl3, representative 
signals) δ 6.61 (d, 3JHH = 19.3, 1H), 6.17 (d, 1H, 
3
JHH = 19.3); GC-MS m/z 252 (M
+
), 
223 (M-C2H5, 100), 195, 167, 131.
211
 
triethyl(octyl)silane 3d: 
1
H NMR (300 MHz, CDCl3) δ 1.40 – 1.19 (m, 12H), 0.98 – 
0.84 (m, 12H), 0.60 – 0.44 (m, 8H); GC-MS m/z 200 (M-C2H5), 199 (100), 171, 115, 
87. 
(E)-triethyl(oct-1-en-1-yl)silane 14d: 
1
H NMR (400MHz, CDCl3, representative 
signals) δ 6.13 (dt, 1H, 3JHH = 18.7, 6.3), 5.63 (dt, 1H, 
3
JHH = 18.7, 1.5) 2.17 -2.08 (m, 
2H); GC-MS m/z 226 (M
+
), 207, 197 (M-C2H5, 100), 169.
212
 
triethoxy(hexyl)silane 3e: 
1
H NMR (300 MHz, CDCl3) δ 3.81 (q, 
3
JHH = 7.0, 6H), 1.67 
– 1.47 (m, 17H), 0.94 – 0.82 (m, 3H), 0.70 – 0.58 (m, 2H); GC-MS m/z 248 (M+), 203 
(M-OC2H5, 100), 163, 149, 139, 119.
186b
 
triethoxy(phenethyl)silane 3f: 
1
H NMR (300 MHz, CDCl3) δ 7.34 – 7.13 (m, 5H), 3.83 
(q, 6H, 
3
JHH = 7.0), 2.79 – 2.70 (m, 2H), 1.24 (t, 9H, 
3
JHH = 7.0), 1.04 – 0.96 (m, 2H); 
GC-MS m/z 268 (M
+
), 240, 223, 195, 163 (100).
200
 
(4-chlorophenethyl)triethoxysilane 3g: 
1
H NMR (300 MHz, CDCl3, representative 
signals) δ 3.82 (q, 3JHH = 7.4, 6H), 2.75 – 2.65 (m, 2H), 0.99 – 0.91 (m, 2H); GC-MS 
m/z 287 (M-CH3), 259 (100), 181.
213
 
(E)-(4-chlorostyryl)triethoxysilane 14e: 
1
H NMR (300 MHz, CDCl3, representative 
signals) δ 6.15 (d, 1H, 3JHH = 19.3); GC-MS m/z 285 (M-CH3), 259, 207, 183, 
181(100).
214
 
triethoxy(octyl)silane 3h: 
1
H NMR (300 MHz, CDCl3) δ 3.91 (q, 6H, J = 7.0), 1.58 – 
1.26 (m, 21H), 0.97 (t, 3H, 
3
JHH = 6.7), 0.78 – 0.67 (m, 2H); GC-MS m/z 276 (M
+
), 231, 
207, 187, 163 (100), 149, 135, 119.
215
 
hexyl(methyl)diphenylsilane 3i: 
1
H NMR (300 MHz, CDCl3) δ 7.60 – 7.48 (m, 4H), 
7.43 – 7.28 (m, 6H), 1.44 – 1.20 (m, 8H), 1.12 – 1.04 (m, 2H), 0.81 – 0.93 (m, 3H), 0.56 
(s, 3H); GC-MS m/z 281 (M
-1
), 267 (M-CH3), 225, 204, 197 (100), 183, 165, 121, 
105.
216
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(E)-hex-1-en-1-yl(methyl)diphenylsilane 14f: 
1
H NMR (300 MHz, CDCl3, 
representative signals) δ 6.21 (dt, 1H, 3JHH = 18.5, 6.2), 5.99 (dt, 1H, 
3
JHH = 18.5, 1.3), 
0.95 (t, 3H, 
3
JHH = 7.2), 0.65 (s, 3H); GC-MS m/z 280 (M
+
), 265, 223, 197 (100), 183, 
145, 121, 105.
217
 
methyl(phenethyl)diphenylsilane 3j: 
1
H NMR (300 MHz, CDCl3, representative 
signals) δ 2.72 – 2.64 (m, 2H), 1.47 – 1.40 (m, 2H), 0.56 (s, 3H); GC-MS m/z 287 (M-
CH3), 224, 197 (100), 183, 165, 146, 121, 105.
216-217
  
(E)-methyldiphenyl(styryl)silane 14g: 
1
H NMR (300 MHz, CDCl3, representative 
signals) δ 6.96 (d, 3JHH = 19.0, 1H), 6.75 (d, 1H, 
3
JHH = 19.0), 0.71 (s, 3H); GC-MS m/z 
300 (M
+
), 285, 222, 207 (100), 197, 183, 165, 155, 145, 129, 121, 105.
218
  
(4-chlorophenethyl)(methyl)diphenylsilane 3k: 
1
H NMR (300 MHz, CDCl3, 
representative signals) δ 2.72 – 2.63 (m, 2H), 1.46 – 1.37 (m, 2H), 0.55 (s, 3H); GC-MS 
m/z 321 (M-CH3), 281, 258, 243, 207, 197 (100).
216
  
(E)-(4-chlorostyryl)(methyl)diphenylsilane 14h: 
1
H NMR (300 MHz, CDCl3) δ 7.58 (d, 
2H, 
3
JHH = 7.5), 7.47 (d, 2H, 
3
JHH = 7.6), 7.43 – 7.26 (m, 10H), 6.97 (d, 1H, 
3
JHH = 
19.1), 6.76 (d, 1H, 
3
JHH = 19.1), 0.72 (s, 3H); GC-MS m/z 334 (M
+
), 319, 256, 241 
(100), 222, 207, 183, 179, 165, 155, 121, 105. 
methyl(octyl)diphenylsilane 3l: 
1
H NMR (300 MHz, CDCl3) δ 7.46 – 7.33 (m, 10H), 
1.49 – 1.21 (m, 12H), 1.15 – 1.07 (m, 2H), 0.91 (t, 3H, 3JHH = 7.0), 0.58 (s, 3H); GC-
MS m/z 295 (M-CH3), 232, 197 (100), 183, 165, 121, 105.
216
 
(E)-methyl(oct-1-en-1-yl)diphenylsilane 14i: 
1
H NMR (300 MHz, CDCl3, 
representative signals) δ 6.21 (dt, 1H, 3JHH = 18.6, 6.2), 5.99 (dt, 1H, 
3
JHH = 18.5, 1.4), 
0.65 (s, 3H); GC-MS m/z 308 (M
+
), 293, 281, 223, 197 (100), 183, 145, 121, 105. 
hexyltriphenylsilane 3m: 
1
H NMR (300 MHz, CDCl3, representative signals) δ 0.89 (t, 
2H, 
3
JHH = 7.4); GC-MS m/z 315 (M-C2H5), 282, 267, 259 (100), 181.  
(E)-hex-1-en-1-yltriphenylsilane 14j: 
1
H NMR (300 MHz, CDCl3, representative 
signals) δ 6.28 – 6.34 (m, 2H), 1.02 (t, 2H, 3JHH = 7.2); GC-MS m/z 342 (M
+
), 260, 182 
(100).
209
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phenethyltriphenylsilane 3n: 
1
H NMR (300 MHz, CDCl3, representative signals) δ 2.82 
– 2.72 (m, 2H), 1.80 – 1.69 (m, 2H); GC-MS m/z 287 (M-C6H5), 281, 259 (100), 207, 
181.  
triphenyl(styryl)silane 14k: 
1
H NMR (300 MHz, CDCl3) δ 7.55 – 7.43 (m, 6H), 7.41 – 
7.18 (m, 14H), 7.18 – 7.13 (m, 2H); GC-MS m/z 285 (M-C6H5), 259, 207, 181 (100), 
105.
209
 
triethyl(oct-1-en-2-yl)silane 15a: 
1
H NMR (300 MHz, CDCl3) δ 5.47 – 5.42 (m, 2H), 
1.92 – 2.0 (m, 2H); GC-MS m/z 226 (M+), 197, 169, 115 (100), 87.212 
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4. WELL-DEFINED IRIDIUM(I) HYDROXIDES AND 
THEIR ACTIVITY IN BOND ACTIVATION 
4.1. INTRODUCTION 
Following the successful preparation of Rh(I)-hydroxides (described in Chapters 2 
and 3) we aimed to extend the scope of metal hydroxides to include iridium. The 
relatively high cost of rhodium and iridium encourages innovative preparations and it is 
imperative to develop successively more active generations of metal complexes. NHC 
ligands have proven highly beneficial in enhancing iridium-based catalysis and many Ir-
NHC complexes have been prepared in various forms, finding success in myriad 
applications such as (de)hydrogenation, transfer hydrogenation, hydrosilylation, 
oxidation, H/D exchange, alkylation and hydroamination, among others.
84, 119
 Ir-NHC 
complexes are also known to undergo intramolecular C-H bond activations to generate 
new motifs and have been studied extensively in this regard.
144, 147a, 147c, 147d, 219
 Ir-
hydroxide complexes are relatively scarce. Monomeric Ir(I)- and Ir(III)-hydroxide 
complexes have been prepared predominantly via ligand metathesis with inorganic 
bases or by oxidative addition of water.
14, 15b, c, 19 
Several hydroxide complexes were 
discussed in Chapter 1 and in particular we focused on the following complexes: 
[IrCp
*
(OH)Ph(PMe3)] (1),
45
 [Rh(PPh3)2(µ-OH)]2 (2)
47
 and [Ru(dpme)2(H)(OH)] (3).
53
 
The authors of these reports tested the reactivity of complexes 1 − 3 towards a number 
of organic substrates. In each case, the metal hydroxide was able to deprotonate a range 
of C-H, O-H and N-H bonds to deliver new species of all three metals.  
The first metal hydroxides to be reported by our group were the Au(I) and Cu(I) 
hydroxides, both of which were isolated with the use of the strongly σ-donating IPr 
ligand. Both of these metal hydroxides were very efficient bond activation reagents, 
able to coordinate a large array of substrates by deprotonation of suitably acidic C-H, N-
H, O-H, Si-H and P-H bonds. 
62
  
To the best of our knowledge, only a single NHC-bearing Ir(I)-hydroxide complex 
has been reported in the literature to date: [Ir(cod)(IMes)(OH)] (4a) (IMes = 1,3-(2,4,6-
trimethylphenyl)imidazol-2-ylidene) was isolated serendipitously by Marciniec and co-
workers via the reaction between [Ir(cod)(IMes)Cl] (5a) and KO
t
Bu, presumably in the 
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presence of adventitious water.
177
 Although the authors report a crystal structure for 4a 
there is no proof of bulk purity and hence, this cannot be seen as a general synthetic 
approach. Furthermore, the reactivity of this motif has not been explored. In order to 
approach this important problem, we set out to systematically prepare a series of 
[Ir(cod)(NHC)(OH)] complexes and probe their reactivity with key reagents. Firstly, a 
straightforward, reliable and scalable synthetic method was sought. Once a general 
procedure was established, we endeavoured to fully explore the potential of these 
complexes as synthons for organometallic chemistry and to establish their value in the 
development of new catalytic processes and useful materials. 
4.2. RESULTS AND DISCUSSION 
4.2.1. Iridium(I) hydroxide synthesis 
[Ir(cod)(NHC)Cl] complexes 5a-d were prepared from [Ir(cod)Cl]2 (6) and the 
corresponding free carbene L1-4 following a simple reported procedure (Scheme 
4.1).
81d, 101b, 106, 220
 Subsequent substitution of the chloride moieties on 5a-d using CsOH 
at room temperature produced the desired complexes 4a-d. However, the yields were 
low even after long reaction times, particularly when aryl-substituted NHC ligands were 
used. For example, in the case of 4b, bearing IPr, only 75% conversion was achieved 
under vigorous stirring for 10 days in the presence of eight equivalents of CsOH. 
Similarly, in an attempted one-pot preparation (as described in Chapter 2) of 
[Ir(cod)(NHC)(OH)] from 6 using free NHC and CsOH in THF, attachment of the NHC 
ligand was swift but chloride substitution was still very slow, as determined by 
1
H NMR 
spectroscopy. We considered that the insolubility of CsOH in THF might be responsible 
for the low reactivity. Gratifyingly, when 6 was stirred with free NHC and CsOH in 
THF/H2O (10:1) under inert atmosphere at 40 °C for only 24 h, [Ir(cod)(NHC)(OH)] 
(4a-d, NHC = IMes L1, IPr L2, IDD L3, I
i
Pr
Me
 L4) were afforded in moderate to high 
yields (Scheme 4.1). However, this method was unsuccessful when ICy L5 and 1,3-
diisopropylimidazol-2-ylidene (I
i
Pr L6), were used, leading instead to a mixture of 
products. 
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Scheme 4.1. Preparation of [Ir(cod)(NHC)Cl] (5a-d) and [Ir(cod)(NHC)(OH)] (4a-d) 
complexes from free NHCs. 
a 
CsOH: up to 8 equiv. and time: up to 10 days for IPr.  
When the reactions were performed with ICy L5 or I
i
Pr L6 in the absence of 
CsOH, two products were isolated by silica gel chromatography in each case: 
[Ir(cod)(NHC)Cl] (5e-f) as yellow solids, and [Ir(cod)(NHC)2]
+
Cl
- 
(7e-f) as red solids in 
a 40:60 ratio, respectively (Scheme 4.2). The formation of bis-NHC complexes was not 
altogether surprising since there is a precedent for their preparation in the literature,
10a, 11
 
yet we were surprised that I
i
Pr
Me
 showed no propensity towards dicoordination and that 
5d could be prepared following the one-pot procedure. Once isolated, 5e-f underwent 
reaction with CsOH under mild reaction conditions to provide the corresponding 
hydroxides 4e-f.  
 
Scheme 4.2. Preparation of [Ir(cod)(NHC)Cl] (5e-f)  
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To avoid undesired dicoordination and increase the overall yield, we followed an 
alternative, silver transmetalation route to prepare [Ir(cod)(NHC)Cl] complexes 5e-f 
(Scheme 4.3).
101b, 102-103, 220
 Ag2O was stirred with the imidazolium salts, ICy·HCl and 
I
i
Pr·HCl in CH2Cl2 under air to provide the corresponding silver NHC salts, which were 
then reacted with 6. This method provided easy access to 5e and 5f in moderate to good 
yields (64% and 74% respectively), avoiding free carbenes and hence the need for 
rigorously air-free conditions.  
 
Scheme 4.3. Preparation of [Ir(cod)(NHC)(OH)] bearing small NHC ligands  
Complexes 4a-f were fully characterised by 
1
H and 
13
C{
1
H} NMR spectroscopy 
as well as elemental analysis. 
1
H NMR analysis showed the hydroxyl moiety to resonate 
as a sharp singlet between 1.66 and 2.47 ppm in C6D6. When a drop of degassed D2O 
was added to a THF-d8 solution of 4f, H-D exchange was observed at the hydroxyl 
moiety and only the corresponding 
1
H NMR
 
signal (2.01 ppm) disappeared, thus 
confirming the assignment. Furthermore, the presence of a hydroxide functionality was 
confirmed by FTIR (ATR) spectroscopic analysis of 4f which showed the diagnostic 
hydroxide stretch as a weak band at δ 3612.7 cm-1. Single crystals of 4c-f were grown 
by slow evaporation of saturated alkane solutions; X-ray analysis confirmed the 
structures, which adopt square planar geometries around the metal with the NHC and 
OH ligands cis to each other (Figure 4.1, the X-ray structure for 4a is known
196
). 
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Figure 4.1. Thermal elipsoid representations of [Ir(cod)(NHC)(OH)] (4c-f) (NHC = IDD 4c, 
I
i
Pr
Me
 4d, ICy 4e, I
i
Pr 4f); showing 50% thermal ellipsoid probability. H atoms are omitted for 
clarity. 
Table 4.1. Selected bond lengths (Å) and bond angles (°) for 4c-f 
Entry Complex Ir(1)-C(1) Ir(1)-O(1) C(1)-Ir(1)-O(1) 
1 4c 2.061(6) 2.035(4) 90.27(18) 
2 4d 2.058(10) 2.041(8) 92.0(4) 
3 4e 2.034(12) 2.015(8) 86.8(4) 
4 4f 2.046(9) 2.020(6) 90.1(3) 
 
Table 4.1 provides selected bond lengths and angles for each of 4c-f. The 
differences in Ir-carbene bond lengths are minimal when the error is taken into account, 
as are the Ir-OH bond lengths. TEP values for each of the NHCs, obtained from the 
literature gives an indication of the electron donation from each ligand, and again the 
differences are marginal (2049.6 – 2051.5 cm-1),93b, 94a, 176 indicating a similar level of 
electron donation from each ligand to the Ir centre. In Chapter 3, we reported that 
differences in reactivity between complexes of rhodium, bearing different NHCs are 
more likely to be the result of differences in steric rather than electronic 
4
e 
O1 
Ir1 Ir1 
C1 
C1 
O1 
C1 
Ir1 Ir1 
C1 
O1 
O1 
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characteristics.
13b, 25a 
Since NHC ligands occupy space within the metal sphere, 
differences in steric bulk have a direct impact on the ability of the complex to react with 
other substrates. To quantify the steric bulk of the NHC ligands, percent buried volumes 
(%Vbur) were calculated from the X-ray structures of 4c-f using the SambVca 
software.
98
 Steric contour maps were also generated to give a visual distribution of the 
total %Vbur over four quadrants as viewed along the z-axis (Ir(1)-C(1)) and are shown in 
Figure 4.2.  
It is evident from these calculations (Figure 4.2) that the high degree of flexibility 
associated with cycloalkyl-substituted NHC ligands enables them to adopt 
conformations that exert a minimum amount of steric demand on the metal centre. For 
example, IDD in 4c has a total %Vbur of only 33.4%, with the steric bulk concentrated 
into two quadrants, while NHC ligands in 4d-f show low %Vbur with a more even 
distribution of bulk around the metal centre. I
i
Pr
Me
 shows greater bulk than ICy and I
i
Pr, 
which explains why it does not form bis-NHC complexes in the same way as ICy and 
I
i
Pr do. One might expect the cyclohexyl rings on ICy to impart greater bulk than the 
isopropyl groups on I
i
Pr
Me
. However, the flexibility of the cyclohexyl rings means that 
they may adopt an arrangement that exerts a minimal amount of steric pressure on the 
metal centre, occupying equal space to an isopropyl group within the metal sphere.
220
 
Hence, the difference in steric bulk between ICy and I
i
Pr
Me
 is likely the result of steric 
repulsion between the backbone substituents and the N-substituents. Our group
221
 and 
Grubbs
222
 have shown experimentally that substitution on the backbone of aryl-
substituted NHC ligands has a noticeable effect on electronics and sterics. Grubbs 
indicated that backbone substitution imposes rotational barriers on the N-substituents, 
which increases the stability of corresponding Ru-complexes by minimising 
decomposition. Cavallo and co-workers have supported this hypothesis with theoretical 
calculations, indicating that backbone substitution could significantly alter the 
conformational behaviour of aryl-substituted NHC ligands
223
 and thus disfavour the first 
step of Ru-catalyst decomposition via C-H insertion on the aryl rings.
224
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Figure 4.2. Steric contour maps for complexes 4c-f showing %Vbur for each NHC.
 
Calculated 
using SambVca software (sphere radius = 3.5, distance from centre of sphere = 2.00, mesh 
spacing = 0.1, hydrogens omitted).
98 
 
 36.3 
 29.0 
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In an effort to better understand the effect of backbone substitution on the spatial 
arrangement of isopropyl and cyclohexyl N-substituents, Dr David Nelson modelled 
simplified NHCs 8a-d using Gaussian 09.
225
 8a-d were constructed ( = 0°) and 
geometries were optimised (B3LYP/6-31+G*) with the cyclohexyl rings in the chair 
conformation and the imidazolium ring in the equatorial position. Dihedral angle  was 
stepped in 10° increments using a relaxed PES scan. The (electronic) energy was 
evaluated at each step (Scheme 4.4, Figure 4.3). 
 
Scheme 4.4. Theoretical NHC compounds 8a-d modelled using DFT calculations 
  
Figure 4.3. Plot of energy (B3LYP/6-31+G*) vs. angle  in theoretical compounds 8a (iPr/H), 
8b (
i
Pr/Me), 8c (Cy/H) and 8d (Cy/Me); all energies are relative to E( = 180°). 
Figure 4.3 illustrates that the relative energies at  = 0° (alkyl groups pointing 
towards where the metal centre would be) and  = 180° (alkyl groups pointing away 
from the metal centre), and the barriers between those two conformations, vary greatly 
depending on the backbone substitution pattern. However, isopropyl- and cyclohexyl-
substituted compounds behave in the same manner, so the backbone substitution only 
appears to interact with functionality close to the nitrogen atom. Compounds without 
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backbone substitution (8a,c) prefer  = 180° (by ca. 2-fold), while when R' = Me 
(8b,d),  = 0° is preferred (by ca. 20 fold). It should be noted, however, that these 
compounds are models due to the vastly increased computational cost of considering 
full complexes, and do not contain the metal centre; the inclusion of a (square planar) 
iridium centre would likely alter the energies of the rotation. However, we feel that this 
can go some way to explain why I
i
Pr
Me
 L4 behaves as if it is considerably more bulky 
than ICy L5 or I
i
Pr L6 and forms only monocoordinated complexes of Ir, while ICy and 
I
i
Pr favour dicoordination.  
4.2.2. Reactivity 
Having developed a synthetic route for Ir(I)-hydroxides, their reactivity with a 
range of functional groups was explored. [Ir(cod)(I
i
Pr)(OH)] (4f) was used as a model 
complex since previous experience with the isoelectronic Rh(I)-hydroxides dictated that 
the complexes bearing the smallest NHC ligands were the most active
226
 and the highly 
diagnostic 
1
H NMR spectrum of 4f made it simple to follow the reaction progress. First, 
nucleophilic attack of (or transmetalation with) arylboronic acids was investigated, 
since coupling with boronic acids provides convenient access to M-Ar compounds, 
which are important intermediates for C-C coupling reactions such as conjugate 
additions.
15
 The reaction between phenylboronic acid and Rh-ICy hydroxide gives 
quantitative conversion to the Rh(I)-phenyl complex almost instantly at room 
temperature (Chapter 2).
227
 However, the reaction between arylboronic acids and 4f was 
much slower, requiring heating at 60 °C for 16 h to give 9a-b, which were isolated as 
red solids in only 35 and 46% yield (Scheme 4.5). X-ray analysis of single crystals of 
9b (Figure 4.4) confirmed the identity of the square planar complex with the aryl group 
cis to the NHC ligand, and slightly twisted from the Ir(1)-carbene plane, analogous to 
the Rh(I)-phenyl complex.
227
 In the conjugate addition study (Chapter 2) we reported 
that the high activity displayed by Rh-ICy hydroxide was largely due to the ease with 
which it underwent transmetallation with arylboronic acids, yet this is clearly not the 
case for iridium(I)-hydroxide. 
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Scheme 4.5. Transmetalation with arylboronic acids. 
  
Figure 4.4. Thermal ellipsoid representation of [Ir(cod)(I
i
Pr)(p-MeOC6H4)] (9b), showing 50% 
thermal ellipsoid probability. H atoms are omitted for clarity. Selected bond lengths (Å) and 
bond angles (°): Ir(1)-C(1): 2.057(10), Ir(1)-C(12): 2.065(8), C(1)-Ir(1)-C(12): 89.5(4).  
 Next we probed the activation of silicon compounds, an important step in the 
preparation of organosilicons and hydrosilylation reactions.
186-187, 226
 Reaction of 4f with 
PhSi(OMe)3 liberated MeOH to give Ir(I)-siloxide 10 (Scheme 4.6, Figure 4.5). Metal 
siloxide complexes have been investigated extensively due to their immobilisation 
capabilities on silicate surfaces.
14a
 However, reports of siloxide complexes of LTMs are 
relatively scarce in comparison to those of early TMs.
228
 Monomeric Ir(I)-siloxides 
were first reported in 2002, by Marciniec.
229
 The same group reported the preparation of 
[Ir(cod)(IMes)(OSiMe3)] in 2008 from the corresponding Ir-(µ-siloxide) dimer
177
 and 
they have shown extensive catalytic potential for Ir-siloxides in silicon-related 
catalysis.
202, 230 
The isolation of an Ir-Si complex from the reaction with HSiR3 was not 
possible, since the formation of an Si-O bond is highly favourable
231
 and reaction 
between 4f and HSiPh3 again resulted in formation of an Ir(I)-siloxide 11. X-ray 
analysis of single crystals confirmed the structure of 11 (Figure 4.5). The Ir(1)-O(1)-
Si(1) bond angle for 10 (137.7(2)°) is more acute than for 11 (155.2(5)°). In agreement 
with this observation, Marciniec has reported that steric strain has a powerful influence 
on the Ir-siloxide bond angle and the angle increases with steric bulk of the siloxide 
substituents.
228
 The unexpected formation of 11 was interesting since it represents the 
preparation of an Ir(I)-siloxide complex via deprotonation of a very bulky silane and 
release of H2. It is important to mention that during preparation of 11, H2 was released 
9
b 
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as a side product. If the reaction vessel was not vented to the atmosphere then an 
intractable mixture of hydride complexes was obtained as well as 11, indicating the 
instability of 4f to the presence of hydrogen.  
 
Scheme 4.6. Silane activation with Ir(I)-hydroxides.  
  
Figure 4.5. Thermal ellipsoid representations of [Ir(cod)(I
i
Pr)(OSi(OMe)2 Ph)] (10) and 
[Ir(cod)(I
i
Pr)(OSiPh3)] (11) showing 50% thermal ellipsoid probability. H atoms are omitted for 
clarity. Selected bond lengths (Å) and bond angles (°): 10: Ir(1)-C(1): 2.047(5), Ir(1)-O(1): 
2.041(4), Ir(1)-O(1)-Si(1): 137.7(2); 11: Ir(1)-C(1): 2.056(11), Ir(1)-O(1): 2.034(7), Ir(1)-O(1)-
Si(1): 155.2(5). 
In order to identify a different kind of reaction with silicon substrates we 
examined the reaction between 4f and trimethylsilylcyanide (TMSCN) in the hope of 
preparing an Ir(I)-CN complex. Ir-CN adducts have been prepared previously by 
oxidative addition of HCN to give hydrido-cyano complexes,
232
 while Eisenberg has 
prepared Ir(I)-CN complexes using (N(PPh3)2CN), and demonstrated their usefulness in 
the oxidative addition of H2 and the reduction of CO2 with alkyl silanes.
233
 
Cyclometalated Ir-CN complexes, prepared via chloride substitution on the metal using 
NaCN or KCN, have featured extensively in light-emitting electrochemical cells and 
oxygen sensor applications.
234
 Gratifyingly, 4f reacted instantaneously with TMSCN at 
-40 °C to give 12 in 90% yield (Scheme 4.6 and Figure 4.6).
62a, 62d
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Figure 4.6. Thermal ellipsoid representation of [Ir(cod)(IiPr)(CN)] 12 showing 50% thermal 
ellipsoid probability. H atoms have been omitted for clarity. Selected bond lengths (Å) and bond 
angles (°):Ir1-C1 2.044(7), Ir1 C31 2.012(9), N31 C31 1.141(12) 
Next, we turned our attention to C-H, N-H and O-H bond activation. The 
attraction of an Ir(I)-hydroxide synthon is that reactivity should be confined to the 
hydroxyl moiety, which can act as an internal base that is capable of removing suitably 
acidic protons, to afford new iridium complexes without increasing the oxidation state 
of the metal. Furthermore, these bond activations should release only water as a by-
product, enabling atom efficient transformations with simple purifications. Indeed, 4f 
deprotonated MeOH at room temperature to give the Ir(I)-methoxide 13 in almost 
quantitative yield (Scheme 4.7). Similarly, 4f reacted with phenol to give the Ir(I)-
phenoxide 14 but was unable to react with tert-butanol. There are two possible reasons 
for this inactivity. Firstly, an Ir(I)-O
t
Bu might be highly sterically strained owing to the 
steric bulk of the butyl group. Secondly, the pKa of 
t
BuOH is higher than that of H2O 
(32.0 vs 31.4 in DMSO from Bordwell’s pKa tables),
235
 hence, the proton may not be 
acidic enough to be activated by the Ir-OH. Similarly, reaction with benzoic acid 
furnished Ir-benzoate complex 15. Single crystal X-ray analysis of 15 confirmed the 
square planar geometry, with the phenyl ring of the benzoate perpendicular to the NHC 
plane (Figure 4.7).  
Several Ir-OR complexes have been reported in the literature, particularly via 
metathesis reactions.
19, 236
 Bergman prepared an Ir(III)-ethoxide complex by treating 
[IrCp
*
(PPh3)Cl2] with NaOEt in EtOH to give [IrCp
*
H(OEt)(PPh3)] and CO2 could be 
inserted into the Ir-OEt to generate an Ir(III)-carbonate complex.
14a, 237
 Both Ir-
alkoxides and Ir-carboxylates have been prepared via oxidative addition of alcohols or 
carboxylic acids, respectively.
238
 However, Ir(I)-NHC-carboxylate complexes are to the 
best of our knowledge, limited to a single example, made by salt metathesis with 
   Chapter 4: Bond Activation 
 
101 
 
AgO2CCF3.
220
 The simple deprotonation method shown here provides a straightforward 
route to Ir(I)-alkoxides and Ir(I)-carboxylates.  
 
Scheme 4.7. Deprotonation of methanol, phenol and benzoic acid by Ir(I)-hydroxide 4f 
The activation of amines was achieved by reacting 4f with p-bromoaniline, 
affording the Ir(I)-anilide 16, and with benzylamine to give the Ir(I)-benzamide 17 
(Scheme 4.8). Amido complexes of iridium have been prepared in the literature by salt 
metathesis
51b
 or oxidative addition of amines.
239
 The scope of reactivity that these 
amido complexes are capable of is vast and exciting.
19, 240
 The field has been accelerated 
by the ability to prepare terminal amido-complexes via the activation of anilines and 
ammonia, and several researchers have made tremendous strides in this regard.
241
  
 
Scheme 4.8. N-H bond activation by 4f with bromoaniline and benzylamine  
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Figure 4.7. Thermal ellipsoid representation of [Ir(cod)(I
i
Pr)(OC(O)Ph)] (15) and 
[Ir(cod)(I
i
Pr)(NH(C6H4Br)] (16) showing 50% thermal ellipsoid probability. H atoms have been 
omitted for clarity. Selected bond lengths (Å) and bond angles (°): 15: Ir(1)-C(1): 2.08(2), Ir(1)-
O(1): 2.068(15), C(1)-Ir(1)-O(1): 90.6(7), Ir(1)-O(1)-C(12): 124.4(14); 16: Ir(1)-C(1): 2.053(8), 
Ir(1)-N(1): 2.057(7), N(1)-C(12): 1.395(9), C(1)-Ir(1)-N(1): 94.3(3), Ir(1)-N(1)-C(12): 140.3(5). 
 Some of the most important bond activations in synthetic chemistry are those 
involving C-H bonds. The discovery of catalysts capable of selective activation and 
functionalisation of C-H bonds under mild conditions with low generation of waste is an 
area of high importance.
242
 In addition to the reports of metal hydroxides by Alper
47
 and 
Bergman and their co-workers,
45, 51a, 53
 which were discussed in Chapter 1, Burger and 
Bergman reported the preparation of [Ir(Cp*)Me(OTf)(PMe3)] (18), which is capable of 
deprotonating a range of organic substrates, generating methane as a by-product and 
furnishing the corresponding Ir-alkyl products.
243
 Somewhat similarly, Murata et al. 
have deprotonated phenylacetylene, acetone and nitromethane using [Ir(Cp*)((S,S)-
TsCYDN)] (19) ((S,S)-TsCYDN = (1S,2S)N-(p-toluenesulfonyl)-1,2-cyclohexane-
diamine), whereby the activated proton is transferred to the amide ligand, yielding an 
amine, while the remainder of the fragment coordinates to the metal centre.
244
 Oro et al. 
reported the deprotonation of terminal alkynes with Ir(I)-OMe complexes, generating 
methanol as the by-product and yielding Ir(I)-acetylides,
245
 which have been implicated 
as intermediates in the coupling of terminal alkynes with trialkylsilyl halides
246
 and the 
dimerisation of alkynes;
247
 Ir(I)-acetylides are also useful intermediates en route to 
phosphorescent allenylidene complexes.
248
 
 We tested the activity of 4f in the deprotonation of a number of alkyl complexes 
bearing sp, sp
2
 and sp
3
 hybridised centres. Gratifyingly, activation of nitromethane by 4f 
was incredibly swift. Yellow Ir(I)-hydroxide 4f turned an intense red colour 
immediately upon contact with the substrate. 
1
H NMR analysis of the product indicated 
full conversion to nitromethylene complex 20 (Scheme 4.9), and single crystal X-ray 
   Chapter 4: Bond Activation 
 
103 
 
analysis (Figure 4.8) showed the sp
3
-methylene (Ir(1)-C(12)-N(13) = 114.5°) to be 
slightly twisted from the Ir-NHC bond axis.  
 
Scheme 4.9. C-H bond activations using 4f. 
 In addition, 4f was able to deprotonate acetone and dimethyl malonate to give 
the alkyl complexes 21 and 22 respectively (Scheme 4.9). Multinuclear NMR and single 
crystal X-ray analyses for 21 (Figure 4.8) and 22 (Figure 4.9) explicitly confirmed the 
formal C-H activation in each case to give Ir(I)-alkyl bonds and not co-ordination via an 
oxygen atom. Activation of a C-H bond on an sp-hybridised carbon centre was 
accomplished via reaction of 4f with phenylacetylene to give a terminal acetylide 
complex 23 (Scheme 4.9). Single crystal X-ray analysis confirmed the linear triple bond 
of the acetylide fragment (C(12)-C(13) 1.216(12), Figure 4.9).  
 
Figure 4.8 Thermal ellipsoid representations of [Ir(cod)(I
i
Pr)(CH2NO2)] (20), 
[Ir(cod)(I
i
Pr)(CH2COCH3)] (21) showing 50% thermal ellipsoid probability. H atoms have been 
omitted for clarity. Selected bond lengths (Å) and bond angles (°): 20: Ir(1)-C(1): 2.056(10), 
Ir(1)-C(12): 2.116(12), C(1)-Ir(1)-C(12): 95.2(5), Ir(1)-C(12)-N(13): 114.5(10); 21: Ir(1)-C(1): 
2.048(14), Ir(1)-C(31): 2.134(18) 
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Figure 4.9. Thermal ellipsoid representations of [Ir(cod)(I
i
Pr)(CH(COOMe)2] (22) and 
[Ir(cod)(I
i
Pr)(CCPh)] (23) showing 50% thermal ellipsoid probability. H atoms have been 
omitted for clarity. Selected bond lengths (Å) and bond angles (°): 22: Ir(1)-C(1): 2.025(9), 
Ir(1)-C(14): 2.169(9), C(1)-Ir(1)-C(14): 87.7(4), Ir(1)-C(14)-C(13): 109.3(6); 23: Ir(1)-C(1): 
2.043(7), Ir(1)-C(12): 2.007(8), C(12)-C(13): 1.216(12). 
C-H activations of sp
2
 carbon centres were also investigated via reactions with 
fluorinated arenes. If the Ir(I)-hydroxide is viewed as a Brønsted base
62a, 62d
 then C-H 
activation of fluorinated arenes provides an indication of the acidity of protons that can 
be activated by 4f. Indeed we were able to activate pentafluorobenzene at 60 °C (24, 
Scheme 4.9) but unable to activate 1,3,5-trifluorobenzene. Guo and co-workers have 
calculated pKa (± 1.1 units) for a range of aromatic compounds, including 
fluoroarenes.
249
 Eisenstein and Perutz have calculated C-H and M-C bond strengths for 
a range of fluoroarenes, and explored the effects of the metal centre and ligand sphere 
on the strength of the M-C bond.
250
 The ortho-fluorines were found to have the largest 
effect on the C-H bond strengths, followed by the para-fluorines, while the C-H bond 
was effectively insensitive to the meta-fluorines. Therefore, although pKa may not be 
the only factor, it does provide a good indication of the substrates that the metal 
hydroxide will react with. Figure 4.10 shows the substrates that 4f was able to 
deprotonate, arranged according to pKa as taken from Bordwell’s pKa tables.
235a, 235c, 235d
 
Inability to react with 1,3,5-trifluorobenzene or tert-butanol indicates that the Ir(I)-
hydroxide can activate C-H bonds with a pKa approaching that of H2O (31.4 in 
DMSO)
235a, 235c, 235d
 but not higher. 
 
 
1
8 
1
9 
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Figure 4.10 Organic substrates that Ir(I)-hydroxide 4f is able to deprotonate, arranged according 
to pKa and compared to H2O. Values are taken from Bordwell’s pKa tables and calculated from 
DMSO solutions.
235a, 235c, 235d
  
 
4.3.  CONCLUSIONS 
We were able to extend the methodology for preparation of metal hydroxides to 
include convenient and straightforward methods for the preparation of 
[Ir(cod)(NHC)(OH)] complexes. We have reported, with full characterisation, six 
analogous Ir(I)-hydroxide complexes, five of which are novel. We have investigated the 
structural and steric characteristics of each complex with the use of single crystal X-ray 
analysis and computational methods. In particular, %Vbur and DFT studies helped us to 
explain the steric differences between alkyl-substituted NHC ligands and the effect that 
they have on the Ir-centre. These data, together with the experimental results, have 
indicated the ability of backbone substitution to alter the steric bulk of 1,3-bis(alkyl) 
NHC ligands by hindering rotation of the N-substituents. 
We have probed the reactivity of Ir(I)-hydroxides, using [Ir(cod)(I
i
Pr)(OH)] (4f) 
as a model substrate. Herein, we have reported transmetalation with boronic acids, 
which proved to be less facile than with the Rh(I)-hydroxide examined in Chapter 2. 
Reactivity of the Ir(I)-hydroxide towards various silicon substrates was examined and 
we have reported a novel route to Ir(I)-siloxide complexes under very mild conditions. 
We have also investigated bond activation by deprotonation of various O-H, N-H, and 
C-H moieties under mild conditions with water as the sole by-product. Hence, 
deprotonation of alcohols allowed isolation of Ir(I)-alkoxides from methanol and 
phenol, while deprotonation of benzoic acid led to an Ir(I)-carboxylate. The method also 
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provided access to Ir(I)-amides by deprotonation of anilines and amines. Several Ir(I)-
alkyl complexes bearing various sp-, sp
2
- and sp
3
-hybridised centres were prepared by 
deprotonation of substrates such as acetone and nitromethane. These deprotonation 
procedures were typically very straightforward, without the need for solvent and 
occurring instantaneously, accompanied by very dramatic colour changes.  
This Ir(I)-hydroxide motif has provided rapid access to a wide range of important 
complexes that were previously only accessible via specialised routes. When 
considering these facile bond activation processes in the context of the extensive 
literature on metal catalysed C-H, O-H and N-H bond activation, it is important to make 
the distinction between deprotonation and oxidative addition. The processes described 
herein are explicitly deprotonation reactions, generating only the desired Ir-C, Ir-O or 
Ir-N bond and H2O without oxidation of the metal centre.  
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4.4. EXPERIMENTAL DETAILS 
4.4.1. General considerations 
All manipulations and reactions were performed inside an Argon-filled MBraun 
Glovebox unless stated otherwise. All reagents were supplied by Aldrich and used 
without further purification. Solvents were distilled and dried as required. NMR data 
was obtained using either a Bruker 400 MHz or 300 MHz spectrometer at 303 K in the 
specified deuterated solvent. All chemical shifts are given in ppm and coupling 
constants in Hz. Signals on the 
13
C{
1
H} NMR spectra are singlets unless otherwise 
stated. Spectra were referenced to residual protonated solvent signals (for 
1
H) or solvent 
signals (for 
13
C): (C6D6: 
1H δ 7.16 ppm, 13C δ 128.06 ppm; CD2Cl2: 
1H δ 5.32 ppm, 13C 
δ 53.82 ppm; THF-d8: 
1H δ 1.72, 3.58 ppm, 13C 67.57, 25.35 ppm). Infrared spectra (ν) 
were recorded on a Shimadzu Fourier transform IR Affinity-1 Infrared 
spectrophotometer using a MIRacle
TM 
single reflection horizontal ATR (diamond). 
Samples were placed directly on the crystal (ATR) in the solid state. Only characteristic 
peaks have been quoted. Elemental analyses were performed at the London 
Metropolitan University. CCDC-915472 (4c), CCDC-915473 (4d), CCDC-915474 (4e), 
CCDC-915475 (4f), CCDC-915476 (9b), CCDC-915477 (10), CCDC-915478 (11), 
CCDC-915479 (12), CCDC-915480 (15), CCDC-915481 (16), CCDC-915482 (20), 
CCDC-915483 (21), CCDC-915484 (22), CCDC-915485 (23), Crystallographic data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
4.4.2. Synthesis and characterisation data 
Preparation of known compounds: [Ir(cod)(NHC)Cl] 5a-f via free NHC 
A round bottom flask was charged with [Ir(cod)Cl]2 (6), free NHC 2 and THF. 
The resultant mixture was stirred at rt overnight. When complete, the reaction mixture 
was reduced in vacuo to a solid and washed with n-pentane to give [Ir(cod)(NHC)Cl] 
(5a-d). 
1
H NMR data matched reported characterisation data.
94a, 147d, 176
 In the case of 5e 
and 5f, instead of washing with pentane, the crude product mixture was removed from 
the glove box and purified by column chromatography (silica gel chromatography, 
elution with EtOAc/pentane (4:1) to elute [Ir(cod)(NHC)Cl] (5e or 5f), followed by 
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elution with CH2Cl2 to recover [Ir(cod)(NHC)2]
+
Cl
- 
(7e or 7f). 
1
H NMR data matched 
reported characterisation data for 5e, 5f and 7e.
101b, 251
  
Preparation of [Ir(cod)(NHC)Cl] 5e and 5f using Ag2O 
Following modified versions of literature procedures,
101b, 102-103, 220
 the NHC·HCl 
salts ICy·HCl and IiPr·HCl were stirred with Ag2O (5 equiv.) in CH2Cl2 (5 mL) in the 
dark for 2 h at rt in air. Upon completion, the reaction mixture was filtered through 
celite and the filtrate was concentrated in vacuo. The resultant brown solid was washed 
with n-pentane (3 x 5 mL) to give the [AgCl(NHC)]2 compound as a white solid. The 
Ag-complex was stirred with [Ir(cod)Cl]2 (6) (0.5 equiv.) at rt in CH2Cl2 (5 mL) for 3 h, 
after which time the mixture was filtered through celite and concentrated in vacuo to a 
solid. The crude product was purified by column chromatography (silica gel 
chromatography, elution with EtOAc/n-pentane (4:1)) to give [Ir(cod)(ICy)Cl] (5e) as a 
yellow solid (60%); and [Ir(cod)(I
i
Pr)Cl] (5f) as a yellow solid (74%). 
1
H NMR data 
matched reported characterisation data.
101b
  
 
 
[Ir(cod)(IMes)Cl] 5a 
The procedure given above for the preparation of [Ir(cod)(NHC)Cl] complexes 
was followed to give [Ir(cod)(IMes)Cl] (5a) as a yellow solid. 
1
H NMR (400 MHz, 
C6D6): δ 6.80 (s, 2H, ArH), 6.79 (s, 2H, ArH), 6.11 (s, 2H, N-(CH)2-N), 4.73 – 4.66 (m, 
2H, cod-CH), 3.21 – 3.13 (m, 2H, cod-CH), 2.58 (s, 6H, Ar-CH3), 2.11 (s, 6H, Ar-CH3), 
2.04 (s, 6H, Ar-CH3), 1.90 – 1.70 (m, 4H, cod-CH2), 1.42 – 1.28 (m, 4H, cod-CH2); 
13
C{
1
H} NMR (100 MHz, C6D6): δ 182.0 (Ir-Ccarbene), 138.6 (ArC), 137.9 (ArC), 136.7 
(ArC), 134.4 (ArCH), 130.1 (ArCH), 122.1 (N-(CH)2-N), 83.4 (cod-CH), 50.8 (cod-
CH), 34.1 (cod-CH2), 29.4 (cod-CH2), 21.1 (Ar-CH3), 20.2 (Ar-CH3), 18.3 (Ar-CH3).
4 
 
[Ir(cod)(IMes)(OH)] 4a 
A 25 mL Schlenk flask was charged with [Ir(cod)Cl]2 (6) (50.0 mg, 0.07 mmol), 
IMes 2a (45.3 mg, 0.15 mmol) and CsOH (45.0 mg, 0.30 mmol.) in THF (5 mL). The 
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resultant mixture was removed from the glove box and stirred for ca. 30 min before 
degassed H2O (0.5 mL) was added under Ar on a Schlenk line. The reaction mixture 
was stirred at 40 °C for 24 h under Ar (progress was monitored by 
1
H NMR 
spectroscopy). Upon completion, the reaction mixture was reduced in vacuo to a green 
solid and returned to the glove box. The crude product was resuspended in THF and the 
solids were filtered off. The filtrate was reduced in vacuo and n-pentane was added (3 
mL) to form an azeotrope to remove residual solvent. The resultant solid was washed 
with cold n-pentane (3 x 3 mL) and dried in vacuo to give [Ir(cod)(IMes)(OH)] (4a) 
(79.6 mg, 86%) as a green solid. 
1
H NMR (300 MHz, C6D6): δ 6.83 (s, 4H, ArH), 6.16 
(s, 2H, N-(CH)2-N), 3.83 – 3.71 (m, 2H, cod-CH), 2.92 – 2.81 (m, 2H, cod-CH), 2.55 – 
2.21 (m, 12H, Ar-CH3), 2.13 (s, 6H, Ar-CH3), 2.06 – 1.87 (m, 2H, cod-CH2), 1.86 – 
1.68 (m, 2H, cod-CH2), 1.68 – 1.53 (m, 2H, cod-CH2), 1.66 (s, 1H, OH), 1.47 – 1.26 (m, 
2H, cod-CH2); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 185.8 (Ir-Ccarbene), 138.3 (ArC), 137.1 
(ArC), 129.0 (ArCH)*, 122.3 (N-(CH)2-N), 78.6 (cod-CH), 45.7 (cod-CH), 34.8 (cod-
CH2), 29.7 (cod-CH2), 21.1 (Ar-CH3), 18.8 (Ar-CH3); 
1
H NMR (300 MHz, CD2Cl2): δ 
7.01 (br, 4H, ArH), 6.97 (s, 2H, N-(CH)2-N), 3.64 – 3.54 (m, 2H, cod-CH), 2.59 – 2.47 
(m, 2H, cod-CH), 2.37 (s, 6H, Ar-CH3), 2.24 (s, 12H, Ar-CH3), 1.74 – 1.55 (m, 4H, 
cod-CH2), 1.44 (s, 1H, OH), 1.40 – 1.15 (m, 4H, cod-CH2); 
13
C{
1
H} NMR (75 MHz, 
CD2Cl2): δ 184.0 (Ir-Ccarbene), 138.8 (ArC), 136.8 (ArC), 136.1 (ArC), 129.0 (ArCH), 
123.3 (N-(CH)2-N), 79.6 (cod-CH), 46.5 (cod-CH), 34.3 (cod-CH2), 29.2 (cod-CH2), 
21.2 (Ar-CH3), 18.6 (Ar-CH3); Anal. Calcd. for C29H37IrN2O (MW 621.83): C, 56.01; 
H, 6.00; N, 4.50. Found: C, 55.83; H, 6.09; N, 4.39. 
*
One ArC signal was undetected in 
the 
13
C{
1
H} NMR spectrum in C6D6. These data differ from those reported by 
Marciniec and co-workers, whose data are consistent with [Ir(cod)(IMes)Cl] (5a).
177
 
 
 [Ir(cod)(IPr)(OH)] 4b 
A 25 mL Schlenk flask was charged with [Ir(cod)Cl]2 (6) (50.0 mg, 0.07 mmol), 
IPr (58.0 mg, 0.15 mmol) and CsOH (45.0 mg, 0.30 mmol) in THF (5 mL). The 
resultant mixture was removed from the glove box and stirred for ca. 30 mins before 
degassed H2O (0.5 mL) was added under Ar on a Schlenk line. The reaction mixture 
was stirred at 40 °C for 24 h under Ar (progress was monitored by 
1
H NMR 
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spectroscopy). Upon completion, the reaction mixture was reduced in vacuo to a 
yellow-brown solid and returned to the glove box. The crude product was resuspended 
in THF and the solids were filtered off. The filtrate was reduced in vacuo and n-pentane 
was added (3 mL) to form an azeotrope to remove residual solvent. The resultant solid 
was washed with cold n-pentane (3 x 3 mL) and dried in vacuo to give 
[Ir(cod)(IPr)(OH)] (4b) (58.9 mg, 56%) as a yellow-brown solid. 
1
H NMR (300 MHz, 
C6D6): δ 7.29 – 7.19 (m, 2H, ArH), 7.15 – 7.04 (m, 4H, ArH), 6.51 (s, 2H, N-(CH)2-N), 
3.85 – 3.76 (m , 2H, cod-CH), 3.49 – 3.15 (m, 4H, CH(CH3)2), 2.79 – 2.59 (m, 2H, cod-
CH), 1.94 – 1.70 (m, 4H, cod-CH2), 1.60 (s, 1H, OH), 1.45 (d, 12H, 
3
JHH = 6.7, CH3), 
1.40 – 1.20 (m, 4H, cod-CH2), 1.03 (d, 12H, 
3
JHH = 6.9, CH3); 
13
C{
1
H} NMR (75 MHz, 
C6D6): δ 186.6 (Ir-Ccarbene), 146.9 (ArC), 137.0 (ArC), 129.9 (ArCH)
*
, 123.7 (N-(CH)2-
N), 79.4 (cod-CH), 45.7 (cod-CH), 34.8 (cod-CH2), 29.5 (cod-CH2), 29.1 (CH(CH3)2), 
26.4 (CH3), 23.1 (CH3); 
1
H NMR (300 MHz, CD2Cl2): δ 7.50 (t, 2H, 
3
JHH = 7.7, ArH), 
7.33 (d, 4H, 
3
JHH = 7.7, ArH), 7.01 (s, 2H, N-(CH)2-N), 3.85 – 3.70 (m, 2H, cod-CH), 
3.01 (sept., 4H, 
3
JHH = 6.8, (CH(CH3)2), 2.49 – 2.37 (m, 2H, cod-CH), 1.82 – 1.50 (m, 
4H, cod-CH2), 1.60 (s, 1H, OH), 1.38 (d, 12H, 
3
JHH = 6.8, CH3), 1.34 – 1.21 (m, 4H, 
cod-CH2), 1.11 (d, 12H, 
3
JHH = 6.8, CH3); 
13
C{
1
H} NMR (75 MHz, CD2Cl2): δ 184.2 
(Ir-Ccarbene), 146.5 (ArC), 136.9 (ArC), 129.9 (ArCH), 124.6 (ArCH), 124.0 (N-(CH)2-
N), 81.6 (cod-CH), 46.5 (cod-CH), 34.3 (cod-CH2), 29.3 (CH(CH3)2), 28.9 (cod-CH2), 
26.2 (CH3), 22.9 (CH3); FTIR (ATR): ν = 3649.32 (w, OH), 1317.38 (s), 800.46 (s) 
cm
-1
. Anal. Calcd. for C35H49IrN2O (MW 705.99): C, 59.54; H, 7.00; N, 3.97. Found: 
C, 59.47; H, 7.10; N, 3.88. 
*
One ArC signal was undetected in the 
13
C{
1
H} NMR 
spectrum in C6D6. 
 
[Ir(cod)(IDD)(OH)] 4c  
A 25 mL Schlenk flask was charged with [Ir(cod)Cl]2 (6) (50.0 mg, 0.07 mmol), 
IDD (60.0 mg, 0.15 mmol) and CsOH (45.0 mg, 0.30 mmol) in THF (5 mL). The 
resultant mixture was removed from the glove box and stirred for ca. 30 mins before 
degassed H2O (0.5 mL) was added under Ar on a Schlenk line. The reaction mixture 
was stirred at 40 °C for 24 h under Ar (progress was monitored by 
1
H NMR 
spectroscopy). Upon completion, the reaction mixture was reduced in vacuo to a yellow 
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solid and returned to the glove box. The crude product was resuspended in THF and the 
solids were filtered off. The filtrate was reduced in vacuo and n-pentane was added (3 
mL) to form an azeotrope to remove residual solvent. The resultant solid was washed 
with cold n-pentane (3 x 3 mL) and dried in vacuo to give [Ir(cod)(IDD)(OH)] (4c) 
(82.3 mg, 77%) as a yellow solid. The n-pentane washings were passed through a micro 
filter to remove solids and added to hexane (0.5 mL). Single crystals were grown by 
slow evaporation of the solution for X-ray crystal analysis which indicated the 
incorporation of an independent H2O molecule in the lattice. However, CHN and NMR 
analysis showed that H2O is not present in the bulk material after purification. 
1
H NMR 
(300 MHz, C6D6): δ 6.41 (s, 2H, N-(CH)2-N), 5.81 – 5.59 (m, 2H, (N-CH(CH2)2), 4.59 
– 4.48 (m, 2H, cod-CH), 2.88 – 2.75 (m, 2H, cod-CH), 2.67 – 2.36 (m, 4H, cod-CH), 
2.19 (s, 1H, OH), 2.64 – 2.09 (m, 18H, cod-CH2 + IDD-CH2), 1.63 – 1.15 (m, 30H, 
IDD-CH2); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 183.3 (Ir-Ccarbene); 116.9 (N-(CH)2-N), 
81.1 (cod-CH), 56.8 (cod-CH), 44.8 (cod-CH2), 35.2 (cod-CH2), 32.4, 31.6, 30.2, 25.1, 
24.9, 24.2, 24.1, 23.9, 23.8, 23.6, 23.2, 22.4 (IDD). Anal. Calcd. for C35H61IrN2O (MW 
718.09): C, 58.54; H, 8.56; N, 3.90. Found: C, 58.39; H, 8.41; N, 3.86. 
 
[Ir(cod)( I
i
Pr
Me
)(OH)] 4d 
A 25 mL Schlenk flask was charged with [Ir(cod)Cl]2 (6) (50.0 mg, 0.07 mmol), 
I
i
Pr
Me
 (54.0 mg, 0.15 mmol) and CsOH (45.0 mg, 0.30 mmol.) in THF (5 mL). The 
resultant mixture was removed from the glove box and stirred for ca. 30 mins before 
degassed H2O (0.5 mL) was added under Ar on a Schlenk line. The reaction mixture 
was stirred at 40 °C for 24 h under Ar (progress was monitored by 
1
H NMR 
spectroscopy). Upon completion, the reaction mixture was reduced in vacuo to a yellow 
solid and returned to the glove box. The crude product was resuspended in THF and the 
solids were filtered off. The filtrate was reduced in vacuo and n-pentane was added (3 
mL) to form an azeotrope to remove residual solvent. The resultant solid was washed 
with cold n-pentane (3 x 3 mL) and dried in vacuo to give [Ir(cod)(I
i
Pr
Me
)(OH)] (4d) 
(63.0 mg, 85%) as a yellow solid. The n-pentane washings were passed through a micro 
filter to remove solids and added to hexane (0.5 mL) Single crystals were grown by 
slow evaporation of the solution for X-ray crystal analysis which indicated the 
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incorporation of an independent H2O molecule in the lattice. However, CHN and NMR 
analysis showed that H2O is not present in the bulk material after purification. 
1
H NMR 
(300 MHz, C6D6): δ 6.37 (sept., 2H 
3
JHH = 5.3, N-CH), 4.79 – 4.63 (m, 2H, cod-CH), 
3.00 – 2.83 (m, 2H, cod-CH), 2.62 – 2.31 (m, 4H, cod-CH2), 2.40 (s, 1H, OH), 2.07 – 
1.89 (m, 2H, cod-CH2), 1.89 – 1.72 (m, 2H, cod-CH2), 1.61 (s, 6H, CH3), 1.28 (d, 6H, 
3
JHH = 7.3, CH(CH3)2), 1.25 (d, 6H, 
3
JHH = 7.1, CH(CH3)2)); 
13
C{
1
H} NMR (75 MHz, 
C6D6): δ 182.2 (Ir-Ccarbene), 124.2 (NC), 80.9 (cod-CH), 53.5 (N-CH), 44.8 (cod-CH), 
35.2 (cod-CH2), 30.2 (cod-CH2), 22.3 (CH3), 22.2 (CH3), 10.0(CH3); Anal. Calcd. for 
C19H33IrN2O (MW 497.70): C, 45.85, H, 6.68, N, 5.63. Found: C, 45.79; H, 6.57; N, 
5.58. 
 
[Ir(cod)(ICy)(OH)] 4e  
A round bottom flask was charged with [Ir(cod)(ICy)Cl] (5e) (100 mg, 0.18 
mmol) and CsOH (53.0 mg, 0.35 mmol) in THF (5 mL). The resultant mixture was 
stirred at rt for 16 h. The reaction progress was monitored periodically by 
1
H NMR 
spectroscopy. Upon completion, the reaction mixture was filtered through celite and the 
filtrate was reduced in vacuo. The resultant solid was washed with cold n-pentane (3 x 3 
mL) and dried in vacuo to give [Ir(cod)(ICy)(OH)] (4e) (62.9 mg, 65%) as a yellow 
solid. 
1
H NMR (300 MHz, C6D6): δ 6.34 (s, 2H, N(CH)2N), 5.55 (tt, 2H, 
3
JHH = 11.9, 
3.7, N-CH(CH2)2), 4.75 – 4.64 (m, 2H, cod-CH), 2.91 – 2.75 (m, 2H, cod-CH), 2.62 – 
2.33 (m, 4H, cod-CH2), 2.44 (s, 1H, OH), 2.32 – 2.19 (m, 2H), 2.05 – 1.76 (m, 6H, cod-
CH2 and ICy-CH2), 1.73 – 1.17 (m, 10H, ICy-CH2), 1.17 – 1.04 (m, 2H, ICy-CH2), 1.03 
– 0.80 (m, 4H, ICy-CH2); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 182.5 (Ir-Ccarbene), 116.5 
(N(CH)2N), 81.7 (cod-CH), 60.0 (cod-CH), 44.9 (CH(CH2)2), 35.3 (cod-CH2), 34.8 
(cod-CH2), 34.4, 30.3, 26.3, 26.0, 25.7 (ICy-CH2); Anal. Calcd. for C23H37IrN2O (MW 
549.77): C, 50.25; H, 6.78; N, 5.10. Found: C, 50.39; H, 6.82; N, 5.12. 
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[Ir(cod)(I
i
Pr)(OH)] 4f  
A round bottom flask was charged with [Ir(cod)(I
i
Pr)Cl] (5f) (250 mg, 0.51 mmol) 
and CsOH (154.0 mg, 1.02 mmol) in THF (10 mL). The resultant mixture was stirred at 
rt for 16 h. The reaction progress was monitored periodically by 
1
H NMR spectroscopy. 
Upon completion, the reaction mixture was filtered through celite and the filtrate was 
reduced in vacuo. The resultant solid was washed with cold n-pentane (3 x 5 mL) and 
dried in vacuo to give [Ir(cod)(I
i
Pr)(OH)] (4f) (180.0 mg, 75%) as a yellow solid. 
1
H 
NMR (300 MHz, C6D6): δ 6.24 (s, 2H, N(CH)2), 5.87 (sept., 2H, 
3
JHH = 6.8, 
CH(CH3)2), 4.77 – 4.62 (m, 2H, cod-CH), 2.89 – 2.76 (m, 2H, cod-CH), 2.59 – 2.29 (m, 
4H, cod-CH2), 2.47 (s, 1H, OH), 2.03 – 1.87 (m, 2H, cod-CH2), 1.87 – 1.83 (m, 2H, 
cod-CH2), 1.15 (d, 6H, 
3
JHH = 6.7, CH3), 1.10 (d, 
3
JHH = 6.9, 6H, CH3); 
13
C{
1
H} NMR 
(75 MHz, C6D6): δ 182.1 (Ir-Ccarbene), 116.0 (N(CH)2N), 81.9 (cod-CH), 52.2 
(CH(CH3)2), 44.8 (cod-CH), 35.1 (cod-CH2), 30.2 (cod-CH2), 24.2 (CH3), 23.0 (CH3). 
FTIR (ATR): ν = 3612.67 (w, OH), 1217.08 (s), 877.61 (s) cm-1. Anal. Calcd. for 
C17H29IrN2O (MW 469.64): C, 43.48; H, 6.22; N, 5.96. Found: C, 43.37; H, 6.36; N, 
5.97. 
 
[Ir(cod)(I
i
Pr)2]
+
Cl
-
 7f  
A suspension of NaH (10 mg, 0.4 mmol) in EtOH (2 mL) was added slowly to a 
suspension of [Ir(cod)Cl]2 (6) (40 mg, 0.06 mmol) in EtOH (3 mL) and the resultant 
mixture was stirred at room temperature for 45 mins. I
i
Pr·HCl (56 mg, 0.3 mmol) was 
added to the mixture and stirring was continued for 5 h. Upon completion, the reaction 
mixture was filtered through celite and concentrated in vacuo.
101b
 The resultant product 
was washed with n-pentane (3 x 6 mL) and dried to give [Ir(cod)(I
i
Pr)2]
+
Cl
-
 (7f) (74.7 
mg, 98%) as a red solid. 
1
H NMR (300 MHz, CD2Cl2): δ 7.17 (s, 4H, N(CH)2), 5.01 
(sept., 4H 
3
JHH = 6.7, CH(CH3)2), 3.91 (m, 4H, cod-CH), 2.32 – 2.10 (m, 4H, cod-CH), 
1.92 – 1.80 (m, 4H, cod-CH2), 1.52 (d, 12H, 
3
JHH = 6.7, CH3), 1.23 (d, 12H, 
3
JHH = 6.7, 
CH3); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 174.3 (Ir-Ccarbene), 119.0 (N(CH)2), 75.1 
(CH(CH3)2), 53.2 (cod), 32.0 (cod), 24.7 (CH3), 23.6 (CH3). 
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[Ir(cod)(I
i
Pr)(Ph)] 9a  
A 25 mL Schlenk flask was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.043 
mmol) and phenylboronic acid (5.2 mg, 0.043 mmol) in PhMe (5 mL). The reaction 
mixture was removed from the glove box and stirred at 50
 
°C for 16 h. Upon 
completion, the reaction mixture was concentrated in vacuo and returned to the glove 
box. The crude product was washed with n-pentane (3 x 2 mL) and dried in vacuo to 
give [Ir(cod)(I
i
Pr)(Ph)] (9a) (7.9 mg, 35%) as a red solid. 
1
H NMR (300 MHz, C6D6): δ 
7.75 – 7.64 (m, 2H, ArH), 7.32 (t, 2H, 3JHH = 7.5, m-ArH), 7.01 (tt, 1H, 
3
JHH = 7.3, 1.4, 
p-ArH), 6.09 (s, 2H, N-(CH)2-N), 5.61 (sept., 2H, 
3
JHH = 6.6, CH(CH3)2), 4.46 – 4.32 
(m, 2H, cod-CH), 3.57 – 3.46 (m, 2H, cod-CH), 2.47 – 2.20 (m, 4H, cod-CH2), 2.06 – 
1.84 (m, 4H, cod-CH2), 1.08 (d, 6H, 
3
JHH = 6.6, CH3), 1.00 (d, 6H, 
3
JHH = 6.7, CH3); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 184.1 (Ir-Ccarbene), 173.9 (Ir-ArC), 138.0 (Ar), 127.4 
(Ar), 121.4 (Ar), 115.9 (N-CH)2N), 76.2 (cod-CH), 65.5 (cod-CH), 52.0 (CH(CH3)2), 
32.5 (cod-CH2), 32.4 (cod-CH2), 23.8 (CH3), 23.7 (CH3); Anal. Calcd. for C23H33IrN2 
(MW 529.74): C, 52.15; H, 6.28; N, 5.29. Found: C, 52.23; H, 6.41; N, 5.05. 
 
[Ir(cod)(I
i
Pr)(p-MeOC6H4)] 9b  
A 25 mL Schlenk flask was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.043 
mmol) and p-methoxyphenylboronic acid (6.5 mg, 0.043 mmol) in PhMe (5 mL). The 
reaction mixture was removed from the glove box and stirred at 50
 
°C for 16 h. Upon 
completion, the reaction mixture was concentrated in vacuo and returned to the glove 
box. The crude product was washed with n-pentane (3 x 2 mL) and dried in vacuo to 
give [Ir(cod)(I
i
Pr)(p-MeOC6H4)] (9b) (11.0 mg, 46%) as a red solid. 
1
H NMR (300 
MHz, C6D6): δ 7.53 (d, 2H, 
3
JHH = 8.4, ArH), 7.00 (d, 2H, 
3
JHH = 8.4, ArH), 6.14 (s, 2H, 
N-(CH)2), 5.60 (sept., 2H, 
3
JHH = 6.7, CH(CH3)2), 4.56 – 4.71 (m, 2H, cod-CH), 3.49 (s, 
3H, OCH3), 3.52 – 3.45 (m, 2H, cod-CH), 2.46 – 2.27 (m, 4H, cod-CH2), 2.05 – 1.90 
(m, 4H, cod-CH2), 1.09 (d, 6H, 
3
JHH = 6.8, CH3), 0.98 (d, 6H, 
3
JHH = 6.7, CH3); 
13
C{
1
H} 
NMR (75 MHz, C6D6): δ 184.9 (Ir-Ccarbene), 160.7 (Ir-ArC), 156.2 (Ar), 138.6 (Ar), 
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116.0 (N-(CH)2), 113.6 (Ar-CO), 75.8 (cod-CH), 64.5 (cod-CH), 54.6 (OCH3), 52.0 
(CH-(CH3)2), 32.6 (cod-CH2), 32.3 (cod-CH2), 23.8 (CH3), 23.5 (CH3). Anal. Calcd. 
for C24H35IrN2O (MW 559.76): C, 51.50; H, 6.30; N, 5.00. Found: C, 51.37; H, 6.46; N, 
4.91. 
 
[Ir(cod)(I
i
Pr)(OSi(OMe)2Ph)] 10  
A 10 mL vial was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.043 mmol) and 
phenyl trimethoxysilane (8.4 mg, 0.43 mmol) in PhMe (0.5 mL) and the resultant 
mixture was stirred at rt for 2 h. Upon completion, the reaction mixture was 
concentrated in vacuo and washed with n-pentane (3 x 2 mL) before being dried in 
vacuo to give [Ir(cod)(I
i
Pr)(OSi(OMe)2Ph)] (10) (27.0 mg, 99%) as a yellow solid. 
1
H 
NMR (400 MHz, C6D6): δ 8.02 – 7.94 (m, 2H, ArH), 7.37 – 7.22 (m, 2H, ArH), 6.20 (s, 
2H, N-(CH)2-N), 5.79 (sept., 2H 
3
JHH = 6.8, CH(CH3)2), 4.96 – 4.88 (m, 2H, cod-CH), 
3.57 (s, 6H, OCH3), 2.97 – 2.84 (m, 2H, cod-CH), 2.47 – 2.23 (m, 4H, cod-CH2), 1.84 – 
1.66 (m, 4H, cod-CH2), 1.20 (d, 6H, 
3
JHH = 6.7, CH(CH3)2), 1.10 (d, 6H, 
3
JHH = 6.8, 
CH(CH3)2); 
13
C{
1
H} NMR (100 MHz, C6D6): δ 179.9 (Ir-Ccarbene), 138.5 (ArC), 135.7 
(ArCH), 128.8 (ArCH), 127.6 (ArCH), 116.0 (N-(CH)2-N), 84.5 (cod-CH), 52.3 (cod-
CH), 50.1(OCH3), 45.2 (CH(CH3)2), 34.8 (cod-CH2), 30.2 (cod-CH2), 23.8 (CH(CH3)2), 
23.3 (CH(CH3)2). Anal. Calcd. for C25H39IrN2O3Si (MW 635.89): C, 47.22; H, 6.18; N, 
4.41. Found: C, 47.38; H, 6.26; N, 4.48. 
 
[Ir(cod)(I
i
Pr)(OSiPh3)] 11 
A 10 mL vial was charged with [Ir(cod)(IiPr)(OH)] (4f) (10 mg, 0.043 mmol) and 
triphenylsilane (5.2 mg, 0.43 mmol) in PhMe (0.5 mL) and the resultant mixture was 
stirred at rt for 16 h in a vial with a pierced cap. Upon completion, the reaction mixture 
was concentrated in vacuo and washed with n-pentane (3 x 2 mL) before being dried in 
vacuo to give [Ir(cod)(I
i
Pr)(OSi(Ph)3)] (11) (8.0 mg, 60%) as a yellow solid. 
1
H NMR 
(400 MHz, C6D6): δ 7.93 – 7.77 (m, 6H, ArH), 7.31 – 7.20 (m, 9H, ArH), 6.20 (s, 2H, 
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N-(CH)2-N), 5.80 (sept., 2H, 
3
JHH = 6.7, CH(CH3)2), 4.78 – 4.66 (m, 2H, cod-CH), 3.01 
– 2.88 (m, 2H, cod-CH), 2.45 – 2.17 (m, 4H, cod-CH2), 1.84 – 1.56 (m, 4H, cod-CH2), 
1.06 (d, 
3
JHH = 6.8, 6H, CH3), 0.89 (d, 
3
JHH = 6.6, 6H, CH3); 
13
C{
1
H} NMR (75 MHz, 
C6D6): δ 180.1 (Ir-Ccarbene), 143.2 (ArC), 135.8 (ArCH), 127.5 (ArCH), 116.0 (N-(CH)2-
N), 84.1 (cod-CH), 52.3 (CH(CH3)2), 45.0 (cod-CH), 34.7 (cod-CH2), 29.8 (cod-CH2), 
23.9 (CH3), 23.2 (CH3); Anal. Calcd. for C35H43IrN2OSi (MW 728.03): C, 57.74; H, 
5.95; N, 3.85. Found: C, 57.66; H, 5.86; N 3.77. 
 
[Ir(cod)(I
i
Pr)(CN)] 12  
[Ir(cod)(I
i
Pr)(OH)] (4f) (10mg, 0.02 mmol) and TMSCN (2.50 mg, 0.025 mmol) 
were weighed into separate 10 mL vials, dissolved in PhMe (0.5 mL) and chilled to -
40 °C. The TMSCN solution was added drop wise to the solution of 4f, which instantly 
changed colour from yellow to red. After stirring for ca. 2 mins, the reaction mixture 
was reduced in vacuo to ca. 0.2 mL. Cold n-pentane (0.5 mL) was added to the mixture 
and the resulting precipitate was filtered off, washed with n-pentane (3 x 1 mL), and 
dried in vacuo to give [Ir(cod)(I
i
Pr)(CN)] (12) (9.0 mg, 90%) as a red solid. 
1
H NMR 
(400 MHz, C6D6): 6.25 (s, 2H, N-(CH)2-N), 5.31 (sept., 2H, 
3
JHH = 6.8, (CH(CH3)2), 
5.01 – 4.96 (m, 2H, cod-CH), 3.58 – 3.49 (m, 2H, cod-CH), 2.10 – 2.02 (m, 4H, cod-
CH2), 1.76 – 1.69 (m, 4H, cod-CH2) 1.21 (d, 6H, 
3
JHH = 6.8, CH3), 1.00 (d, 6H, 
3
JHH = 
6.7, CH3); 
13
C{
1
H} NMR (100 MHz, C6D6): δ 176.7 (Ir-Ccarbene), 137.5 (CN), 116.7 (N-
(CH)2-N), 76.8 (cod-CH), 70.2 (cod-CH), 52.6 (CH(CH3)2), 32.2 (cod-CH2), 31.7 (cod-
CH2), 23.6 (CH3), 22.8 (CH3). Anal. Calcd. for C18H28IrN3 (MW 478.65): C, 45.17; H, 
5.90; N, 8.78. Found: C, 45.25; H, 6.05; N, 8.67. 
 
[Ir(cod)(I
i
Pr)(OMe)] 13  
A 10 mL vial was charged with [Ir(cod)( I
i
Pr)(OH)] (4f) (20 mg, 0.043 mmol) and 
MeOH (0.5 mL) and the resultant mixture was stirred at rt for 16 h. Upon completion, 
the reaction mixture was concentrated in vacuo and taken up in n-pentane (2 mL) and 
the solid impurities were filtered off. The filtrate was concentrated in vacuo to give 
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[Ir(cod)(I
i
Pr)(OMe)] (13) (20.4 mg, 99%) as a yellow-brown solid. 
1
H NMR (300 MHz, 
C6D6): δ 6.20 (s, 2H, N-(CH)2-N), 5.85 (sept., 2H, 
3
JHH = 6.8, CH(CH3)2), 5.01 – 4.90 
(m, 2H, cod-CH), 4.37 (s, 3H, OCH3), 2.70 – 2.63 (m, 2H, cod-CH), 2.54 – 2.34 (m, 
4H, cod-CH2), 1.97 – 1.74 (m, 4H, cod-CH2), 1.14 (d, 6H, 
3
JHH = 6.7, CH3), 1.12 (d, 
6H, 
3
JHH = 6.7, CH3); 
13
C{
1
H} NMR (75 MHz, C6D6): δ 182.2 (Ir-Ccarbene), 115.9 (N-
(CH)2-N), 83.7 (cod-CH), 64.0 (OCH3), 52.2 (CH(CH3)2), 44.3 (cod-CH), 34.8 (cod-
CH2), 29.9 (cod-CH2), 23.7 (CH3), 23.6 (CH3); Anal. Calcd. for C18H31IrN2O (MW 
483.67): C, 44.70; H, 6.46; N, 5.79. Found: C, 44.62; H, 6.39; N, 5.85. 
 
[Ir(cod)(I
i
Pr)(OPh)] 14 
A vial was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20.0 mg, 0.043 mmol) and 
phenol (4.1 mg, 0.043 mmol) in PhMe (1 mL) and the reaction mixture was stirred at rt 
for 16 h. Once complete, the mixture was concentrated in vacuo and the resultant solid 
was washed with cold pentane (3 x 1 mL) and dried in vacuo to give 
[Ir(cod)(I
i
Pr)(OPh)] (14) (22.1 mg, 94%) as a yellow solid. 
1
H NMR (300 MHz, C6D6): 
δ 7.24 (t, 2H, 3JHH = 7.8, m-ArH), 6.96 (d, 2H, 
3
JHH = 8.4, o-ArH), 6.74 (tt, 1H, 
3
JHH = 
7.2, 1.0, p-ArH), 6.13 (s, 2H, N-(CH)2-N), 5.77 (sept., 2H, 
3
JHH = 6.8, N-CH(CH3)2), 
4.92– 4.82 (m, 2H, cod-CH), 2.96 – 2.84 (m, 2H, cod-CH), 2.41 – 2.21 (m, 4H, cod-
CH2), 1.81 – 1.57 (m, 4H, cod-CH2), 1.12 (d, 6H, 
3
JHH = 6.7, CH3), 1.09 (d, 6H, 
3
JHH = 
6.8, CH3). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 179.4 (Ir-Ccarbene), 171.3 (ArC), 129.3 
(ArCH), 121.4 (ArCH), 116.1 (N-(CH)2-N), 115.6 (ArCH), 83.1 (cod-CH), 52.4 (N-
CH(CH3)2), 45.9 (cod-CH), 34.5 (cod-CH2), 29.6 (cod-CH2), 23.7 (CH3), 23.5 (CH3). 
Anal. Calcd. for C24H33IrN2O (MW 545.74): C, 50.62; H, 6.09; N, 5.13. Found: C, 
50.55; H, 5.93; N, 5.17. 
 
[Ir(cod)(I
i
Pr)(OCOPh)] 15  
A 10 mL vial was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.043 mmol) and 
benzoic acid (5.2 mg, 0.43 mmol) in PhMe (0.5 mL) and the resultant mixture was 
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stirred at rt for 1 h. Upon completion, the reaction mixture was concentrated in vacuo 
and washed with n-pentane (3 x 2 mL) before being dried in vacuo to give 
[Ir(cod)(I
i
Pr)(OCOPh)] (15) (20.4 mg, 99%) as an orange solid. 
1
H NMR (300 MHz, 
CD2Cl2): δ 7.90 – 7.80 (m, 2H, ArH), 7.38 – 7.20 (m, 3H, ArH), 6.90 (s, 2H, N-(CH)2-
N), 5.67 (sept., 2H, 
3
JHH = 5.8, CH(CH3)2), 4.60 – 4.50 (m, 2H, cod-CH), 2.84 – 3.00 
(m, 2H, cod-CH), 2.38 – 2.14 (m, 4H, cod-CH2), 1.75 – 1.55 (m, 4H, cod-CH2), 1.48 (d, 
6H, 
3
JHH = 6.8, CH3), 1.37 (d, 6H, 
3
JHH = 6.7, CH3); 
13
C{
1
H} NMR (75 MHz, CD2Cl2): 
δ 177.7 (Ir-Ccarbene), 170.8 (ArC), 130.3 (ArCH), 129.7 (ArCH), 127.8 (ArCH), 116.7 
(N-(CH)2-N), 83.1 (cod-CH), 52.8 (CH(CH3)2), 48.5 (cod-CH), 34.0 (cod-CH2), 29.4 
(cod-CH2), 24.0 (CH3), 23.7 (CH3). Anal. Calcd. for C24H33IrN2O2 (MW 483.67): C, 
50.24; H, 5.80; N, 4.88. Found: C, 50.34; H, 5.83; N, 4.97. *The
 
C=O 
13
C{
1
H} NMR 
signal was not observed. 
 
[Ir(cod)(I
i
Pr)(NH(-p-BrPh))] 16  
A 10 mL vial was charged with [Ir(cod)( I
i
Pr)(OH)] (4f) (20 mg, 0.043 mmol) and 
p-bromoaniline (7.3 mg, 0.43 mmol) in PhMe (0.5 mL) and the resultant mixture was 
stirred at rt for 1 h. Upon completion, the reaction mixture was concentrated in vacuo 
and washed with n-pentane (3 x 2 mL) before being dried in vacuo to give 
[Ir(cod)(I
i
Pr)(NH(-p-BrPh))] (16) (19.1 mg, 72%) as an orange solid. 
1
H NMR (400 
MHz, C6D6): δ 7.07 (d, 2H, 
3
JHH = 8.9, ArH), 6.23 (s, 2H, N-(CH)2-N), 5.66 (d, 2H, 
3
JHH = 8.9, ArH), 5.57 (sept., 2H, 
3
JHH = 6.8, CH(CH3)2), 5.10 (s, 1H, NH), 4.15 – 4.06 
(m, 2H, cod-CH), 2.67 – 2.57 (m, 2H, cod-CH), 2.50 – 2.37 (m, 2H, cod-CH2), 2.36 – 
2.23 (m, 2H, cod-CH2), 2.03 - 1.89 (m, 2H, cod-CH2), 1.86 – 1.72 (m, 2H, cod-CH2), 
1.03 (d, 6H, 
3
JHH = 6.8, CH3), 0.90 (d, 6H, 
3
JHH = 6.7, CH3); 
13
C{
1
H} NMR (100 MHz, 
C6D6): δ 179.1 (Ir-Ccarbene), 159.2 (ArC), 131.4 (ArCH), 118.4 (ArCH), 116.6 (N-(CH)2-
N), 104.4 (ArC), 80.5 (cod-CH), 52.6 (CH(CH3)2), 50.3 (cod-CH), 34.5 (cod-CH2), 30.1 
(cod-CH2), 24.0 (CH3), 23.0 (CH3). Anal. Calcd. for C23H33BrIrN3 (MW 623.65): C, 
44.30; H, 5.33; N, 6.74. Found: C, 44.20; H, 5.37; N, 6.62. 
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[Ir(cod)(I
i
Pr)(NHBn)] 17 
A vial was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20.0 mg, 0.043 mmol) and 
benzylamine (4.7 mg, 0.043 mmol) in PhMe (1.0 mL) and the reaction mixture was 
stirred at rt for 16 h. Once complete, the mixture was concentrated in vacuo, washed 
with n-pentane (3 x 1 mL) and dried to give [Ir(cod)(I
i
Pr)(NHBn)] (17) (17.4 mg, 72%) 
as a yellow solid. 
1
H NMR (300 MHz, C6D6): δ 7.61 (d, 2H, 
3
JHH = 7.4, o-ArH), 7.28 (t, 
2H, 
3
JHH = 7.5, m-ArH), 7.19 – 7.08 (m, 1H, p-ArH), 6.17 (s, 2H, N-(CH)2-N), 5.97 
(sept., 2H, 
3
JHH = 6.7, N-CH(CH3)2), 4.50 (d, 2H, 
3
JHH = 7.8, NH-CH2), 4.50 – 4.36 (m, 
2H, cod-CH), 2.63 (br., 2H, cod-CH), 2.70 – 2.35 (m, 4H, cod-CH2), 2.28 – 2.10 (m, 
2H, cod-CH2), 2.05 – 1.90 (m, 2H, cod-CH2), 1.12 (d, 6H, 
3
JHH = 6.9, CH3), 1.02 (d, 
6H, 
3
JHH = 6.7, CH3). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 182.2 (Ir-Ccarbene), 149.6 (ArC), 
128.1 (m-ArCH), 127.4 (o-ArCH), 125.9 (p-ArCH), 115.8 (N-(CH)2-N), 76.3 (cod-CH), 
59.1 (NH-CH2), 52.4 (N-CH(CH3)2), 45.4 (cod-CH), 35.0 (cod-CH2), 31.2 (cod-CH2), 
23.6 (CH3), 23.5 (CH3). Anal. Calcd. for C24H36IrN3 (MW 558.78): C, 51.59; H, 6.49; 
N, 7.52. Found: C, 51.25; H, 6.37; N, 7.38.  
 
[Ir(cod)(I
i
Pr)(CH2NO2)] 20  
A 10 mL vial was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.043 mmol). 
Upon addition of nitromethane (3.0 mg, 0.05 mmol), the yellow solid turned to an 
intense red colour. 
1
H NMR analysis of the compound in C6D6 indicated that the 
reaction was complete. To ensure completion, the reaction mixture was further stirred in 
PhMe (0.5 mL) at rt for 1 h before being concentrated in vacuo and washed with n-
pentane (3 x 2 mL). The product was dried in vacuo to give [Ir(cod)(I
i
Pr)(CH2NO2)] 
(20) (16.8 mg, 77%) as a red solid. 
1
H NMR (400 MHz, C6D6): δ 6.23 (s, 2H, N-(CH)2-
N), 5.28 (s, 2H, CH2), 5.24 (sept., 2H, 
3
JHH = 6.7, CH(CH3)2), 4.11 – 4.00 (m, 2H, cod-
CH), 3.32 – 3.22 (m, 2H, cod-CH), 2.19 – 2.02 (m, 4H, cod-CH2), 1.97 – 1.74 (m, 4H, 
cod-CH2), 1.26 (d, 6H, 
3
JHH = 6.8, CH3), 1.03 (d, 6H, 
3
JHH = 6.7, CH3); 
13
C{
1
H} NMR 
(100 MHz, C6D6): δ 181.4 (Ir-Ccarbene), 116.9 (N-(CH)2-N), 77.3 (cod-CH), 75.9 (CH2), 
62.0 (cod-CH), 52.3 (CH(CH3)2), 32.6 (cod-CH2), 31.0 (cod-CH2), 23.9 (CH3), 23.5 
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(CH3). Anal. Calcd. for C18H30IrN3O2 (MW 512.67): C, 42.17; H, 5.90; N, 8.20. Found: 
C, 42.11; H, 5.92; N, 8.26. 
 
[Ir(cod)(I
i
Pr)(CH2COCH3)] 21  
A 10 mL vial was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.043 mmol) and 
acetone (0.5 mL). The resultant mixture was stirred at rt for 16 h before being 
concentrated in vacuo and washed with n-pentane (3 x 2 mL). The product was dried in 
vacuo to give [Ir(cod)(I
i
Pr)(CH2COCH3)] (21) (21.5 mg, 99%) as a red solid. 
1
H NMR 
(400 MHz, C6D6): δ 6.27 (s, 2H, N-(CH)2-N), 5.19 (sept., 2H, 
3
JHH = 6.8, CH(CH3)2), 
4.47 – 4.35 (m, 2H, cod-CH), 3.27 – 3.16 (m, 2H, cod-CH), 2.93 (s, 2H, Ir-CH2), 2.31 – 
2.08 (m, 4H, cod-CH2), 2.05 (s, 3H, CO-CH3), 1.90 – 1.87 (m, 2H, cod-CH2), 1.76 – 
1.60 (m, 2H, cod-CH2), 1.22 (d, 6H, 
3
JHH = 6.7, CH3), 1.06 (d, 6H, 
3
JHH = 6.7, CH3); 
13
C{
1
H} NMR (100 MHz, C6D6): δ 209.4 (CO), 183.4 (Ir-Ccarbene), 116.5 (N-(CH)2-N), 
76.8 (cod-CH), 59.4 (cod-CH), 51.8 (CH(CH3)2), 43.9 (CH2), 32.9 (cod-CH2), 31.6 
(cod-CH2), 31.2 (CO-CH3), 23.9 (CH3), 23.4 (CH3). Anal. Calcd. for C20H33IrN2O 
(MW 509.71): C, 47.13; H, 6.53; N, 5.50. Found: C, 46.98; H, 6.69; N, 5.37. 
 
[Ir(cod)(I
i
Pr)(CH(CO2Me)2)] 22  
A 10 mL vial was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.043 mmol). 
Upon addition of dimethylmalonate (5.6 mg, 0.043 mmol), the yellow solid turned to an 
intense red colour. The reaction mixture was stirred in PhMe (0.5 mL) for 1 h before 
being concentrated in vacuo and washed with n-pentane (3 x 2 mL). The product was 
dried in vacuo to give [Ir(cod)(I
i
Pr)(CH(CO2Me)2)] (22) (18.6 mg, 75%) as a red solid. 
1
H NMR (400 MHz, C6D6): δ 6.29 (s, 2H, N-(CH)2-N), 5.31 (sept., 2H, 
3
JHH = 6.6, 
CH(CH3)2), 4.92 – 4.83 (m, 2H, cod-CH), 4.28 (s, 1H, Ir-CH), 3.45 (s, 6H, CO-CH3), 
3.22 – 3.13 (m, 2H, cod-CH), 2.28 – 2.03 (m, 4H, cod-CH2), 1.84 – 1.70 (m, 2H, cod-
CH2), 1.67 – 1.55 (m, 2H, cod-CH2), 1.35 (d, 6H, 
3
JHH = 6.6, CH3), 1.09 (d, 6H, 
3
JHH = 
6.8, CH3); 
13
C{
1
H} NMR (100 MHz, C6D6): δ 180.7 (Ir-Ccarbene), 174.2 (CO), 116.7 (N-
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(CH)2-N), 80.7 (cod-CH), 58.9 (OCH3), 52.2 (CH(CH3)2), 49.9 (cod-CH), 41.2 (Ir-
Ccarbene), 32.6 (cod-CH2), 31.1 (cod-CH2), 24.7 (CH3), 23.4 (CH3). Anal. Calcd. for 
C22H35IrN2O4 (MW 583.74): C, 45.27; H, 6.04; N, 4.80. Found: C, 45.19; H, 6.11; N, 
4.89. 
 
[Ir(cod)(I
i
Pr)(CCPh)] 23  
A 10 mL vial was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.43 mmol). 
Upon addition of phenylacetylene (4.4 mg, 0.043 mmol), the yellow solid turned to an 
intense red colour. The reaction mixture was stirred in PhMe (0.5 mL) for 1 h before 
being concentrated in vacuo and washed with n-pentane (3 x 2 mL). The product was 
dried in vacuo to give [Ir(cod)(I
i
Pr)(CCPh)] (23) (16.0 mg, 68%) as a red solid. 
1
H 
NMR (400 MHz, C6D6): δ 7.54 (d, 2H, 
3
JHH = 7.4, o-ArH), 7.07 (t, 2H, 
3
JHH = 7.7, m-
ArH), 6.91 (t, 1H, 
3
JHH = 7.3, p-ArH), 6.24 (s, 2H, N-(CH)2-N), 5.60 (sept., 2H, 
3
JHH = 
6.8, CH(CH3)2), 5.16 – 5.05 (m, 2H, cod-CH), 3.58 – 3.47 (m, 2H, cod-CH), 2.38 – 2.21 
(m, 4H, cod-CH2), 2.01 – 1.85 (m, 4H, cod-CH2) 1.27 (d, 6H, 
3
JHH = 6.7, CH3), 1.08 (d, 
6H, 
3
JHH = 7.0, CH3); 
13
C{
1
H} NMR (100 MHz, C6D6): δ 180.6 (Ir-Ccarbene), 131.5 
(ArC), 130.0 (ArCH), 125.4 (C≡C), 124.7 (ArCH), 118.9 (C≡C), 116.1(N-(CH)2-N), 
76.6 (cod-CH), 66.2 (cod-CH), 52.3 (CH(CH3)2), 32.9 (cod-CH2), 32.0 (cod-CH2), 23.7 
(CH3), 22.8 (CH3). Anal. Calcd. for C25H33IrN2 (MW 553.76): C, 54.22; H, 6.01; N, 
5.06. Found: C, 54.20; H, 6.08; N, 4.98. 
 
[Ir(cod)(I
i
Pr)(C6F5)] 24 
A 10 mL Schlenk flask was charged with [Ir(cod)(I
i
Pr)(OH)] (4f) (20 mg, 0.043 
mmol) and pentafluorobenzene (0.1 mL, 0.9 mmol). The reaction mixture was removed 
from the glove box to be stirred at 60
 
°C for 16h. Upon completion, the reaction mixture 
was concentrated in vacuo and returned to the glove box. The crude product was 
washed with n-pentane (3 x 2 mL) and dried in vacuo to give [Ir(cod)(I
i
Pr)(C6F5)] (24) 
(16.1 mg, 61%) as an orange solid. 
1
H NMR (400 MHz, C6D6): δ 6.08 (s, 2H, N-(CH)2-
N), 5.55 (sept., 2H, 
3
JHH = 6.7, CH(CH3)2), 4.42 – 4.33 (m, 2H, cod-CH), 3.48 – 3.37 
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(m, 2H, cod-CH), 2.33 – 2.13 (m, 4H, cod-CH2), 1.86 – 1.69 (m, 4H, cod-CH2) 1.03 (d, 
6H, 
3
JHH = 6.8, CH3), 1.02 (d, 6H, 
3
JHH = 6.6, CH3); 
19
F{
1
H} NMR (377 MHz, C6D6): δ 
-117.5 (d, 
3
JFF = 27, o-F), -164.5 (t, 
3
JFF = 20, p-F), -165.2 (t, 
3
JFF = 23, m-F). 
13
C{
1
H} 
NMR (100 MHz, C6D6): δ 178.4 (Ir-Ccarbene), 116.6 (N-(CH)2-N), 77.0 (cod-CH), 65.6 
(cod-CH), 52.1 (CH(CH3)2), 32.3 (cod-CH2), 31.7 (cod-CH2), 23.9 (CH3), 23.4 (CH3);* 
Signals assigned to the C6F5 moiety could not be detected due to multiple F-C coupling 
interactions. Anal. Calcd. for C23H28IrF5N2 (MW 619.69): C, 44.58; H, 4.55; N, 4.52. 
Found: C, 44.58; H, 4.60; N, 4.67. 
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5. CO2 FIXATION BY IRIDIUM(I) ALKOXIDE AND 
AMIDE COMPLEXES  
5.1. INTRODUCTION 
Green-house gas emissions are constantly increasing, with carbon dioxide being 
the single largest contributor.
252
 Emissions have arguably contributed to the global 
warming crisis faced by mankind and there is continued pressure on world leaders and 
on the scientific community to develop strategies for the reduction of atmospheric 
CO2.
253
 Reduction in atmospheric levels can be tackled by three contrasting strategies: 
(i) decreasing emissions; (ii) storage; and (iii) utilisation of CO2. The reduction of CO2 
emissions requires a shift from the use of fossil fuels towards renewable resources such 
as hydrogen. The recovery or sequestering of CO2 from the atmosphere or from energy 
conversion processes requires advancements in storage, and finally the recycling of CO2 
for synthetic purposes focuses on CO2 as an attractive carbon source.
253
  
The application of carbon dioxide as a C1 source is not only a strategy towards 
reduction of greenhouse gases but also presents an opportunity for catalytic 
development and is an area of fundamental attraction. As well as being an attractive and 
relatively low molecular weight single carbon unit, its origin as a waste product in vast 
quantities renders it a cost-effective reagent.
253-254
 However CO2 activation is still a 
greatly underdeveloped area of investigation. This is mainly due to its thermodynamic 
and kinetic stability.
252
 In fact, its use as a chemical feedstock on an industrial scale is 
limited to only a few processes, including the synthesis of urea, carbonates, methanol 
and salicylic acid.
252-253, 255
 Further utilisation of CO2 is possible only with successful 
activation of this inert species. Of the CO2 activation pathways under investigation, 
including bioconversion, thermal heterogeneous and homogeneous catalysis, 
electrochemical or photochemical reduction and transition metal activation; all of them 
share a common process: the coordination of CO2 to a metal centre.
252, 256
 Coordination 
to a TM centre lowers the activation barrier associated with subsequent processes and 
therefore enables conversion of CO2 into useful products.
252
  
Transition metals, equipped with the appropriate ligand set, can activate a range of 
important and useful small molecules. Since the coordination of CO2 to a metal centre is 
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a key step in transition metal-catalysed processes utilising it as a feedstock,
252
 a 
thorough understanding of the interaction between CO2 and metal complexes is of 
fundamental importance.
257
 Traditionally, it has been regarded as a poor coordinating 
ligand, however TM complexes are known to bind CO2 in a variety of fashions, with a 
large number of coordination modes having been described.
257d
 The different modes of 
coordination are the result of CO2 being made up of two Lewis basic sites (oxygens) 
and a Lewis acidic site (carbon), giving it multiple points for attachment. The linear 
geometry of the CO2 moiety usually bends upon coordination, as the LUMO orbitals are 
occupied, leading to four typical coordination modes in monomeric complexes (A, 
Figure 5.1).
257d
 CO2 has the ability to act as a bridging ligand, linking as many as four 
metals together in a myriad of theoretical binding modes such as those shown (*B, C, 
Figure 5.1).
257d
 
 
Figure 5.1. Binding modes of CO2 in A: monomeric complexes; and B, C: polymetallic 
complexes
257d
  
The first crystal structure of an Ir-CO2 complex was reported in 1995 by 
Bergman,
258
 in the form of an [Ir-(µ2-κ
2
C,O-CO2)-Zr] complex 2 by direct insertion of 
CO2 into the Ir-Zr bond of 1 (Scheme 5.1).  
 
Scheme 5.1. Preparation of [Ir-(µ2- κ
2
C,O-CO2)-Zr] 2 by Bergman
258
 
Until recently, the only monometallic iridium complexes containing a CO2 ligand 
were those reported by Herskovitz in 1977
259
 and by Morales-Morales in 2003.
260
 
Herskovitz reported that CO2 reacted with [Ir{(CH3)2P(CH2)2P(CH3)2}2]Cl to form 
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[Ir{(CH3)2P(CH2)2P(CH3)2}2]Cl·CO2, assigned as an Ir-η
1
-CO2 complex.
259
 Morales-
Morales reported that reaction between the Ir(III)-dihydride complex 3 and tert-butyl 
ethylether (
t
be) in the presence of CO2 (Scheme 5.2) gave the η
2
-CO2 complex 4. This 
structural assignment was based on NMR and IR spectroscopies (which indicated two 
strong bands at 1756 and 1149 cm
-1
, assigned to the asymmetric and symmetric 
stretches respectively). Isolation and full characterisation of 4 was difficult due to the 
fact that it reacted with adventitious water (present as vapour in the CO2) to form the 
hydrogen carbonate adduct 5. Complex 5 was also prepared via CO2 insertion into the 
Ir-OH bond of 6, indicating that the order in which CO2 and H2O were added was not 
important (Scheme 5.2).
260
 
 
Scheme 5.2. Preparation of Ir-CO2 complexes by Morales-Morales
260
 
Early reports of CO2 insertion on metal hydroxides to form metal carbonates were 
by Vaska
261
 on the reversible insertion of CO2 on trans-[M(CO)(OH)(PPh3)2] (M = 
Rh/Ir) under mild conditions. A Pd(II) hydroxide complex, analogous to 6 was shown to 
react with CO2 to selectively form the [(PCP)Pd(II)-(η
1
-OCO2H)] complex.
262
 Several 
other LTM hydroxides have been successfully reacted with CO2 to give metal 
carbonates, mostly of the type [M2(µ-κ
2
O,O:κ2O,O-CO3)] (M = Cd, Ni, Cu, Co) or 
[M2(µ-κ
1
O:κ1O-CO3)] in the case of Cu.
262-263
 Limited examples of group nine metal 
hydroxides reacting with CO2 have been reported,
260, 264
 including that of Morales-
Morales
260
 vide supra. Braun
265
 has reported that both the Ir hydrido-hydroxo complex 
7 and the Ir hydrido-fluoride 9 (in the presence of adventitious water, Scheme 5.3) react 
with CO2 to give the bicarbonate Ir-(κ
2
O,O-CO3H) 8. Singh and co-workers reported 
the novel dinuclear cobalt complex, [Co2(L2)(µ-κ
1
O:κ2O,O-CO3)] 11, formed from a 
Co(II)-hydroxide [Co{HB(3-
t
Bu-5-
i
Prpz)3}(OH)] (10) (HB(3-
t
Bu-5-
i
Prpz)3 = hydro-
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tris(3-tert-butyl-5-isopropylpyrazol-l-yl)borate) (Scheme 5.3).
264a
 Krogsrud has 
prepared a similar complex, exhibiting the same binding mode in the form of [Rh2(µ-
κ1O:κ2O,O-CO3)(PPh3)5]·C6H6 (12) from [Rh(H)(PPh)4] or [Rh(H)(PPh)3] in toluene at 
20 °C, under CO2 over several days.
266
 
 
Scheme 5.3. Preparation of [Ir(:κ2O,O-CO3H)] 8 by Braun.
265
 and Co2(µ-κ
1
O:κ2O,O-CO3) 11 by 
Singh
264a
 
 A large majority of the synthetic interest in preparing carbonates from metal 
hydroxides stems from the biological activity of metalloenzymes in sequestering and 
hydrolysing CO2. For example, carbonic anhydrase, arguably the most efficient CO2-
sequestering catalyst known is deprotonated from Zn-OH2 to give Zn-OH. CO2 then 
inserts into the Zn-OH bond to give Zn-OCO2H which undergoes reversible hydrolysis 
to extrude HCO3
-
.
22
 
In Chapter 4 we reported that [Ir(cod)(I
i
Pr)(OH)] (13) was a powerful bond 
activating agent, able to deprotonate a wide range of organic substrates to yield a 
number of new organoiridium(I) complexes.
267
 In this investigation we aimed to expand 
on the reported activity, by utilising 13 and its derivatives to coordinate CO2. We hoped 
to prepare new Ir(I)-carbonate and -carbamate complexes so that we may develop an 
understanding of CO2 coordination at Ir(I) as a starting point for developing catalytic 
strategies using CO2 as a C1-source. 
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5.2. RESULTS AND DISCUSSION 
5.2.1. Reactivity 
When a benzene-d6 solution of 13 was exposed to CO2 (ca. 1 atm), a precipitate 
formed almost immediately. Analysis by 
1
H NMR indicated downfield shifts of all 
signals, compared to the starting material, and disappearance of the signal 
corresponding to the hydroxyl moiety (δ 2.47 ppm). 13C{1H} NMR analysis of the 
product was inconclusive since no signal corresponding to a potential carbonate carbon 
was observed. Analysis by FTIR (ATR) of the solid product indicated that the signal 
corresponding to the hydroxyl group in the starting material (ν 3612.7 cm-1) had 
disappeared and had been replaced by two very broad, strong bands at 1616.4 cm
-1
 and 
1415.8 cm
-1
 which we tentatively assigned to a carbonate moiety. It was only when we 
obtained an X-ray structure from single crystals grown by slow evaporation of a 
saturated hexane solution that we were able to fully elucidate the structure of the 
product. Scheme 5.4 and Figure 5.2 show the product as a dimeric carbonate. One Ir(I) 
fragment adopts the conventional 16-electron square planar geometry, whilst the second 
adopts an 18-electron distorted trigonal bipyramidal geometry. The two iridium centres 
are bound to the same central (essentially planar) carbonate moiety in a µ-κ1O:κ2O,O 
fashion and twisted almost 180° away from each other to give [{Ir(cod)(I
i
Pr)}2(µ-
κ1O:κ2O,O-CO3)] (14).  
 
Scheme 5.4. Addition of CO2 to Ir-hydroxide 13 to give [{Ir(cod)(I
i
Pr)}2(µ-κ
1:κ2-CO3)] (14) 
The chelate nature of the carbonate moiety causes the O-C-O bond angle to 
decrease from 120° to 116.9(10)°.
266
 Notably, the distance between Ir31 and O71 is too 
long (ca. 3.17 Å) for an Ir-O bond and excludes the [M2-(µ-κ
2
O,O:κ2O,O-CO3)] 
conformation often encountered with bridging carbonates.
263b
 In solution, the magnetic 
equivalency (at both 187 K and 300 K) of the cod and I
i
Pr ligands on both iridium 
centres suggests that the 16e
-
 and the 18e
-
 conformations are fluxional and that de-
coordination/re-coordination of the carbonyl oxygen may be too fast to be observed on 
the NMR timescale, hence 
1
H NMR analysis showed a symmetrical compound. The µ-
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κ1:κ2-CO3 coordination has been observed in a number of metal systems such as the Co 
and Rh complexes described earlier.
264a, 266
 The facile insertion of CO2 into Ir-OH under 
very mild conditions, has yielded, to our knowledge, a unique [{Ir(I)}2-(µ-κ
1
O:κ2O,O-
CO3)] complex. 
 
Figure 5.2. Thermal ellipsoid representation of 14 showing 50% thermal ellipsoid probability. 
H atoms are omitted for clarity. Selected bond lengths (Å) and bond angles (°): Ir1-O71 
2.252(7), Ir1-O72 2.273(8), Ir31-O73 2.068(7), O71-C70 1.291(14), O72-C70 1.281(12), O73-
C70 1.282(14), O71-Ir1-O72 57.9(3), O71-C70-O72 116.9(10). 
As mentioned, analysis of 14 by 
13
C{
1
H} NMR spectroscopy indicated that the 
carbonate 
13
C{
1
H} NMR signal was unobservable at natural 
13
C abundance. To further 
confirm the solution structure of 14 and incorporation of CO2, the reaction was repeated 
using 
13
CO2, allowing this key signal to be located as a broad resonance at 170.0 ppm 
(THF-d8). Interestingly, placing a sample of the labelled complex (14-
13
C) under an 
atmosphere of CO2 led to the loss of 
13
C enrichment at this position. This scrambling 
has been reported for early transition metal carbamates such as W(O2CNMe2)
268
 and 
indicates that the CO2 insertion and elimination processes are both facile and reversible.  
The CO2 insertion proved to be extremely facile and could be completed in the 
solid state by simply passing CO2 over a sample of 13 for ca. 2 mins, giving complete 
conversion to the carbonate 14 (Scheme 5.5). This was confirmed by both FTIR (ATR) 
and 
1
H NMR analysis after three vacuum/purge cycles with argon to remove the CO2 
atmosphere.  
 
Scheme 5.5. Preparation of 14 in the solid state 
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Following the successful preparation of 14, we examined the reaction with an 
Ir(I)-hydroxide bearing a more bulky NHC ligand to determine if the procedure was 
general. Hence [Ir(cod)(IPr)(OH)] (15) was reacted with CO2 in the same way as before 
(Scheme 5.6). Analysis of the reaction mixture by 
1
H and 
13
C{
1
H} NMR spectroscopies 
indicated that a carbonate complex had formed. However, upon release of the CO2 
atmosphere by bubbling Ar through the reaction mixture, the carbonate complex was 
converted quantitatively back to starting material. Even in the presence of molecular 
sieves (4 Å) only the starting material could be recovered. It appeared that the increased 
steric bulk of the IPr ligand had a destabilising effect on the final product and that the 
equilibrium was dependant on the CO2 concentration.  
 
Scheme 5.6. reaction between [Ir(cod)(IPr)(OH)] and CO2 
When the reaction was repeated with [Rh(cod)(ICy)(OH)], the product was 
isolated and identified as a Rh-carbonate complex (17) by 
1
H and 
13
C{
1
H} NMR 
spectroscopies. However, the product appeared to be unstable and after several days 
under Ar, the solid had decomposed substantially (by 
1
H NMR) and every attempt to 
analyse the purity of 17 by elemental analysis failed. 
The ease with which CO2 could be inserted into an Ir-OH bond, particularly on the 
Ir-I
i
Pr motif (13), led us to examine CO2 insertion into other Ir(I)-alkoxide bonds in 
detail. Hence, [Ir(cod)(I
i
Pr)(OMe)] (18) and [Ir(cod)(I
i
Pr)(OPh)] (19) (prepared as 
detailed in Chapter 4),
267
 were exposed to CO2. Both complexes rapidly reacted (ca. 10 
min) to give the corresponding carbonate complexes [Ir(cod)(I
i
Pr)(κ1O-O2COMe)] (20) 
and [Ir(cod)(I
i
Pr)(κ1O-O2COPh)] (21) respectively (Scheme 5.7), which were isolated as 
yellow solids quantitatively. When 20 was exposed to methanol, full conversion back to 
the Ir(I)-methoxide 18 was observed. Presumably methyl hydrogen carbonate was 
liberated, which is known to spontaneously decompose to yield methanol and CO2 at 
temperatures above -36 °C.
269
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Scheme 5.7. Preparation of monomeric Ir-carbonates by CO2 insertion.  
Amide complexes [Ir(cod)(I
i
Pr)(NHBn)] (22) and [Ir(cod)(I
i
Pr)(NH(-p-BrC6H4))] 
(23) showed similar reactivity. CO2 insertion was very fast to give the Ir(I)-carbamate 
complexes [Ir(cod)(I
i
Pr)(κ1O-O2CNHBn)] (24) and [Ir(cod)(I
i
Pr)(κ1O-O2CNH(-p-
BrC6H4))] (25), respectively (Scheme 5.8). Notably, while both products could be 
observed and characterised using multinuclear NMR spectroscopies, the former was 
isolable in quantitative yield, while the latter was only observed under an atmosphere of 
CO2. When the CO2 atmosphere was removed in vacuo or Ar was bubbled through the 
solution, only complex 23 was observed. 
 
Scheme 5.8. CO2 insertion to prepare Ir(I)-carbamates 
Single crystals of 24, suitable for X-ray analysis were grown from a saturated 
hexane solution (Figure 5.3). The Ir1-O1 bond is 2.072(6) Å, compared to 2.020(6) Å 
for Ir(I)-hydroxide 13.
267
 The O1-C1 distance is 1.300(10) Å, while O2-C1 is 1.232(10) 
Å, indicating that the double bond character of the carbonyl is retained. 
13
C{
1
H} NMR 
analysis showed that the quaternary carbamate carbons resonate at 163.2 ppm (24) and 
159.7 ppm (25). This is in agreement with the reported spectra of [Ir(CO)(O2CNH-(o-
MePh))(PPh3)2], prepared via reaction of CO2 with an amide analogue of Vaska’s 
complex.
270
 CO2 insertion into Ir-N bonds may be a crucial step in the conversion of 
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amines to carbamates or carbamic acids, using CO2 as a carbon source. This insertion 
reaction has been reported on several metals, however reports with Ir are scarce.
257d
 The 
insertion of CO2 into palladium and platinum amide complexes (bearing PCP pincer 
ligands) has also been reported, with the carbamate carbon signal resonating at 160.2 
ppm (
13
C{
1
H} NMR, C6D6) for the latter complex.
271
 
 
Figure 5.3. Thermal ellipsoid representation of [Ir(cod)(I
i
Pr)(κ1O-O2CNHBn)] 24 showing 50% 
thermal ellipsoid probability. Selected bond lengths (Å) and angles (°): Ir1-O1 2.072(6), Ir1-C1 
2.058(9), O1-C12 1.300(10), O12-C12 1.232(10), O1-Ir1-C1 91.0(3). 
Based on the successful insertion of CO2 into Ir-N and Ir-O bonds, we proposed 
that the mechanism might conceivably benefit from a heteroatom on Ir bearing a lone 
pair. Hence, the proposed mechanism is shown in Scheme 5.9. Nucleophilic attack on 
the electron-deficient carbon centre of CO2 by the lone pair of the oxygen or nitrogen 
(X in compound I) would result in transfer of the hydroxide, alkoxide or amide to the 
carbon atom of the CO2 moiety, via a cyclic transition state II. In the case of the starting 
material being one of the alkoxides or amides, III would be the final product, a 
monomeric carbonate or carbamate respectively. However, if I is the Ir(I)-hydroxide 
(13), III will be an Ir(I) hydrogen carbonate. The newly formed Ir(I) hydrogen 
carbonate will have a pKa of ca. 10 (pKa of NaCO3H and KCO3H is 10.3)
272
 and is 
therefore open to deprotonation by a second molecule of 13. This will release a 
molecule of water and give the bridged carbonate species 14.  
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Scheme 5.9. Proposed mechanism for CO2 insertion into Ir-heteroatom bonds. 
To further investigate the scope of this transformation, CO2 insertion into Ir-C 
bonds within this scaffold was attempted. There is a precedent for insertion reactions on 
metal-alkyl complexes, including Rh,
273
 Pd
274
 and Ni,
275
 hence CO2 insertion was 
attempted with various Ir(I)-alkyl complexes bearing sp, sp
2
 and sp
3
 carbon centres (26 
– 29, Scheme 5.10, prepared via deprotonation reactions from 13, Chapter 4). 
Unfortunately all of these complexes proved completely unreactive towards CO2. 
In order to understand whether this inactivity was a result of a lack of 
thermodynamic favourability or due to a kinetic barrier, we investigated the 
(de)carboxylation processes involved. Hence, [Ir(cod)(I
i
Pr)(O2CPh)] (30) was prepared 
from 13 and PhCO2H (Chapter 4) and dissolved in C6D6. Neither heat (50 °C for 3 h) 
nor vacuum led to any change in the compound structure (as determined by 
1
H NMR 
analysis). The sample was then placed under ca. 1 atm. of 
13
CO2 for 12 h, and 
13
C{
1
H} 
NMR spectroscopic analysis revealed no 
13
C-enrichment on the carbonyl moiety and 
hence no CO2 scrambling. These results would suggest that, while both 27 and 30 are 
stable species, there is a considerable kinetic barrier to the (de)carboxylation processes 
that might link them.
276
 These results were consistent with our proposed mechanism 
whereby the CO2 moiety undergoes nucleophilic attack by an electron-rich heteroatom 
bound to iridium (Scheme 5.9). 
Chapter 5: CO2 Fixation 
 
133 
 
 
Scheme 5.10. Attempted carboxylation of Ir-C bonds and decarboxylation of Ir-O2CPh. 
5.2.2. Mechanistic studies 
Following these results, we were intrigued by how facile the CO2 insertion 
reaction was, particularly the reaction with 13 in the solid state. Coupled to this, we 
sought a better understanding of the reaction mechanism. The nature of the insertion 
reaction makes it very difficult to isolate potential intermediates and hence, fully 
elucidate the mechanism. Our approach to the problem was two-fold. We wanted to 
probe the reaction from a kinetic perspective, using experimental results to calculate the 
activation parameters. Secondly, we wanted to develop a model of the energy surface to 
identify potential intermediates and transition states. It was our aim to correlate the 
experimentally derived activation energies and the theoretically calculated energies to 
determine the reaction pathway and therefore understand the reaction barriers involved 
in this reaction. In order to do this, we established collaborations with Dr Paul Webb at 
Sasol Technologies UK Ltd., to assist us with the kinetic experiments and with 
Professor Michael Bühl and Hedi Kruger, who investigated the potential energy surface 
using DFT methods at a PBEO-D3 level of theory.  
It is important to know the limitations of theoretical calculations, the accuracy of 
DFT can be best measured when compared with experimental results obtained by 
examination of well-defined systems,
277
 therefore it is important that the two go hand in 
hand. Investigations of CO2 insertion into TM-X bonds (where X is an alkoxide or 
amide) are numerous. However, theoretical investigations of CO2 insertions of this kind 
are more limited and direct comparisons between experimental and theoretical findings 
are rare.
11, 257d
 A good example that draws comparisons between the two approaches has 
been reported by Lee et al.,
278
 who examined the rapid CO2 insertion into planar 
[Ni(II)(pyN2)(OH)]
-
 (pyN2 = N’,N’-(2,6-pyridinedicaboxamidate) to form a Ni-
bicarbonate complex.
278
 The authors reported activation enthalpy (∆Hǂ = 3.2(5) kcal 
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mol
-1) and entropy (∆Sǂ = -20(3) cal K-1 mol-1), obtained by monitoring CO2 fixation by 
UV/vis spectroscopy. They also performed DFT calculations at the BP86 and B3LYP 
levels of theory and obtained comparable results for the activation enthalpy (differing 
by only 1 − 2 kcal mol-1). However, the experimental entropies were consistently lower 
than the theoretical calculations by ca. 14 − 17 cal K-1 mol-1.278 The absolute entropies 
(and, thus the Gibbs free-energy barriers) are strongly overestimated in computations 
due to the ideal-gas approximation made in the standard thermodynamic expressions. 
The activation free energies will suffer from the same over-estimation, particularly in 
the case of associative, multimolecular transformations, where entropy has a larger 
contribution to the free energy expression than enthalpy.  
Analysis of the Ir(I)-hydroxide 13 by FTIR (ATR) had revealed that the OH 
stretch was extremely diagnostic (ν = 3612.7 cm-1). Furthermore, the IR spectrum of the 
product 14 showed no distinct bands in this region. Hence, the hydroxide band of 13 
provided a perfect spectroscopic handle with which to monitor reaction progress. An 
FTIR cell inside a DRIFTS chamber was loaded with 13 (ca. 40 mg) and sealed under 
N2. A continuous stream of N2/CO2 (50:50, 1 atm., 40 mL min
-1
) was passed over the 
cell and the reaction progress was monitored by in situ FTIR. Figure 5.4 shows a sample 
stacked plot of the raw FTIR data for the reduced region (ν 3645 – 3577 cm-1) 
containing the band that corresponds to the OH stretch.  
 
Figure 5.4. Sample raw FTIR data for kinetic experiment (ν 3645 – 3577 cm-1) 
Single beam spectra were ratioed against a background of KBr under the same gas 
atmosphere. The kinetic trace was then determined by measuring the peak height of the 
OH band as a function of time and the reaction was repeated at five different 
temperatures between 278 K and 358 K (Figure 5.5). The reaction was studied under 
pseudo-first order conditions (accounting for a large excess of CO2) and the kinetic 
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traces at different temperatures (Figure 5.5) indicated that the reaction was in fact 
pseudo first order (rate = kobs[13]). 
 
Figure 5.5. Peak height of OH stretch (ν = 3612.7 cm-1) vs time at different temperatures 
Rate constants were obtained by fitting the kinetic traces to a single exponential 
using Origin
©
 (see experimental section). A linear Eyring plot was obtained with R
2
 = 
0.9966 (Figure 5.6) according to the Eyring equation, 
     
   
 
  
    
   with              .  
 
Figure 5.6. Eyring plot (1/T vs ln(k/T) for reaction between 13 and CO2 in the solid state. 
Activation parameters were determined, with error calculated using the least 
squares method as follows: ∆Hǂ = 3.6 ± 0.3 kcal mol-1, ∆Sǂ = -51.5 ± 0.9 cal K-1 mol-1 
and ∆Gǂ (298 K) = 18.9 ± 0.4 kcal mol-1. The activation parameters indicate that the 
insertion of CO2 is an exergonic process with a small energy barrier to surmount. The 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0
P
ea
k 
H
ei
gh
t 
(v
 =
 3
61
2 
cm
-1
) 
Time (mins) 
278K
298K
318K
338K
358K
y = -1804.4x - 2.196 
R² = 0.9966 
-8.7
-8.5
-8.3
-8.1
-7.9
-7.7
-7.5
-7.3
-7.12.7E-03 2.9E-03 3.1E-03 3.3E-03 3.5E-03
ln
(k
/T
) 
1/T K-1  
Chapter 5: CO2 Fixation 
 
136 
 
large negative value for entropy is consistent with an associative transition state 
involving at least two converging molecules. 
Following the kinetic experiments, Hedi Kruger and Professor Michael Bühl 
investigated the potential energy surface using DFT methods at the PBE0-D3 level of 
theory. Based on our proposed mechanism, the first step in the reaction was considered 
to be insertion of CO2 into the Ir-OH bond to yield an iridium hydrogen carbonate 
intermediate (32). An encounter complex was identified as an additional intermediate 
(31) formed by the CO2 molecule approaching the Ir(I)-OH. Insertion of CO2 into the Ir-
OH bond occurs via the four-membered transition state, presenting the first reaction 
barrier (TS31-32, Figure 5.7). Transformation from 31 to TS31-32 is accompanied by a 
decrease in inter-atomic distance between the carbon atom and the oxygen atom of the 
hydroxide moiety (2.62 to 1.54 Å). More importantly, an elongation of the Ir-O bond 
from 2.02 Å to 2.17 Å was observed. As expected, the geometry of the CO2 molecule 
changes from linear to bent with an O-C-O angle of 139.30° as the Ir-OH bond is 
broken to form the η1-bicarbonate intermediate (32). The insertion of CO2 to form the 
bicarbonate intermediate is strongly exothermic such that the enthalpic barrier is 
insignificant. Hence, the rate limiting step must occur during the encounter with a 
second molecule of 13 and concomitant elimination of water. 
 
Figure 5.7. Reaction profile (PBE0-D3 level of theory) for CO2 uptake by 13  
Of the different pathways for dimerisation that were characterised 
computationally, the most favourable one is shown in Figure 5.8. The encounter 
between intermediate 32 and a second molecule of 13 leads to formation of a tetrahedral 
diol intermediate 33. From intermediate 33, H2O elimination occurs via an autocatalytic 
process. An independent water molecule acts as a proton relay, leading to a six 
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membered transition state (TS34-14) and concomitant release of two water molecules to 
give the final product.  
The first enthalpic barrier encountered in the reaction pathway is in the formation 
of TS32-33 (∆Hǂ = 11.06 kcal mol-1 and ∆Sǂ = -57.8 cal K-1 mol-1 at the PBE0-D3 level 
of theory). The second reaction barrier is the formation of (TS34-14), with ∆Hǂ = 3.47 
kcal mol
-1
 and ∆Sǂ = -88.5 cal K-1 mol-1 (both relative to intermediate 32). At ambient 
temperature, the first barrier exhibits a ∆Gǂ = 28.30 kcal mol-1, whilst the second shows 
a ∆Gǂ = 29.96 kcal mol-1. The free-energy barrier is largely entropic in nature, in 
accordance with an associative transition state.  
Figure 5.8. Computed (PBE0-D3 level of theory) reaction profile for CO2 uptake by 13  
The absolute entropies (and, thus the Gibbs free-energy barriers) are strongly 
overestimated as discussed earlier. Coupled to this is the fact that the kinetic 
experiments are performed in the solid state and translational entropies in condensed 
phase tend to be smaller than in the gas phase. Since computed enthalpies are not 
affected by the overestimation, the near-quantitative accord between measured and 
calculated ∆Hǂ (3.6 kcal mol-1) gives us confidence that the DFT-derived pathway in 
Figure 5.7 and 5.8 is reasonable. This implies that a similar mechanism is dominant in 
the solid state where H2O would have to diffuse through the solid. It should be noted 
that 14 is prepared under anhydrous conditions and since the mechanism that is 
presented depends on the inclusion of autocatalytic water it is reasonable to assume that 
either the H2O is present as vapour in the CO2 and/or that it comes from the reaction 
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itself. Either way, this will not be the only pathway in operation but rather, it is the most 
energetically favourable and will become more dominant as the reaction progresses.  
In order to understand the apparent equilibrium displayed during the reaction 
between [Ir(cod)(IPr)(OH)] (15) and CO2 our colleagues calculated the driving force for 
formation of 16 at the PBEO-D3 level of theory. The driving force for formation of 16 
is much lower (∆H = -23.8 kcal mol-1, ∆G = -4.0 kcal mol-1) than for the corresponding 
Ir-I
i
Pr product 14 (∆H = -30.9 kcal mol-1, ∆G = -15.3 kcal mol-1, Figure 5.9). The small 
value for ∆G of -4.0 kcal mol-1 is consistent with the reversible nature of the reaction. 
The destabilising effect exerted by the added steric bulk appears to manifest in a 
predicted change in coordination mode from the expected [Ir2-(µ-κ
1
O:κ2O,O-CO3)]
 
to 
[Ir2-(µ-κ
1
O:κ1O-CO3)]. Figure 5.9 shows a comparison between the bond lengths of 14 
from the obtained crystal structure (italics), calculated bond lengths for 14 (normal type-
face) and calculated bond lengths for 16 (bold type-face). From the calculated bond 
lengths for 16 there appears to be a considerable elongation of the bond between Ir and 
O
2
 (ca. 2.80 Å). The increase in interatomic distance between these two atoms and 
decrease in the bond length between Ir and O
3
 indicates that the µ-κ1:κ1 coordination 
mode is favoured for this complex. The [{Ir2}-(µ-κ
1
O:κ1O-CO3)] 16 (Figure 5.9) may 
be unstable and hence, is only observed when under a CO2 atmosphere.  
 
Figure 5.9. Carbonate complexes 14 and 16. Bond distances shown in Å, 14: experimental 
(italics), Calculated (normal type-face), 16 (bold). Calculated at PBEO level of theory. 
5.3. CONCLUSIONS 
In summary, we have explored the reactivity of a range of iridium(I) complexes 
with carbon dioxide, towards the aim of developing new CO2 fixation strategies. 
Reaction between Ir(I)-hydroxide and CO2 led to the isolation of the interesting dimeric 
16e
-
/18e
-
 species [{Ir(I)}2(µ-κ
1
O:κ2O,O-CO3)] while CO2 insertion into Ir(I)-alkoxide 
and Ir(I)-amide bonds led to monomeric Ir(I)-carbonate and Ir(I)-carbamate complexes 
respectively. The formation of the Ir(I)-carbonate 14 was extremely facile, even in the 
solid state. The proposed mechanism for CO2 insertion describes a nucleophilic attack 
on CO2 by the lone pair of the bound oxygen or nitrogen atom, resulting in formation of 
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a new Ir-heteroatom bond. In the case of Ir(I)-hydroxide 13, a secondary event involves 
nucleophilic attack by another molecule of Ir(I)-hydroxide to release water and deliver 
the dimeric carbonate 14. CO2 insertion into a variety of Ir(I)-alkyl bonds was 
unsuccessful, indicating that the mechanism would benefit from the presence of a 
nucleophilic heteroatom on Ir. To understand the facile nature of the reaction between 
Ir(I)-hydroxide and CO2 we performed kinetic investigations in the solid state using 
FTIR. The derived activation parameters indicated an exergonic reaction with a small 
energy barrier and an associative transition state. Our collaborators studied the reaction 
using DFT methods at the PBEO-D3 level of theory based on our proposed mechanism. 
They found that insertion of CO2 into the Ir-OH bond was extremely facile with a 
negligible energy barrier to formation of an iridium hydrogen carbonate intermediate. 
The rate limiting step involves autocatalytic formation of a six-membered transition 
state where an independent water molecule acts as a proton relay. In accordance with 
the experimental values, the entropy for formation of this transition state was high 
owing to the associative nature of four entities converging. The calculated enthalpy of 
activation for formation of the transition state (∆Hǂ = 3.6 kcal mol-1) is in very good 
agreement with the experimental value.  
In this study we have shown that iridium complexes may be good candidates for 
capture of CO2 and synthetic transformations involving CO2 as a feedstock. A thorough 
mechanistic study with comparative theoretical and experimental insights provided 
valuable information about the nature of CO2 fixation by Ir(I)-hydroxide.  
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5.4. EXPERIMENTAL DETAILS 
5.4.1. General considerations 
All manipulations and reactions were performed on an Ar or CO2 filled schlenk 
line unless stated otherwise. All reagents were supplied by Aldrich and used without 
further purification. Solvents were distilled and dried as required. NMR data was 
obtained using either a Bruker 300 MHz or 400 MHz spectrometer at 303 K in the 
specified deuterated solvent. All chemical shifts are given in ppm and coupling 
constants in Hz. Signals on the 
13
C{
1
H} NMR spectra are singlets unless otherwise 
stated. Spectra were referenced to residual protonated solvent signals (for 
1
H) or solvent 
signals (for 
13
C): (C6D6: 
1
H δ 7.16 ppm, 13C δ 128.06 ppm; THF-d8: 
1
H δ 1.72, 3.58 
ppm, 
13
C δ 25.31, 67.21 ppm). Infrared spectra (ν) were recorded on a Shimadzu Fourier 
transform IR Affinity-1 Infrared spectrophotometer using a MIRacle
TM 
single reflection 
horizontal ATR (diamond). Samples were placed directly on the crystal (ATR) in the 
solid state. Only characteristic peaks have been quoted. Elemental analyses were 
performed at the London Metropolitan University. Known compounds were prepared 
following the procedures reported in the previous chapters. CCDC-956511 (14), CCDC-
956512 (24) contain structural data for new complexes characterised by X-ray single 
crystal diffraction. Crystallographic data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
5.4.2. Synthesis and characterisation data 
 
[{Ir(cod)(I
i
Pr)}2(µ-κ
1
O:κ2O,O-CO3)] 14 
Method A: A J. Young NMR tube was charged with [Ir(cod)(I
i
Pr)(OH)] 13 (15.0 
mg, 0.032 mmol) in C6D6 (0.6 mL). The sample was frozen in liquid N2 and the Ar 
atmosphere was removed in vacuo. The sample was allowed to thaw before CO2 (ca. 1 
atm.) was added, a ppt. formed after a few minutes. The reaction mixture was agitated 
for at least 10 mins before being placed under an Ar atmosphere via three vacuum-Ar 
purge cycles. 
1
H
 
NMR analysis revealed full conversion to the product. The product was 
Chapter 5: CO2 Fixation 
 
141 
 
dried in vacuo to give [{Ir(cod)(I
i
Pr)}2(µ-κ
1
O:κ2O,O-CO3)] 14 (15.2 mg, 98%) as a 
yellow solid.  
Method B: [Ir(cod)(I
i
Pr)(OH)] 13 (5 mg, 0.011 mmol) was placed in a septum 
sealed vial and the Ar atmosphere was replaced with CO2 (1 atm.) by purging the vial 
for approximately 2 mins. The sample was then placed back under an Ar atmosphere via 
three vacuum-Ar purge cycles before being analysed by IR (ATR) and dissolved in 
C6D6 for analysis by 
1
H NMR, which indicated complete conversion to 14. 
*13
C{
1
H} 
NMR analysis was conducted in THF-d8 due to insufficient solubility in C6D6. 
1
H NMR (500 MHz, C6D6): δ 6.30 (s, 4H, N-(CH)2-N), 5.88 (sept., 4H, 
3
JHH = 
6.7, N-CH(CH3)2), 4.60 – 4.53 (m, 4H, cod-CH), 2.76 – 2.65 (m, 4H, cod-CH), 2.41 – 
2.30 (m, 4H, cod-CH2), 2.30 – 2.20 (m, 4H, cod-CH2), 1.76 – 1.59 (m, 8H, cod-CH2), 
1.47 (d, 12H, 
3
JHH = 5.3, CH3), 1.91 (d, 12H, 
3
JHH = 2.8, CH3); 
13
C{
1
H} NMR (75 MHz, 
THF-d8): δ 178.8 (Ir-Ccarbene), 170.0 (CO), 116.9 (N-(CH)2-N), 82.6 (cod-CH), 53.0 (N-
CH(CH3)2), 38.8 (cod-CH), 35.3 (cod-CH2), 30.1 (cod-CH2), 24.3 (CH3), 24.1 (CH3). 
FTIR (ATR) ν = 1610.6 (s, CO3), 1411.9 (s, CO3), 1207.4 (s) cm
-1
. Anal. Calcd. for 
C35H56Ir2N4O3 (MW 965.28): C, 43.55; H, 5.85; N, 5.80. Found: C, 43.44; H, 5.86; N, 
5.73. 
 
[(Ir(cod)(IPr))2(CO3)] 16 
A J-Young type NMR tube was charged with [Ir(cod)(IPr)(OH)] 15 (25 mg, 0.035 
mmol) in C6D6 (0.6 mL). The sample was frozen in liquid N2 and the Ar atmosphere 
was removed in vacuo. The sample was allowed to thaw before CO2 (ca. 1 atm.) was 
added, and the reaction mixture was agitated for at least 10 mins before NMR analysis 
was conducted. 
1
H NMR (300 MHz, C6D6): δ 7.29 (t, 5H, 
3
JHH = 7.6, Ar-H), 7.24 – 
7.17 (m, 7H, Ar-H), 6.53 (s, 4H, N-(CH)2-N), 5.51 – 5.38 (m, 4H, cod-CH), 3.01 – 2.89 
(m, 4H, cod-CH), 1.76 – 1.39 (m, 40H, cod-CH2, CH3), 1.33 – 1.16 (m, 8H, cod-CH2), 
1.04 (d, 24H, 
3
JHH = 6.7, CH3). 
13
C{
1
H} NMR (125 MHz, CD2Cl2): δ 184.7 (Ir-Ccarbene), 
164.6 (CO3), 147.1 (ArC), 136.2 (N-ArC), 130.2 (ArCH), 130.0 (ArCH), 124.3 (N-
(CH)2-N), 123.9 (ArCH), 83.7 (cod-CH), 46.7 (cod-CH), 33.3 (CH(CH3)2), 29.4 (cod-
CH2), 29.0 (cod-CH2), 26.8 (CH3), 22.8 (CH3).  
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[{Rh(cod)(ICy)}2(µ-CO3)] 17 
A J-Young NMR tube was charged with [Ir(cod)(ICy)(OH)] (10.0 mg, 0.0217 
mmol) in C6D6 (0.6 mL). The sample was frozen in liquid N2 and the Ar atmosphere 
was removed in vacuo. The sample was allowed to thaw before CO2 (ca. 1 atm.) was 
added. The reaction mixture was agitated for at least 10 mins before NMR analysis was 
conducted. Once complete, the CO2 was removed in vacuo before the sample was 
returned to the glove-box. The product was dried to give [{Rh(cod)(ICy)}2(µ-CO3)] 17 
(11.1 mg, >99%) as a yellow solid. However, the product proved to be unstable in the 
solid state since 
1
H NMR analysis of the same sample after being stored for several days 
under Ar showed a decomposed product and elemental analysis of the bulk material 
consistently failed. 
1
H NMR (300 MHz, C6D6): δ 6.36 (s, 4H, N-(CH)2-N), 5.56 (tt, 4H, 
3
JHH = 12.0, 3.8, N-CH(CH2)2), 5.54 – 5.46 (m, 4H, cod-CH), 3.46 – 3.29 (m, 4H, cod), 
2.75 – 2.60 (m, 4H, ICy-CH2), 2.51 – 2.26 (m, 8H, cod-CH2), 2.00 – 0.90 (m, 44H, cod-
CH2, ICy-CH2). 
13
C{
1
H} NMR (75 MHz, THF-d8): δ 182.2 (app. d, Rh-Ccarbene), 169.3 
(
13
CO), 117.2 (N-(CH)2-N), 97.9 (d, J = 7.0, cod-CH), 66.7 (d, J = 14.3, cod-CH), 60.5 
(N-CH(CH2)2), 34.4 (cod-CH2), 34.3 (ICy-CH2), 33.7 (ICy-CH2), 29.5 (cod-CH2), 26.5 
(ICy-CH2), 26.0 (ICy-CH2), 25.7 (ICy-CH2).  
 
[Ir(cod)(I
i
Pr)(κ1O-OCO2CH3)] 20 
A J. Young NMR tube was charged with [Ir(cod)(I
i
Pr)(OMe)] 18 (10.0 mg, 0.021 
mmol, prepared following literature procedure
267
) in C6D6 (0.6 mL). The sample was 
frozen in liquid N2 and the Ar atmosphere was removed in vacuo. The sample was 
allowed to thaw before CO2 (ca. 1 atm.) was added. The reaction mixture was mixed for 
at least 10 mins before NMR analysis was conducted. Once complete, the CO2 
atmosphere was removed in vacuo before the sample was returned to the glove-box 
where it was dried in vacuo to give [Ir(cod)(I
i
Pr)(κ1O-OCO2CH3)] 20 (11 mg, 99%) as a 
yellow solid. 
1
H NMR (300 MHz, C6D6): δ 6.22 (s, 2H, N-(CH)2-N), 5.84 (sept., 2H, 
3
JHH = 6.6, CH(CH3)2), 5.03 – 4.82 (m, 2H, cod-CH), 3.58 (s, 3H, OCH3), 3.00 – 2.83 
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(m, 2H, cod-CH), 2.37 – 2.12 (m, 4H, cod-CH2), 1.71 – 1.51 (m, 4H, cod-CH2), 1.31 (d, 
6H, 
3
JHH = 6.4, 6H, N-CH(CH3)2), 1.12 (d, 6H, 
3
JHH = 6.8, N-CH(CH3)2). 
13
C{
1
H} NMR 
(75 MHz, C6D6): δ 178.3 (Ir-Ccarbene), 160.9 (Ir-OCO), 116.3 (N-(CH)2-N), 84.3 (N-
CH(CH3)2), 53.2 (cod-CH), 52.5 (OCH3), 47.7 (cod-CH), 34.2 (cod-CH2), 29.4 (cod-
CH2), 23.7 (N-CH(CH3)2), 23.6 (N-CH(CH3)2). FTIR (ATR) ν = 1649.14 (w), 1624.06 
(w), 1411.89 (s), 1207.49 (s) cm
-1
. Anal. Calcd. for C19H31IrN2O3 (MW 527.68): C, 
43.25; H, 5.92; N, 5.31. Found: C, 43.17; H, 6.01; N, 5.40. 
 
[Ir(cod)(I
i
Pr)(κ1OCO2Ph)] 21 
A J. Young NMR tube was charged with [Ir(cod)(I
i
Pr)(OPh)] 19 (16.9 mg, 0.031 
mmol) in C6D6 (0.6 mL). The sample was frozen in liquid N2 and the Ar atmosphere 
was removed in vacuo. The sample was allowed to thaw before CO2 (ca. 1 atm.) was 
added. The reaction mixture was mixed for at least 10 mins before NMR analysis was 
conducted. Once complete, the CO2 atmosphere was removed in vacuo before the 
sample was returned to the glove-box where it was dried in vacuo to give 
[Ir(cod)(I
i
Pr)(κ1OCO2Ph)] 21 (18.4 mg, >99%) as a yellow solid. 
1
H NMR (300 MHz, 
C6D6): δ 7.22 (t, 2H, 
3
JHH = 7.3, m-ArH), 7.09 – 6.94 (m, 2H, o-ArH), 6.75 (t, 1H, 
3
JHH = 
7.2, p-ArH), 6.14 (s, 2H, N-(CH)2-N), 5.76 (sept., 2H 
3
JHH = 6.7, N-CH(CH3)2), 4.92– 
4.82 (m, 2H, cod-CH), 2.95 – 2.83 (m, 2H, cod-CH), 2.39 – 2.18 (m, 4H, cod-CH2), 
1.77 – 1.57 (m, 4H, cod-CH2), 1.13 (d, 6H, 
3
JHH = 6.7, CH3), 1.09 (d, 6H, 
3
JHH = 6.8, 
CH3). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 179.2 (Ir-Ccarbene), 129.1 (ArCH), 128.8 
(ArCH), 124.8 (ArCH), 116.2 (N-(CH)2-N), 83.1 (cod-CH), 52.4 (N-CH(CH3)2), 46.0 
(cod-CH), 34.4 (cod-CH2), 29.6 (cod-CH2), 23.7 (CH3), 23.5 (CH3). 
13
C{
1
H} NMR (75 
MHz, THF-d8): δ 179.2 (Ir-Ccarbene), 176.9 (ArC), 162.9 (br., CO), 128.5 (ArCH), 121.1 
(ArCH), 117.2 (N-(CH)2-N), 114.8 (ArCH), 82.2 (cod-CH), 52.9 (N-CH(CH3)2), 46.1 
(cod-CH), 34.5 (cod-CH2), 29.7 (cod-CH2), 23.7 (CH3), 23.5 (CH3). FTIR (ATR) ν = 
1583.56 (s), 1477.47 (s), 1296.16 (s), 1209.37 (s) cm
-1
. Anal. Calcd. for C24H33IrN2O3 
(MW 589.75): C, 48.88; H, 5.64; N, 4.75. Found: C, 48.77; H, 5.68; N, 4.79. *ArC and 
CO 
13
C{
1
H} NMR
 
signals were not observed in C6D6.  
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[Ir(cod)(I
i
Pr)(κ1O2CNHBn)] 24 
A vial was charged with [Ir(cod)(I
i
Pr)(NHBn)] 22 (17.4 mg, 0.031 mmol) and 
C6D6 (0.6 mL). The sample was frozen in liquid N2 and the Ar atmosphere was removed 
in vacuo. The sample was allowed to thaw before CO2 (ca. 1 atm.) was added. The 
reaction mixture was mixed for at least 10 mins before NMR analysis was conducted. 
Once complete, the CO2 was removed in vacuo before the sample was returned to the 
glove-box and was dried in vacuo to give [Ir(cod)(I
i
Pr)(κ1O2CNHBn)] 24 (17.1 mg, 
92%) as a yellow solid. 
1
H NMR (300 MHz, C6D6): δ 7.15 – 7.00 (m, 5H, ArH), 6.29 
(s, 2H, N-(CH)2-N), 5.74 (sept., 2H, 
3
JHH = 6.7, N-CH(CH3)2), 4.95 – 4.82 (m, 2H, cod-
CH), 4.49 (t, 1H, 
3
JHH = 5.8, NH), 4.30 (d, 2H, 
3
JHH = 5.6, NH-CH2), 2.98 – 2.86 (m, 
2H, cod-CH), 2.41 – 2.19 (m, 4H, cod-CH2), 1.76 – 1.59 (m, 4H, cod-CH2), 1.33 (d, 6H, 
3
JHH = 6.6, CH3), 1.16 (d, 6H 
3
JHH = 6.8, CH3). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 179.0 
(Ir-Ccarbene), 163.2 (CO), 142.7 (ArC), 128.2 (ArCH, from HSQC and HMBC), 126.4 
(ArCH), 116.1 (N-(CH)2-N), 83.7 (cod-CH), 52.5 (N-CH(CH3)2), 47.0 (cod-CH), 46.5 
(NH-CH2), 34.4 (cod-CH2), 29.5 (cod-CH2), 23.9 (CH3), 23.6 (CH3). 
1
H NMR (400 
MHz, THF-d8): δ 7.18 – 7.09 (m, 5H, ArH), 7.06 (s, 2H, N-(CH)2-N), 5.58 (sept., 2H, 
3
JHH = 6.7, N-CH(CH3)2), 4.91 (br., 1H, NH), 4.39 (br., 2H, cod-CH), 4.08 (d, 2H, 
3
JHH 
= 6.08, NH-CH2), 2.70 (br., 2H, cod-CH), 2.27 – 2.07 (m, 4H, cod-CH2), 1.64 – 1.51 
(m, 4H, cod-CH2), 1.45 (d, 6H, 
3
JHH = 6.6, CH3), 1.36 (d, 6H, 
3
JHH = 6.5, CH3). 
13
C{
1
H} 
NMR (100 MHz, THF-d8): δ 179.0 (Ir-Ccarbene), 163.3 (CO), 143.6 (ArC), 128.3 
(ArCH), 127.8 (ArCH), 126.4 (ArCH), 116.9 (N-(CH)2-N), 82.9 (cod-CH), 52.9 (N-
CH(CH3)2), 46.7 (cod-CH), 46.4 (NH-CH2), 34.4 (cod-CH2), 29.6 (cod-CH2), 23.9 
(CH3), 23.4 (CH3). FTIR (ATR) ν = 2054.19 (s), 1967.39 (s), 1409.96 (s), 1209.37 (s) 
cm
-1
.
 
Anal. Calcd. for C25H36IrN3O2 (MW 602.79): C, 49.81; H, 6.02; N, 6.97. Found: 
C, 49.80; H, 5.87; N, 7.02. *NMR was run in THF-d8 in order to locate all Ar signals. 
 
 
Chapter 5: CO2 Fixation 
 
145 
 
 
[Ir(cod)(I
i
Pr)(κ1O2CNH-(p-BrC6H4)] 25 
A J. Young NMR tube was charged with [Ir(cod)(I
i
Pr)(NH-(p-BrC6H4)] 23 (20.0 
mg, 0.032 mmol, prepared following literature procedure
267
) in C6D6. The sample was 
frozen in liquid N2 and the Ar atmosphere was removed in vacuo. The sample was 
allowed to thaw before CO2 (ca. 1 atm.) was added. The reaction mixture was mixed for 
at least 10 mins before NMR analysis was conducted. Upon completion it was found 
that either bubbling Ar through the reaction mixture or concentrating the sample in 
vacuo converted the product back to 23. 
1
H NMR (300 MHz, C6D6): δ 7.27 – 7.18 (m, 
4H, ArH), 6.24 (s, 2H, N-(CH)2-N), 5.68 (sept., 2H, 
3
JHH = 6.7, N-CH(CH3)2), 4.96 – 
4.86 (m, 2H, cod-CH), 2.98 – 2.4 (m, 2H, cod-CH), 2.38 – 2.16 (m, 4H, cod-CH2), 1.74 
– 1.55 (m, 4H, cod-CH2), 1.25 (d, 6H, 
3
JHH = 6.7, CH3), 1.11 (d, 6H, 
3
JHH = 6.8, CH3). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 178.1 (Ir-Ccarbene), 159.7 (CO), 142.0 (N-ArC), 131.6 
(m-ArCH), 119.4 (o-ArCH), 116.3 (N-(CH)2-N), 112.4 (ArCBr), 83.8 (cod-CH), 52.5 
(N-CH(CH3)2), 47.7 (cod-CH), 34.3 (cod-CH2), 29.4 (cod-CH2), 23.7 (CH3), 23.6 
(CH3).  
5.4.1. Kinetic Experiments 
Kinetic measurements were performed in the solid state using a low temperature 
DRIFTS chamber (Harrick). Complex 13 (ca. 40 mg) was loaded into the chamber, 
which was then purged with N2 (50 mL min
-1
) for ca. 30 minutes. The chamber was 
then heated or cooled to the desired reaction temperature and isolated using ball valves 
situated at the inlet and outlet lines. The gas inlet line was then purged with a mixture of 
N2 and CO2 (1:1, 1 atm, 40 mL min
-1
 combined). During the collection of a data series 
(Nicolet Nexus FTIR spectrometer, 4 cm
-1
 resolution, 32 scans per spectrum) the 
N2/CO2 gas stream was passed through the chamber at 40 mL min
-1
. Single beam 
spectra were ratioed against a background of KBr under the same gas atmosphere. 
Kinetic traces were then determined by measurement of the peak height of the OH 
stretch of Ir-OH as a function of time.  
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Figure 5.10 Sample raw FTIR data for kinetic experiment (ν 3700 – 1000 cm-1) 
 
 
Figure 5.11 Sample raw FTIR data for kinetic experiment (ν 3700 – 2600 cm-1) 
Table 5.1 Peak Height vs time at 278K 
Time 
(mins) 
Peak 
Height 
Normalised 
time (mins) 
Normalised 
peak Height 
2.5260 0.5540 0.5000 1.0000 
3.3690 0.5450 1.3430 0.9838 
4.2110 0.5300 2.1850 0.9567 
5.0530 0.5130 3.0270 0.9260 
9.2630 0.4370 7.2370 0.7888 
13.4740 0.3570 11.4480 0.6444 
17.6840 0.2870 15.6580 0.5181 
21.8950 0.2290 19.8690 0.4134 
26.1060 0.1830 24.0800 0.3303 
30.3170 0.1480 28.2910 0.2671 
34.5280 0.1200 32.5020 0.2166 
38.7380 0.0980 36.7120 0.1769 
42.9490 0.0810 40.9230 0.1462 
47.1590 0.0680 45.1330 0.1227 
51.3690 0.0570 49.3430 0.1029 
55.5790 0.0480 53.5530 0.0866 
59.7890 0.0410 57.7630 0.0740 
64.0000 0.0350 61.9740 0.0632 
68.2100 0.0290 66.1840 0.0523 
72.4210 0.0250 70.3950 0.0451 
68.2100 0.0290 66.1840 0.0523 
72.4210 0.0250 70.3950 0.0451 
 
Table 5.2 Peak Height vs time at 298K (A) 
Time 
(mins) 
Peak 
Height 
Normalised 
time (mins) 
Normalised 
peak Height 
2.5260 0.5960 0.5000 1.0000 
4.6320 0.5130 2.6060 0.8607 
6.7370 0.4370 4.7110 0.7332 
8.8420 0.3710 6.8160 0.6225 
10.9470 0.3120 8.9210 0.5235 
13.0510 0.2620 11.0250 0.4396 
15.1550 0.2200 13.1290 0.3691 
17.2590 0.1830 15.2330 0.3070 
19.3640 0.1540 17.3380 0.2584 
21.4680 0.1300 19.4420 0.2181 
23.5720 0.1120 21.5460 0.1879 
25.6760 0.0960 23.6500 0.1611 
27.7800 0.0800 25.7540 0.1342 
29.8840 0.0700 27.8580 0.1174 
31.9890 0.0600 29.9630 0.1007 
34.0930 0.0510 32.0670 0.0856 
36.1970 0.0450 34.1710 0.0755 
38.3010 0.0360 36.2750 0.0604 
40.4050 0.0320 38.3790 0.0537 
42.5100 0.0250 40.4840 0.0419 
44.6150 0.0210 42.5890 0.0352 
46.7200 0.0180 44.6940 0.0302 
48.8240 0.0110 46.7980 0.0185 
50.9280 0.0090 48.9020 0.0151 
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53.0320 0.0070 51.0060 0.0117 
55.1370 0.0040 53.1110 0.0067 
57.2410 0.0010 55.2150 0.0017 
57.2410 0.0010 60.0000 0.0017 
 
Table 5.3 Peak Height vs time at 298K (B) 
Time 
(mins) 
Peak 
Height 
Normalised 
time (mins) 
Normalised 
peak Height 
2.1050 0.5640 0.5000 1.0000 
2.5260 0.5550 0.9210 0.9840 
4.6310 0.4950 3.0260 0.8777 
6.7350 0.4250 5.1300 0.7535 
8.8400 0.3570 7.2350 0.6330 
10.9440 0.3020 9.3390 0.5355 
13.0480 0.2560 11.4430 0.4539 
15.1530 0.2180 13.5480 0.3865 
17.2570 0.1860 15.6520 0.3298 
19.3610 0.1630 17.7560 0.2890 
21.4650 0.1420 19.8600 0.2518 
23.5690 0.1250 21.9640 0.2216 
25.6730 0.1100 24.0680 0.1950 
27.7770 0.0970 26.1720 0.1720 
29.8810 0.0870 28.2760 0.1543 
31.9860 0.0770 30.3810 0.1365 
34.0900 0.0690 32.4850 0.1223 
36.1940 0.0610 34.5890 0.1082 
38.2980 0.0540 36.6930 0.0957 
40.4020 0.0490 38.7970 0.0869 
42.5060 0.0430 40.9010 0.0762 
44.6110 0.0390 43.0060 0.0691 
46.7150 0.0340 45.1100 0.0603 
48.8190 0.0300 47.2140 0.0532 
50.9240 0.0270 49.3190 0.0479 
53.0280 0.0240 51.4230 0.0426 
55.1310 0.0210 53.5260 0.0372 
57.2350 0.0180 55.6300 0.0319 
57.2350 0.0180 60.0000 0.0319 
57.2350 0.0180 65.0000 0.0319 
57.2350 0.0180 70.0000 0.0319 
 
Table 5.4 Peak Height vs time at 318K  
Time 
(mins) 
Peak 
Height 
Normalised 
time (mins) 
Normalised 
peak Height 
2.5270 0.5570 0.5000 1.0000 
4.6320 0.4430 2.6050 0.7953 
6.7380 0.3400 4.7110 0.6104 
8.8430 0.2600 6.8160 0.4668 
10.9480 0.2020 8.9210 0.3627 
13.0530 0.1620 11.0260 0.2908 
15.1580 0.1310 13.1310 0.2352 
17.2630 0.1070 15.2360 0.1921 
19.3690 0.0880 17.3420 0.1580 
21.4740 0.0720 19.4470 0.1293 
23.5800 0.0600 21.5530 0.1077 
25.6850 0.0500 23.6580 0.0898 
27.7900 0.0410 25.7630 0.0610 
29.8950 0.0340 27.8680 0.0503 
31.9990 0.0280 29.9720 0.0395 
34.1030 0.0220 32.0760 0.0341 
36.2070 0.0190 34.1800 0.0269 
38.3110 0.0150 36.2840 0.0215 
40.4150 0.0120 38.3880 0.0215 
42.5190 0.0120 40.4920 0.0180 
44.6230 0.0100 42.5960 0.0144 
46.7270 0.0080 44.7000 0.0108 
48.8310 0.0060 46.8040 0.0090 
50.9350 0.0050 48.9080 0.0072 
53.0390 0.0040 51.0120 0.0054 
55.1430 0.0030 53.1160 0.0036 
57.2470 0.0020 55.2200 0.0036 
57.2470 0.0020 60.0000 0.0036 
57.2470 0.0020 65.0000 0.0036 
57.2470 0.0020 70.0000 0.0036 
 
Table 5.5 Peak Height vs time at 338K 
Time 
(mins) 
Peak 
Height 
Normalised 
time (mins) 
Normalised 
peak Height 
1.6850 0.5660 0.5000 1.0000 
2.1060 0.5380 0.9210 0.9505 
2.5270 0.5020 1.3420 0.8869 
4.6340 0.3450 3.4490 0.6095 
6.7390 0.2340 5.5540 0.4134 
8.8450 0.1580 7.6600 0.2792 
10.9500 0.1080 9.7650 0.1908 
13.0550 0.0730 11.8700 0.1290 
15.1590 0.0500 13.9740 0.0883 
17.2630 0.0350 16.0780 0.0618 
19.3670 0.0250 18.1820 0.0442 
21.4710 0.0170 20.2860 0.0300 
23.5750 0.0123 22.3900 0.0217 
25.6790 0.0090 24.4940 0.0159 
27.7830 0.0080 26.5980 0.0141 
29.8880 0.0060 28.7030 0.0106 
31.9920 0.0050 30.8070 0.0088 
34.0970 0.0050 32.9120 0.0088 
36.2020 0.0040 35.0170 0.0071 
38.3070 0.0030 37.1220 0.0053 
40.4120 0.0030 39.2270 0.0053 
42.5160 0.0030 41.3310 0.0053 
44.6210 0.0030 43.4360 0.0053 
46.7250 0.0040 45.5400 0.0071 
48.8300 0.0030 47.6450 0.0053 
50.9340 0.0020 49.7490 0.0035 
53.0390 0.0030 51.8540 0.0053 
55.1430 0.0030 53.9580 0.0053 
55.1430 0.0030 55.0000 0.0053 
55.1430 0.0030 60.0000 0.0053 
55.1430 0.0030 65.0000 0.0053 
55.1430 0.0030 70.0000 0.0053 
 
Table 5.6 Peak Height vs time at 358K 
Time 
(mins) 
Peak 
Height 
Normalised 
time (mins) 
Normalised 
peak Height 
1.6850 0.5570 0.5000 1.0000 
2.1070 0.4910 0.9220 0.8815 
2.5280 0.4270 1.3430 0.7666 
2.9490 0.3650 1.7640 0.6553 
3.3700 0.3090 2.1850 0.5548 
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3.7910 0.2600 2.6060 0.4668 
4.2120 0.2140 3.0270 0.3842 
4.6340 0.1760 3.4490 0.3160 
5.4750 0.1160 4.2900 0.2083 
5.8960 0.0950 4.7110 0.1706 
6.3170 0.0790 5.1320 0.1418 
7.1590 0.0570 5.9740 0.1023 
7.5800 0.0480 6.3950 0.0862 
8.0010 0.0400 6.8160 0.0718 
8.8440 0.0300 7.6590 0.0539 
10.9500 0.0150 9.7650 0.0269 
13.0550 0.0090 11.8700 0.0162 
15.1610 0.0070 13.9760 0.0126 
17.2670 0.0050 16.0820 0.0090 
19.3730 0.0040 18.1880 0.0072 
21.4790 0.0040 20.2940 0.0072 
21.4790 0.0040 25.0000 0.0072 
21.4790 0.0040 30.0000 0.0072 
21.4790 0.0040 35.0000 0.0072 
21.4790 0.0040 40.0000 0.0072 
21.4790 0.0040 45.0000 0.0072 
21.4790 0.0040 50.0000 0.0072 
21.4790 0.0040 55.0000 0.0072 
21.4790 0.0040 60.0000 0.0072 
21.4790 0.0040 65.0000 0.0072 
21.4790 0.0040 70.0000 0.0072 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12 Single exponential fit for data 
collected at 278K  
 
Figure 5.13 Single exponential fit for data 
collected at 298K 
 
Figure 5.14 Single exponential fit for data 
collected at 298K 
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Figure 5.15 Single exponential fit for data 
collected at 318K 
 
Figure 5.16 Single exponential fit for data 
collected at 338K 
 
Figure 5.17 Single exponential fit for data 
collected at 358K 
 
 
 
Table 5.7 Values for k, Ln(k) and Ln(k/T) from ORIGIN fitting 
T(K) 1/T (K
-1
) t1 kobs(s
-1
) ln(k) ln(k/T) 
278 0.003597 20.53112 0.048707 -3.02194 -8.64956 
298 0.003356 12.79514 0.078155 -2.54907 -8.24616 
298 0.003356 13.32633 0.075039 -2.58974 -8.28684 
318 0.003145 8.53349 0.117185 -2.144 -7.90605 
338 0.002959 5.54152 0.180456 -1.71227 -7.53531 
358 0.002793 3.76559 0.265563 -1.3259 -7.20644 
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5.4.2. Calculation of activation parameters 
The Activation parameters were determined using the following equations: 
 
Free energy equation: 
              
Eyring Equation: 
    
   
 
  
    
   
for K = 1: 
  (
 
 
)   
   
 
 
 
 
   (
  
 
)  
   
 
 
k = rate constant (kobs) 
R = 8.3144 J mol
-1
 K
-1
 
K = transmission coefficient; assumed to be 1  
kB  = 1.381 · 10 
-23 
J K 
-1
  
T  = absolute temperature (K) 
h  = Plank’s constant (6.626 10 -34 J s) 
∆Gǂ = free energy of activation 
∆Hǂ = enthalpy of activation 
∆Sǂ = entropy of activation 
 
 
Calculation of errors: 
  
 ⁄
  √
∑ (    ̂ )  
   
 
   
  
 ⁄
√∑ (    ̅)  
 
      ⁄
√
∑     
  ∑ (    ̅)  
 
 
          
          
     √(    )
  (      )
  
               
t95% (n=2) = 4.30 
t95% (n=3) = 3.18 
t95% (n=4) = 2.78 
t95% (n=10) = 2.23 
  
 ⁄
            
              
                 
yi = experimental values on the y axis 
 ̂                                  
n = number of experimental value 
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N = n-2= degrees of freedom 
xi = experimental values on the x axis 
 ̅                    
t = t-student parameter with N degrees of freedom (95% confidence level) 
b = slope 
a = intercept 
 
 
Table 5.8. Calculated activation parameters 
a (intercept) -2.196032   
b (slope) -1804.429   
Sy/x 0.034831   
Sa 0.170036   H
‡
=  3.6 ± 0.3 kcal mol
-1 
Sb 52.9361   S
‡ 
= -51.5 ± 0.9 kcal mol
-1 
 t95% 2.776445   G
‡
(298K)
 
=  18.9 ± 0.4 kcal mol
-1 
KB (cal/K) 3.298E-24   
h (cal s) 1.584E-34   
R (cal/mol K) 1.986   
Error a 0.472095   
Error b 146.9742   
H
‡
 (kcal/mol) 3.6   
S
‡ 
(cal/mol K) -51.5   
G
‡
298K
 
(kcal/mol) 18.9   
SH
‡
 (kcal/mol) 0.11   
SS
‡ 
(cal/mol K) 0.34   
SG
‡
298K
 
(kcal/mol) 0.146   
Error H
‡
 (kcal/mol) 0.3   
Error S
‡ 
(cal/mol K) 0.9   
Error G
‡ 
(kcal/mol) 0.4   
 
5.4.3. DFT Calculations 
Gaussian 09, Revision D.01, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. 
Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. 
Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, 
G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, 
M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, 
Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. 
Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. 
Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, 
V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. 
Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. 
Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, Ö. 
Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. J. Fox, Gaussian, Inc., 
Wallingford CT, 2009. 
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6. FLUORIDE, BIFLUORIDE AND TRIFLUOROMETHYL 
COMPLEXES OF IRIDIUM(I) AND RHODIUM(I) 
6.1. INTRODUCTION 
The importance of ancillary ligands on transition metal complexes has been 
discussed at length. Halides feature prolifically as ancillary ligands in the field of TM 
catalysis, owing in large part to the stability of metal-halide bonds.
279
 However, this 
abundance excludes fluorinated organometallic complexes. Fluorides are known to 
confer properties to the metal unique among the halides and their coordination can lead 
to some fascinating reactivity. Nevertheless metal fluorides remain the least understood 
member of the metal-halide family.
14b
  
The catalytic preparation of fluorinated organic compounds is an area of great 
importance for pharmaceutical, agrochemical, and materials industries.
280,281
 Due to 
fluorine’s high electronegativity and small size, it confers unique properties to organic 
molecules through strong polar interactions.
280
 For example, roughly 20% of all 
pharmaceutical compounds contain fluorine groups. The introduction of fluorine on 
drug targets can make them more bioavailable, lipophilic and metabolically stable as 
well as increasing the strength of the compound’s interactions with target proteins.280 
Roughly 30% of all agrochemicals contain fluorine groups, while in materials one of the 
most important polymers, polytetrafluoroethylene (Teflon), is a perfluorinated 
substance. Perfluorination of Teflon accounts for its low friction coefficient and 
hydrophobicity, making it invaluable as a non-stick coating for cook-ware.
281
 
Perfluorinated solvents, when mixed with organic solvents or water form immiscible 
‘fluorous phases’ that are useful for catalyst recovery and purification procedures.282 In 
positron emission tomography (PET) imaging, the non-natural isotope 
18
F is the most 
commonly used positron-emitter.
281
 The utility of fluorinated substances is 
unquestionable, yet fluorination strategies, particularly for the generation of C-F bonds, 
are extremely challenging.
281
 The isolation of fluorinated organometallic complexes 
allows us to study the behaviour of potential catalysts and catalytic intermediates. This 
knowledge is important in designing new catalytic reactions and improving existing 
fluorination methods.  
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To date, fluorination and trifluoromethylation reactions, particularly of aryl and 
allyl substrates has been dominated by Pd and to a lesser extent, Cu catalysis. The 
preparation of biologically active and radio-labelled aryl fluorides is an area of high 
interest and several investigators have made tremendous strides in this area. Buchwald 
elegantly described an efficient fluorination of aryl triflates,
61a
 and recently aryl 
bromides and iodides,
61c
 using his palladium/BrettPhos system (Scheme 6.1). The 
reactions deliver aryl fluorides in high yields and high selectivity with very low 
generation of protonated arenes, which is considered to be a major side product in these 
reactions. The Buchwald group also described the trifluoromethylation of (hetero)aryl 
chlorides, using the same system.
61b
 High yields were obtained and high functional 
group tolerance was exhibited on a wide range of substrates under mild conditions.  
 
Scheme 6.1. Preparation aryl fluorides by Buchwald and co-workers
61a,61c,61b
 
Doyle and co-workers have reported Pd catalysed nucleophilic fluorination of 
allylic chlorides
61e
 and their detailed mechanistic studies led to the first catalytic allylic 
C-H fluorination reaction using a nucleophilic fluoride source (Et3·3HF) using the 
procedure shown in Scheme 6.2.
61f
  
 
Scheme 6.2. Allylic fluorination
61e,
 
61f
 
Efficient fluorination strategies have been described by Hartwig et al. using 
relatively simple Cu(OTf) complexes and silver fluoride to prepare aryl fluorides from 
aryl iodides.
283
 Hartwig’s method is tolerant of a wide range of functional groups and 
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limited heterocyclic systems and was later extended to include aryl boronate esters, 
affording high yields, even with sterically hindered substrates.
284
 A similar Cu(CF3) 
complex has been employed by the Hartwig group in the trifluoromethylation and 
perfluoroalkylation of aryl iodides and bromides stoichiometrically.
285
  
The fluoride ion, is the smallest and most weakly polarisable of the halides and, 
by the Pearson system,
13
 is considered a hard base. Low-valent transition metal centres 
form weakly polarising cations and hence, are considered as soft acids.
14b
 HSAB theory 
or the Pearson rule-of-thumb predicts that soft acids will form more stable complexes in 
solution with soft bases (as discussed for LTM-hydroxides). This theory accounts in 
large part for the rarity of TM fluorides.
14b, 33, 279
 The expectation of weak TM-fluoride 
bonds is reinforced by reports that fluoride ligands coordinated to Rh(I) and Ir(I) can be 
replaced by chloride, bromide or iodide via salt metathesis with corresponding sodium 
salts.
286
 Another reason for the comparative rarity of metal fluorides is the lack of 
convenient synthetic routes, using easy to handle reagents. For example, the difficulties 
associated with using elemental fluorine and hydrogen fluoride (HF) are major 
deterrents.
14b
 
Stabilisation of M-F bonds and isolation of TM-fluorides has mostly been 
reported using phosphine, N-donor or σ-aryl ancillary ligands.287 Indeed, some of the 
most extensively investigated fluoride complexes are analogues of Vaska’s complex 
([IrCl(CO)(PPh3)2]) and related Rh-complexes.
14b, 288
 In contrast, fluoride complexes 
bearing olefinic ligands remain scarce,
265a, 289
 and even more scarce are those containing 
NHC ligands. NHCs have featured extensively in the literature as electron-rich donor 
ligands, and have proven particularly useful in stabilising hard/soft metal-ligand 
mismatches such as metal hydroxides as discussed in the previous chapters.
227, 267
 
Nevertheless, only a small number of LTM-NHC fluorides have been reported, 
including the Cu(I),
290
 Au(I),
290b, 291
 Ag(I),
290b
 Ni(II),
292
 Ru(II),
293
 and Ir(III)
287
 
complexes shown in Figure 6.1.  
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Figure 6.1. Examples of LTM-fluoride complexes bearing NHC supporting ligands
287, 290-292
 
Bifluoride complexes [M(FHF)] are also very interesting, and since the first report 
by Coulson
294
 on Pt, several examples of metal bifluorides have been reported, 
including Mn,
295
 W,
296
 Pd,
297
 Ru,
298
 Mo,
299
 Ni,
300
 and Rh,
288a, 289, 301
 mostly bearing 
phosphine or amine based supporting ligands. Reports of metal bifluorides bearing 
NHC ligands are limited to only two examples. Riant and Leyssens
302,303
 reported a 
method for the preparation of [Cu(NHC)(HF2)] (1a and 1b, NHC = IPr, SIPr) from 
Et3N·3HF and [Cu(NHC)(O
t
Bu)] (prepared in situ from the [Cu(NHC)Cl]). The same 
method led to bis-NHC complexes 2a and 2b when IMes or SIMes were used as NHC, 
giving [Cu(NHC)2]HF2, Scheme 6.3. Riant and Leyssens demonstrated the catalytic 
efficiency of the Cu(I)-bifluorides 2 in ketone hydrosilylation
303-304
 and recently, Weng 
et al. have reported the fluorination of primary and secondary alkyl bromides using an 
amine based bifluoride Cu complex.
305
  
 
Scheme 6.3. Cu bifluoride complexes
302
  
Whittlesey and co-workers have reported the preparation of Rh(I)-bifluorides 5 
bearing ring expanded six-membered NHC ligands from corresponding Rh(I)-hydrides 
4 in yields up to 65% (Scheme 6.4).
301c, 306
 The authors also prepared Rh(I)-fluorides 
from the Rh(I)-hydrides 4 and perfluoropropene or from the Rh(I)-bifluorides 5 and 
Me4NF.
301c, 306
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Scheme 6.4. Cu and Rh-NHC bifluorides
301c, 302, 306
 
LTM-CF3 complexes capable of transferring a CF3 moiety to an organic substrate 
are extremely important for trifluoromethylation chemistry. To the best of our 
knowledge, there are no reports of Ir- or Rh-NHC complexes bearing CF3 groups. In 
fact reports of [TM(NHC)(CF3)] complexes are exclusive to Cu.
307
 In 2011, Grushin 
and co-workers reported the first successful cupration of fluoroform (HCF3, Scheme 
6.5).
307b
 The ability to use HCF3 as a CF3 source was a major breakthrough due to its 
environmental impact and ready availability. Grushin et al. were able to prepare CuCF3 
via Cu-O
t
Bu (formed in situ from CuCl, Scheme 6.5) in batch
307b
 and later in 
continuous stream.
308
 The Cu-CF3 proved to be a versatile reagent for synthesising 
organic CF3 compounds, but also for the preparation of important Cu-CF3 and Pd-CF3 
complexes. For example, reaction of Cu-CF3 with IPr·HCl salt gives the [Cu(CF3)(IPr)] 
complex, which has already proven very useful in aryl trifluoromethylation.
307a
 The 
‘ligandless’ Cu-CF3 has been successfully employed in the preparation of aryl- and 
heteroaryl-CF3 compounds from a range of aryl halides (I, Br, Cl) with good functional 
group tolerance under mild conditions (Scheme 6.5).
309
 Furthermore their method was 
extended to include the trifluoromethylation of arylboronic acids in air, with full 
conversion to corresponding trifluoromethyl arenes under very mild conditions, 
showing substantial improvements to existing protocols.
310
 Grushin’s group has also 
reported the first nucleophilic trifluoromethylation of carbonyl compounds using CuCF3 
to activate α-haloketones.311 The same group has also extended this methodology to Pd-
CF3 complexes as discussed in Chapter 1.
58
 
 
Scheme 6.5 Cupration of fluoroform and transfer of CF3 group to aryl compounds
307b, 309-310
 
In order to build on the reactivity of Ir(I) and Rh(I), we aimed to establish robust 
methods for the preparation of fluorinated complexes. Based on previous success in 
stabilising M-OH bonds on Rh(I) and Ir(I), our strategy was to use the 
Chapter 6: Fluorinated Organometallics 
 
158 
 
[M(cod)(NHC)(X)] scaffold (M = Rh, Ir; X = Cl, OH) to gain access to M(I)-F, M(I)-
HF2 and M(I)-CF3 complexes.  
6.2. DISCUSSION 
Our first approach was to investigate the preparation of M(I)-F complexes via a 
transmetallation/halide substitution reaction between [Ir(cod)(NHC)Cl] (6) and AgF. 
Gratifyingly, this reaction delivered [Ir(cod)(NHC)F] complexes 7a-d as yellow solids 
in excellent yields at room temperature (Scheme 6.6). Multinuclear NMR spectroscopy 
and elemental analysis were used to unambiguously confirm the identity of the products 
with the 
19F NMR signals corresponding to the Ir(I)−F moiety resonating between -221 
and -227 ppm (see experimental section). 
 
Scheme 6.6. Preparation of Ir(I)-fluoride complexes using AgF 
The Ir(I)-F motif was also accessible from the corresponding Ir(I)-hydroxide 8 
and AgF in similar yields. It was clear that the three species were intrinsically linked 
and we were able to convert the Ir(I)-fluoride 7 to either the Ir(I)-hydroxide 8 (via 
reaction with CsOH or KOH), or to the Ir(I)-chloride 6 (via reaction with NaCl, Figure 
6.2). 
 
Figure 6.2. Processes that link the Ir fluoride, chloride and hydroxide 
However, when we attempted to extend the methodology to rhodium, the 
reactions were at best very slow (65% conversion after 60 h for [Rh(cod)(IPr)Cl] 9a). 
Treating either of the metal chlorides or hydroxides with fluoride salts such as KF or 
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CsF were also unsuccessful and a new approach was investigated. To our delight, the 
Rh(I)-hydroxides 10a-b were able to react with the cheap and readily available KHF2, 
and deliver the desired Rh(I)-fluorides 11a-b in high yield in just 5 h. This method 
proved general for both metals (Scheme 6.7) and analysis by 
19
F NMR indicated that 
Rh(I)-F signals resonated at a higher field than the analogous Ir(I)-F complexes (δ -253, 
d, 
1
JRhF = 77 Hz (11a); δ -258, br (11b)). 
 
Scheme 6.7. Preparation of Ir(I) and Rh(I) fluorides using KHF2 
X-ray analysis of single crystals of complexes 7a, 7b, 11a and 11b (Figure 6.3 
and 6.4) indicated 16e
-
 complexes, adopting the usual square planar geometry and 
crystallising as two independent molecules in the unit cell in 7a and 7b and three 
independent molecules in 11b (selected bond lengths and bond angles in Table 6.1). 
Compared to the parent complexes, the M(I)-F bonds (1.991 – 2.032 Å for Ir and 2.016 
– 2.092 Å for Rh) are shorter than M(I)-Cl bonds (2.334 – 2.382 Å)94a, 108, 312 and closer 
in magnitude to the corresponding M(I)-OH bonds (2.014 – 2.038 Å).226-227, 267 
  
Figure 6.3. Thermal ellipsoid representations of complexes 7a and 7b, showing 50% 
probability. H atoms are omitted for clarity. 
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Figure 6.4. Thermal ellipsoid representations of complexes 11a and 11b showing 50% 
probability. H atoms are omitted for clarity.  
Table 6.1. Selected bond lengths (Å) and bond angles (°) for 7a-b and 11a-b 
Entry Complex M(1)-C(1) M(1)-F(1) C(1)-M(1)-F(1) 
1 7a 2.014(16), 2.029(17) 2.023(9), 2.002(11) 87.5(5), 88.2(6) 
2 7b 2.038(17), 2.035(16) 2.002(10), 2.012(9) 88.4(5), 88.6(5) 
3 11a 2.022(3) 2.028(5) 88.20(11) 
4 11b 
2.044(8), 2.063(8), 
2.035(8) 
2.028(5), 2.086(6), 
2.033(5) 
89.1(3), 85.6(3), 
88.0(3) 
Two independant molecules in the unit cell for 7a and 7b and three independent molecules in the unit cell 
for 11b 
 
As a third method, we examined the reaction between the Rh(I)- and Ir(I)-
hydroxides and Et3N·3HF, since Leyssens et al
302
 reported that the reaction between 
[Cu(NHC)(O
t
Bu)] and Et3N·3HF could be tailored to deliver either the mono- or the 
bifluoride complex. In an effort to test these strategies on our complexes, Ir(I)-
hydroxide complexes 8a and 8b and Rh(I)-hydroxides complexes 10a and 10b were 
reacted with Et3N·3HF (0.33 equiv.) in benzene to successfully deliver the Ir(I)-
fluorides 7a-b and the Rh-fluorides 11a-b (4.5 h, rt; Scheme 6.8). Changing the solvent 
to THF and increasing the relative volume of Et3N·3HF (0.66 equiv.) allowed 
[Ir(cod)(IPr)(OH)] (8a) and [Rh(cod)(IPr)(OH)] (10a) to afford the expected bifluoride 
species, [Ir(cod)(IPr)(HF2)] (12a) and [Rh(cod)(IPr)(HF2)] (13a), as bright yellow solids 
in each case (Scheme 6.8). The NMR analysis of these new complexes showed subtle 
differences to the analogous fluoride complexes (7a and 11a). At room temperature the 
1
H NMR spectra for each compound contained a low-field broad doublet (δ 11.4, 1JFH = 
395.0 Hz (12a); δ 12.3, 1JFH = 350.0 (13a)). Upon cooling (200K, CD2Cl2) the signals 
partially resolved into doublets of doublets in each case with a spin-spin coupling of 395 
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and 40 Hz for 12a and 350 and 25 Hz for 13a (see experimental). These 
1
H NMR 
signals were assigned to the acidic proton of the bifluoride moiety; bearing a strong 
bond to one fluoride and a second, weaker bond to another fluoride.  
 
Scheme 6.8. Reaction of Rh(I) and Ir(I) hydroxides with Et3N·3HF 
This assignment was confirmed by the identification of two fluoride groups by 
19
F 
NMR of 12a and 13a. In each case, a 
19
F NMR signal was observed in the same region 
as that on 7a and 11a, corresponding to the metal-bound (proximal) fluoride. In 
addition, a doublet resonated further downfield with a spin-spin coupling constant of 
395 Hz on 12a and 350 Hz on 13a. These signals were assigned to the distal fluoride, 
showing a strong bond to the acidic proton. At 200 K, all 
19
F NMR signals resolved into 
distinct doublets of doublets, e.g. for 12a: 
19
F NMR δ -178 (dd, 1JHF = 395, 
2
JFF = 120, 
Ir-F···HF), - 239 (dd, 2JFF = 120, 
1
JHF = 40, Ir-F···HF, see experimental section). Based 
on these results, we identified the structures of 12a and 13a as [Ir(cod)(IPr)(FHF)] and 
[Rh(cod)(IPr)(FHF)] respectively (Scheme 6.8) with the HF2 moieties comprising a 
strong bond between the metal and the proximal fluoride, and a relatively weak 
hydrogen bond to the HF moiety (i.e. [M]−F···HF as opposed to [M]···F−HF), in 
agreement with literature reports.
298a, 301a, 301b, 302, 306
  
X-ray crystallographic analysis of single crystals of 12a and 13a (Figure 6.5) 
showed square planar complexes, adopting the same geometry as the mono-fluorides 
and co-crystallising in each case as two independent molecules in the unit cell. The X-
ray structure for 12a shows a significantly elongated M-F bond compared to the 
monofluoride 7a, (2.054 − 2.064 (12a) compared to 1.991 – 2.032 Å (7a), Table 6.2). 
This weakening of the M-F bond is a consequence of the hydrogen bond to HF.
298a
 
There is considerable uncertainty involved in accurately locating the acidic proton. 
Hence, when discussing the relative bond strengths and symmetry within the bifluoride 
moiety, it is more useful to discuss the inter-atomic distance between the two fluorines. 
The F−F separation for 12a is in the range of 2.352 − 2.387 Å and 2.316 − 2.331 Å for 
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complex 13a (Table 6.2). These values are considerably less than the sum of the van der 
Waals radii for two F atoms (2.94 Å)
313
 and are indicative of strong hydrogen bonds 
between the proton and the two fluorides, in agreement with reports for other metal 
bifluorides including Mo and Rh.
296, 297c, 298a, 298c, 299-301, 301c, 302, 306
 However, compared 
to true ionic bifluoride salts (2.24 – 2.28 Å),299, 314 the larger interatomic separations 
indicate weaker hydrogen bonds (relative to [HF2]
-
); as a result of the strong interaction 
between the Ir(I)/Rh(I) metal and the proximal fluoride. 
 
Figure 6.5. Thermal ellipsoid representations of 12a and 13a showing 50% thermal ellipsoid 
probability. H atoms are omitted for clarity.  
Table 2. Selected bond lengths (Å) and bond angles (°) for 12a and 12b
a 
Entry Complex Ir(1)-C(1) Ir(1)-F(1) C(1)-Ir(1)-F(1) 
1 12a 2.033(4), 2.049(4) 2.057(3), 2.062(2) 88.92(13), 92.59(12) 
2 13a 2.047(5), 2.035(6) 2.089(3), 2.069(3) 93.09(16), 89.14(18) 
a
Two independent molecules in the unit cell for 12a and 12b 
 
The unsymmetrical nature of the HF2 ligand was further supported by IR analyses 
of 12a and 13a. FTIR (ATR) analyses of 12a and 13a showed two broad absorptions 
each (12a: ν = 2623 and 1807 cm-1; 13a: ν = 2530 and 1890 cm-1) corresponding to the 
H-F modes of the bifluoride (These broad bands are absent from IR spectra of the 
mono-fluorides 7a and 11a).
297b, 299, 306
 Compared to the IR bands expected for free HF 
(ν = 3896 and 3895 cm-1 in an Ar matrix),315 it is clear that there is weakened hydrogen 
bonding within the HF moiety as a result of the H-bond to the proximal fluoride, 
causing a shift to lower wavelength. Compared to symmetrical inorganic bifluoride 
salts, for example Cs
+
, K
+
 or Na
+
 HF2
-
 (1372 – 1284 cm-1),316 the IR bands exhibited for 
12a and 13a are considerably higher in wavelength, indicating that the HF2 moiety in 
these complexes is highly unsymmetrical, with a stronger hydrogen bond to one fluorine 
atom than the other. 
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In addition to 12a and 13a, an alkyl-substituted NHC complex of Ir(I)-(HF2) was 
prepared in the form of [Ir(cod)(I
i
Pr)(HF2)] (12b) (Scheme 6.8). The less sterically 
encumbered (12b) exhibited different structural characteristics to 12a and 13a, both in 
the solid state and in solution. For example, at room temperature the 
1
H NMR signal 
corresponding to the acidic proton resonates as a broad unresolved peak, as do both 
signals in the 
19
F NMR spectrum (see experimental section). Upon cooling to 200 K, the 
signals resolved into doublets of doublets in the same way as 12a and 13a. 
From the X-ray structure of 12b (Figure 6.6) it is clear that while the Ir-F bond is 
comparable to 12a (2.064(5), [2.082(4)] Å) the F-F separation (2.457(6), [2.587(6)] Å) 
is considerably higher, even when compared to the values for most metal bifluorides 
reported to date. This observation is most likely indicative of weaker interactions 
between the proton and the fluoride groups.
289, 296-299, 301-302, 306, 317
 The Ir(1)-F(1)-F(2) 
angle is ca. 116.33° – 117.98°, much lower than that for 12a (ca. 122.13° – 132.36°), 
although the angle between metal and bifluoride tends to vary substantially for different 
compounds in the literature, (109° on Cu to 156° on W).
296, 302
 On closer inspection of 
the X-ray structures of 12a and 13a it is clear that F(1) and the isopropyl proton on each 
side of the IPr ligand are in very close proximity to each other. For 12a this distance lies 
in the range of 2.3316 – 2.4949 Å and for 13a the contact is in the range of 2.3150 – 
2.4348 Å. This is considerably less than the sum of the van der Waals radii for H and F 
(2.67 Å)
313
 The same close proximity of the bifluoride and the NHC substituents is not 
possible on 12b and the added flexibility may account for the fluxional behaviour in 
solution that was associated with complex 12b (this short contact is not observed in 7a). 
 
Figure 6.6. Thermal ellipsoid representation of 12b showing 50% thermal ellipsoid probability. 
H atoms are omitted for clarity. Selected bond lengths (Å) and bond angles (°): Ir(1)-C(1) 
2.045(6), [2.053(6)]; Ir(1)-F(1) 2.064(5), [2.082(4)]; C(1)-Ir(1)-F(1) 91.0(2), [87.5(2)]. 
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Next we studied the relationship between the fluoride and bifluoride complexes. 
The ease with which the bifluoride can be generated from the monofluoride and the 
lability of the HF molecule is especially important for catalytic fluorination and 
fluorination/ring-opening processes,
318
 where catalysts, particularly metal fluorides, are 
coupled with an HF source. In order to examine the persistence of the bifluoride moiety 
in the presence of a base, both the Rh(I)- and Ir(I)-bifluorides (12a and 13a) were 
reacted with a stoichiometric amount of KOH. In both cases, full conversion to the 
corresponding monofluorides (7a and 11a) was seen within 2 h. Interestingly, the 
addition of a second equivalent of KOH yielded the corresponding metal hydroxide 8a 
or 10a; whilst addition of Et3N·3HF (0.33 equiv.) to 7a or 11a regenerated the metal 
bifluorides (12a and 13a). Hence, the three species are inherently linked (Figure 6.7) 
and in the presence of an excess of Et3N·3HF, a metal fluoride will more than likely 
deliver the metal bifluoride. 
 
Figure 6.7. Processes linking M(I)-OH, M(I)-F and M(I)-(HF2) (M = Rh and Ir) 
Having established reliable routes to mono- and bifluoride complexes of Ir(I) and 
Rh(I) as well as studied the processes that link them, our final goal was to access the 
first examples of Ir(I)(NHC)-CF3 and Rh(I)(NHC)-CF3 complexes. Our initial attempts 
were conducted using Ruppert-Prakash's reagent, trifluoromethyl(trimethyl)silane 
(TMSCF3). Unfortunately all attempts to transfer the CF3 from Si to Ir or Rh failed. The 
only complex that reacted with TMSCF3 was [Ir(cod)(I
i
Pr)(OH)] (8a). The reaction 
delivered [Ir(cod)(I
i
Pr)(OSiMe3)] (14) (96%), with HCF3 as a side product. The ease 
with which this substrate reacts with silanes to form Ir(I)-siloxide complexes has been 
discussed in Chapter 4.
267
 No reaction was observed between TMSCF3 and any of the 
other Ir(I)- or Rh(I)-hydroxides (8 or 10), or the chlorides (6 or 9). The fluoride 
complexes (7 and 11) were completely unreactive to TMSCF3 and the reaction between 
the bifluorides (12 and 13) and TMSCF3 only led to inseparable mixtures of products. It 
was clear that TMSCF3 was not an ideal CF3 source and that a new approach was 
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necessary. Roper has reported the preparation of Ir(I)-CF3 complexes from 
[Ir(CO)2(PPh3)2H] using Hg(CF3)2 and similar strategies have been employed on other 
metals using Hg- or Cd(CF3)2.
319
 In an attempt to avoid such toxic reagents, we 
considered that Ag might be a more convenient approach. Hence, AgCF3 was prepared 
in situ from AgF and TMSCF3 at -40 °C
320
 and reacted with [Ir(cod)(I
i
Pr)Cl] (6a) to 
give [Ir(cod)(I
i
Pr)(CF3)] (15a) as a bright red solid (Scheme 6.9).  
 
Scheme 6.9. Preparation of [Ir(cod)(I
i
Pr)(CF3)] (15a)  
All attempts at isolating the Ir(IPr)-CF3 15b and Rh(IPr)-CF3 16a using this 
procedure failed as the products appeared to be unstable. In order to rationalise these 
results we studied the structure of the isolated compound 15a. Hence, single crystals of 
15a were grown and analysed by X-ray diffraction (Figure 6.8). In the solid state it was 
clear that two of the fluorine atoms were in very close proximity to a methine proton on 
each side of the NHC ligand (ca. 2.451 Å). This distance is considerably less than the 
sum of the Van der Waals radii of H and F (2.67 Å)
313
 and may indicate an interaction 
between the two groups. Therefore, it is possible that the isopropyl groups of the I
i
Pr 
ligand are interacting with the CF3, stabilising the complex. Furthermore, this 
interaction is evident in the 
13
C{
1
H} NMR of 15a where a spin-spin coupling interaction 
causes one of the 
13
C{
1H} methyl signals to split into a quartet (δ 22.8 ppm, JFC = 1 
Hz). Since the methyl group is separated from the fluorine atoms by six bonds, the 
interaction must be a "through-space" coupling.
321
 The proximity of the isopropyl 
groups to the CF3 moiety indicated that there were considerable steric constraints to take 
into account. Thus, the presence of bulky NHC ligand substituents such as 
diisopropyl(phenyl) on IPr would hinder the coordination of a CF3 group to the metal 
centre, rendering [M(cod)(IPr)(CF3)] unstable. 
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Figure 6.8. Thermal ellipsoid representation of 15a showing 50% thermal ellipsoid probability. 
H atoms are omitted for clarity. Selected bond lengths (Å) and bond angles (°): Ir(1)-C(1) 
2.065(8); Ir(1)-C(7) 2.086(8); C(7)-F(1) 1.357(10); C(7)-F(2) 1.359(7); C(1)-Ir(1)-C(7) 88.3(3). 
To test this hypothesis, we investigated the reaction between [M(cod)(ICy)Cl] (6c 
and 9b) and AgCF3, which delivered [M(cod)(ICy)(CF3)] (15c and 16c, Scheme 6.10). 
The same structural features were evident in the 
13
C{
1
H} NMR spectrum of 15c, 
showing a spin-spin coupling interaction between a methylene on the cyclohexyl ring 
and the fluoride groups of the CF3. Furthermore, an X-ray crystal structure of 16c 
(Figure 6.9) indicated a similar close proximity between the fluorides and a proton on 
each of the cyclohexyl rings (2.505 – 2.520 Å). Hence, this method was somewhat 
limited by the steric bulk of the NHC ligands and proved more successful for Ir than Rh, 
with 16c being isolated in only 53% yield. However, interesting structural investigations 
have given us further insight into the stability of this scaffold and the viability of the 
method. 
 
Scheme 6.10. Preparation of Ir(I)-CF3 and Rh(I)-CF3 complexes 
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Figure 6.9 Thermal ellipsoid representation of 16c showing 50% thermal ellipsoid probability. 
H atoms are omitted for clarity. Selected bond lengths (Å) and bond angles (°): Rh(1)-C(2) 
2.042(5); Rh(1)-C(18) 2.067(5); C(18)-F(1) 1.366(6); C(18)-F(2) 11.331(8); C(18)-F(3) 
1.354(6); C(8)-Rh(1)-C(29) 87.3(2). 
6.3. CONCLUSIONS 
We have successfully utilised three methods for accessing Ir(I)-NHC fluoride 
compounds via AgF, KHF2 and Et3N·3HF, with the two latter methods proving equally 
effective on rhodium. Synthesis of the first examples of Ir(I) bifluorides was achieved in 
high yields. Access to Ir(I) and Rh(I) mono- and bifluorides allowed us to examine the 
link between the two species. Knowledge of the relationship between the metal 
fluorides and metal bifluorides could prove paramount in developing new fluorination 
strategies since the bifluoride can be quantitatively generated from the monofluoride in 
solution and vice versa. A new methodology was also established to access the first 
examples of Ir(I)-NHC and Rh(I)-NHC trifluoromethyl complexes. Consequently, we 
have assembled a toolbox for the preparation of fluorinated Ir(I) and Rh(I) complexes to 
take advantage of the reactivity of already successful Ir(I)-NHC and Rh(I)-NHC 
scaffolds. These complexes may prove important in the pursuit of fluorination strategies 
and may well provide active catalytic species or intermediates. 
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6.4. EXPERIMENTAL DETAILS 
6.4.1. General considerations 
All manipulations and reactions were performed inside an Argon-filled Innovative 
Technologies glovebox or on an Argon-supplied Schlenk line unless stated otherwise. 
All reagents were supplied by Aldrich and used without further purification. Solvents 
were distilled and dried as required. NMR data was obtained using either a Bruker 300, 
400 or 500 MHz spectrometer at 303 K (unless stated otherwise) in the specified 
deuterated solvent. All chemical shifts are given in ppm and coupling constants in Hz. 
Signals on the 
13
C{
1
H} NMR spectra are singlets unless otherwise stated. Spectra were 
referenced to residual protonated solvent signals (for 
1
H) or solvent signals (for 
13
C): 
(C6D6: 
1
H δ 7.16 ppm, 13C δ 128.06 ppm, CD2Cl2 
1
H δ 5.32 ppm, 13C δ 53.84 ppm). 
Infrared spectra (ν) were recorded on a Shimadzu Fourier transform IR Affinity-1 
Infrared spectrometer using a MIRacle
TM 
single reflection horizontal ATR (diamond). 
Samples were placed directly on the crystal (ATR) in the solid state. Only characteristic 
peaks have been quoted. Elemental analyses were performed at the London 
Metropolitan University. CCDC- 1000750 (7a), 1000751 (7b), 1000754 (11a), 1001352 
(11b), 1000753 (12a), 1000755 (12b), 1000754 (13a), 1000756 (15a), 1000757 (16c), 
contain structural data for complexes characterized by X-ray diffraction. 
Crystallographic data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
6.4.2. Synthesis and Characterisation data 
 
[Ir(cod)(IPr)(F)] 7a 
Method A: A vial was charged with [Ir(cod)(IPr)(Cl)] (6a) (50 mg, 0.071 mmol) 
and AgF (43.8 mg, 0.35 mmol) in CH2Cl2 (1 mL) and the reaction mixture was stirred at 
rt in the dark for 16 h. Once complete, pentane (1 mL) was added to the mixture and left 
to stand for 10 mins. The reaction mixture was filtered through celite and concentrated 
in vacuo to give a yellow solid. The solid was washed with cold pentane (3 x 1 mL), 
taken up in a mixture of THF (0.2 mL) and pentane (1 mL) and filtered through a PTFE 
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syringe filter (0.2 µm) to remove residual Ag compounds. The product was dried in 
vacuo to give [Ir(cod)(IPr)(F)] (7a) (45 mg, 90%) as a yellow solid. 
Method B: A vial was charged with [Ir(cod)(IPr)(OH)] (8a) (20 mg, 0.028 mmol) 
and KHF2 (6.6 mg, 0.085 mmol) in THF (1 mL) and the reaction mixture was stirred at 
rt for 5 h. Once complete, the reaction mixture was filtered through celite and 
concentrated in vacuo to give a yellow solid. The solid was washed with cold pentane (3 
x 1 mL) and dried in vacuo to give [Ir(cod)(IPr)(F)] (7a) (20 mg, 99%) as a yellow 
solid. 
Method C: A Schlenk tube was charged with [Ir(cod)(IPr)(OH)] (8a) (50 mg, 
0.071 mmol) in benzene (1 mL). NEt3.3HF (4.0 µL, 0.024 mmol) was added under Ar 
and the reaction mixture was stirred at rt for 4.5 h. The product was reduced in vacuo 
and azeotroped with hexane (2 x 2 mL) to give a yellow solid. The solid was washed 
with hexane (2 x 1 mL) and dried in vacuo to give [Ir(cod)(IPr)(F)] (7a) (35 mg, 70%) 
as a yellow solid. 
1
H NMR (500 MHz, CD2Cl2): δ 7.51 (t, 2H, 
3
JHH = 7.7, p-ArH), 7.34 
(d, 4H, 
3
JHH = 7.7, m-ArH), 7.02 (s, 2H, N-(CH)2-N), 4.02 – 3.92 (m, 2H, cod-CH), 2.95 
(sept., 4H, 
3
JHH = 6.8, CH(CH3)2), 2.64 – 2.58 (m, 2H, cod-CH), 1.73 – 1.64 (m, 2H, 
cod-CH2), 1.59 – 1.49 (m, 2H, cod-CH2), 1.37 (d, 12H, 
3
JHH = 6.7, CH3), 1.28 – 1.18 
(m, 4H, cod-CH2), 1.10 (d, 12H, 
3
JHH = 6.8, CH3). 
19
F NMR
 
(282 MHz, C6D6): δ -221 
(br.). 
13
C{
1
H} NMR (125 MHz, CD2Cl2): δ 183.6 (Ir-Ccarbene), 146.9 (ArC), 136.3 
(ArC), 129.9 (ArCH), 124.4 (ArCH), 123.9 (N-(CH)2-N), 83.3 (d, 
2
JFC = 4, cod-CH), 
45.0 (d, 
2
JFC = 4, cod-CH), 34.2 (cod-CH2), 29.1 (CH(CH3)2), 28.4 (cod-CH2), 26.3 
(CH3), 22.8 (CH3). FTIR (ATR) ν = 800.46 (s), 756.10 (s) cm
-1
. Anal. Calcd. for 
C35H48FIrN2 (MW 707.98): C, 59.38; H, 6.83; N, 3.96. Found: C, 59.38; H, 6.97; N, 
4.01. 
 
[Ir(cod)(I
i
Pr)(F)] 7b 
Method A: A vial was charged with [Ir(cod)(I
i
Pr)(Cl)] (6b) (50.0 mg, 0.102 
mmol) and AgF (65.0 mg, 0.512 mmol) in CH2Cl2 (1 mL) and the reaction mixture was 
stirred at rt in the dark for 16 h. Once complete, pentane (1 mL) was added to the 
mixture and left to stand for 10 mins. The reaction mixture was filtered through celite 
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and concentrated in vacuo to give a yellow solid. The solid was washed with cold 
pentane (3 x 1 mL), taken up in a mixture of THF (0.2 mL) and pentane (1 mL) and 
filtered through a PTFE syringe filter (0.2 µm) to remove residual Ag compounds. The 
product was dried in vacuo to give [Ir(cod)(I
i
Pr)(F)] (7b) (47 mg, 98%) as a yellow 
solid.  
Method B: A vial was charged with [Ir(cod)(I
i
Pr)(OH)] (8b) (20 mg, 0.043 mmol) 
and KHF2 (10.0 mg, 0.13 mmol) in THF (1 mL) and the reaction mixture was stirred at 
rt for 5 h. Once complete, the reaction mixture was filtered through celite and 
concentrated in vacuo to give a yellow solid. The solid was washed with cold pentane (3 
x 1 mL) and dried in vacuo to give [Ir(cod)(I
i
Pr)(F)] (7b) (15 mg, 74%) as a yellow 
solid. 
Method C: A Schlenk tube was charged with [Ir(cod)(I
i
Pr)(OH)] (8b) (100 mg, 
0.213 mmol) in benzene (1 mL). NEt3.3HF (12 µL, 0.07 mmol) was added under Ar and 
the reaction mixture was stirred at rt for 4.5 h. The product was reduced in vacuo and 
azeotroped with hexane (2 x 2 mL) to give a yellow solid. The solid was washed with 
pentane (3 x 1 mL) and dried to give [Ir(cod)(I
i
Pr)(F)] (7b) (97.9 mg, 97%) as a yellow 
solid. 
1
H NMR (300 MHz, C6D6): δ 6.28 (s, 2H, N-(CH)2-N), 5.80 (sept., 2H, 
3
JHH = 
6.8, N-CH(CH3)2), 5.10 – 4.97 (m, 2H, cod-CH), 2.96 – 2.87 (m, 2H, cod-CH), 2.45 – 
2.22 (m, 4H, cod-CH2), 1.80 – 1.58 (m, 4H, cod-CH2), 1.21 (app. d, 6H, 
3
JHH = 6.4 
CH3), 1.11 (app. d, 6H, 
3
JHH = 6.8, CH3). 
19
F NMR (282 MHz, C6D6): δ -227 (br). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 180.7 (Ir-Ccarbene), 116.2 (N-(CH)2-N), 84.4 (cod-
CH), 52.5 (cod-CH), 43.8 (N-CH(CH3)2), 34.9 (cod-CH2), 29.5 (cod-CH2), 24.3 (CH3), 
23.0 (CH3). FTIR (ATR) ν = 1413.82 (s), 1211.30 (s), 881.47 (w) cm
-1
. Anal. Calcd. 
for C17H28FIrN2 (MW 471.63): C, 43.29; H, 5.98; N, 5.94. Found: C, 43.23; H, 6.05; N, 
6.05. 
 
[Ir(cod)(ICy)(F)] 7c 
A vial was charged with [Ir(cod)(ICy)(Cl)] (6c) (50 mg, 0.088 mmol) and AgF 
(56 mg, 0.44 mmol) in CH2Cl2 (1 mL) and the reaction mixture was stirred at rt in the 
dark for 16 h. Once complete, pentane (1 mL) was added to the mixture and left to stand 
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for 10 mins. The reaction mixture was filtered through celite and concentrated in vacuo 
to give a yellow solid. The solid was washed with cold pentane (3 x 1 mL), taken up in 
a mixture of THF (0.2 mL) and pentane (1 mL) and filtered through a PTFE syringe 
filter (0.2 µm) to remove residual Ag compounds. The product was dried in vacuo to 
give [Ir(cod)(ICy)(F)] (7c) (44 mg, 90%) as a yellow solid. 
1
H NMR (300 MHz, C6D6): 
δ 6. 35 (s, 2H, N-(CH)2-N), 5.46 (tt, 2H, 
3
JHH = 11.7, 3.6 N-CH(ICy)), 5.02 – 4.92 (m, 
2H, cod-CH), 3.00 – 2.89 (m, 2H, cod-CH), 2.51 – 2.23 (m, 6H, cod-CH2, ICy-CH2), 
1.94 – 1.81 (m, 2H, ICy-CH2), 1.81 – 1.02 (m, 18H, ICy-CH2), 1.02 – 0.80 (m, 2H, ICy-
CH2). 
19
F{
1
H} NMR (282 MHz, C6D6): δ -227 (s). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 
181.2 (Ir-Ccarbene), 116.6 (N-(CH)2-N), 84.1 (cod-CH), 60.3 (cod-CH), 43.8 (N-
CH(CH3)2), 35.1 (cod-CH2), 34.4 (ICy-CH2), 29.7 (cod-CH2), 26.3, 25.7, 22.7, 14.3 
(ICy-CH2). Anal. Calcd. for C23H36FIrN2 (MW 551.77): C, 50.07; H, 6.58; N, 5.08. 
Found: C, 49.96; H, 6.65; N, 5.12. 
 
[Ir(cod)(IDD)(F)] 7d 
A vial was charged with [Ir(cod)(IDD)(Cl)] (6d) (50.0 mg, 0.068 mmol) and AgF 
(43.0 mg, 0.34 mmol) in CH2Cl2 (1 mL) and the reaction mixture was stirred at rt in the 
dark for 16 h. Once complete, pentane (1 mL) was added to the mixture and left to stand 
for 10 mins. The reaction mixture was filtered through celite and concentrated in vacuo 
to give a yellow solid. The solid was washed with cold pentane (3 x 1 mL), taken up in 
a mixture of THF (0.2 mL) and pentane (1 mL) and filtered through a PTFE syringe 
filter (0.2 µm) to remove residual Ag compounds. The product was dried in vacuo to 
give [Ir(cod)(IDD)(F)] (7d) (48 mg, 98%) as a yellow solid. 
1
H NMR (400 MHz, 
C6D6): δ 6.43 (s, 2H, N-(CH)2-N), 5.78 – 5.68 (m, 2H, N-CH(IDD)), 5.04 – 4.96 (m, 
2H, cod-CH), 2.97 – 2.90 (m, 2H, cod-CH), 2.60 – 2.39 (m, 4H, cod-CH2), 2.17 – 2.03 
(m, 2H, IDD-CH2), 2.00 – 1.84 (m, 4H, cod-CH2), 1.83 – 1.61 (m, 12H, IDD-CH2), 1.52 
– 1.17 (m, 30H, IDD-CH2). 
19
F{
1
H} NMR (470 MHz, C6D6): δ -219.7 (s). 
13
C{
1
H} 
NMR (100 MHz, C6D6): δ 182.0 (Ir-Ccarbene), 117.0 (N-(CH)2-N), 84.3 (cod-CH), 56.8 
(cod-CH), 43.3 (N-CH(CH3)2), 35.1 (cod-CH2), 32.5, 31.7, 29.5, 25.3, 25.1, 24.1, 23.8, 
23.7, 23.5, 23.4, 23.3, 22.4. Anal. Calcd. for C35H60FIrN2 (MW 720.09): C, 58.38; H, 
8.40; N, 3.89. Found: C, 58.44; H, 8.48; N, 3.91. 
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[Rh(cod)(IPr)(F)] 11a 
Method A: A Schlenk tube was charged with [Rh(cod)(IPr)(OH)] (10a) (50 mg, 
0.081 mmol) in benzene (1 mL). NEt3.3HF (4.5 µL, 0.027 mmol) was added under Ar 
and the reaction mixture was stirred at rt for 3.5 h. The product was reduced in vacuo 
and azeotroped with hexane (2 x 2 mL) to give a yellow solid. The solid was washed 
with hexane (2 x 1 mL) and dried to give [Rh(cod)(IPr)(F)] (11a) (41.5 mg, 83%) as a 
yellow solid. 
Method B: A vial was charged with [Rh(cod)(IPr)(OH)] (10a) (20 mg, 0.032 
mmol) and KHF2 (8.0 mg, 0.098 mmol) in THF (1 mL) and the reaction mixture was 
stirred at rt for 5 h. Once complete, the reaction mixture was filtered through celite and 
concentrated in vacuo to give a yellow solid. The solid was washed with cold pentane (3 
x 1 mL) and dried in vacuo to give [Rh(cod)(IPr)(F)] (11a) (15.5 mg, 78%) as a yellow 
solid. 
1
H NMR (300 MHz, C6D6): δ 7.33 (t, 2H, 
3
JHH = 7.6, p-ArH), 7.25 (d, 4H, 
3
JHH = 
7.6, m-ArH), 6.57 (s, 2H, N-(CH)2-N), 4.96 – 4.75 (m, 2H, cod-CH), 3.39 – 3.08 (m, 
4H, CH(CH3)2), 3.04 – 2.85 (m, 2H, cod-CH), 1.99 – 1.76 (m, 4H, cod-CH2), 1.52 (d, 
12H, 
3
JHH = 6.7, CH3), 1.45 – 1.20 (m, 4H, cod-CH2), 1.05 (d, 12H, 
3
JHH = 6.9, CH3). 
19
F{
1
H} NMR
 
(282 MHz, C6D6): δ -252.8 (d, 
1
JRhF = 77). 
13
C{
1
H} NMR (75 MHz, 
C6D6): δ 189.1 (d, 
1
JRhC = 54, Rh-Ccarbene), 147.2 (ArC), 136.7 (ArC), 130.1 (ArCH), 
124.0 (N-(CH)2-N), 123.9 (ArCH), 97.0 (d, 
1
JRhC = 5, cod-CH), 61.4 (d, 
1
JRhC = 15, cod-
CH), 33.6 (cod-CH2), 28.9 (CH(CH3)2), 28.2 (cod-CH2), 26.5 (CH3), 23.2 (CH3). IR 
(ATR) ν = 800.46 (s), 754.17 (s) cm-1. Anal. Calcd. for C35H48FRhN2 (MW 618.67): C, 
67.95; H, 7.82; N, 4.53. Found: C, 68.04; H, 7.76; N, 4.39. 
 
[Rh(cod)(ICy)F] 11b 
Method A: A vial was charged with [Rh(cod)(ICy)(OH)] (10b) (20 mg, 0.032 
mmol) and KHF2 (8.0 mg, 0.10 mmol) in THF (1 mL) and the reaction mixture was 
stirred at rt for 5 h. Once complete, the reaction mixture was filtered through celite and 
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concentrated in vacuo to give a yellow solid. The solid was washed with cold pentane (3 
x 1 mL) and dried in vacuo to give [Rh(cod)(ICy)(F)] (11b) (16 mg, 81%) as a yellow 
solid. 
Method B: A Schlenk tube was charged with [Rh(cod)(ICy)OH] (10b) (50 mg, 
0.11 mmol) in benzene (1 mL). NEt3.3HF (6.0 µL, 0.036 mmol) was added under Ar 
and the reaction mixture was stirred at rt for 3.5 h. The product was reduced in vacuo 
and azeotroped with hexane (2 x 2 mL) to give a yellow solid. The solid was washed 
with pentane (2 x 1 mL) and dried to give [Rh(cod)(ICy)(F)] (11b) (43 mg, 86%) as a 
yellow solid. 
1
H NMR (500 MHz, C6D6): δ 6.39 (s, 2H, N-(CH)2-N), 5.69 – 5.56 (m, 
2H, NCH), 5.38 – 5.26 (m, 2H, cod-CH), 3.14 – 3.04 (m, 2H, cod-CH), 2.69 – 2.51 (m, 
2H, ICy-CH2), 2.52 – 2.29 (m, 4H, cod-CH2), 1.96 – 1.80 (m, 4H, cod-CH2), 1.80 – 
1.71 (m, 2H, ICy-CH2), 1.71 – 1.58 (m, 4H, ICy-CH2), 1.57 – 1.05 (m, 10H, ICy-CH2), 
1.05 – 0.85 (m, 2H, ICy-CH2). 
19
F{
1
H} NMR
 
(470 MHz, C6D6): δ -257 (br, Rh-F). 
13
C{
1
H} NMR (125 MHz, CD2Cl2): δ 181.0 (Ir-Ccarbene, from HMBC), 117.4 (N-(CH)2-
N), 98.0 (br, cod-CH), 62.3 (br, cod-CH), 60.8 (N-(CH)2-N), 35.1 (ICy-CH2), 34.6 
(ICy-CH2), 33.7 (cod-CH2), 28.7 (cod-CH2), 26.5 (ICy-CH2), 26.4 (ICy-CH2), 25.8 
(ICy-CH2). FTIR (ATR) ν = 705.95 (s), 1990.24 (w, br), 2924.09 (s) cm
-1
. Anal. 
Calcd. for C23H36FRhN2 (MW 462.45): C, 59.74; H, 7.85; N, 6.06. Found: C, 59.58; H, 
7.66; N, 6.18. 
 
[Ir(cod)(IPr)(HF2)] 12a 
A Schlenk tube was charged with [Ir(cod)(IPr)(OH)] (8a) (400 mg, 0.57 mmol) in 
THF (2 mL). NEt3.3HF (63 µL, 0.38 mmol) was added under Ar and the reaction 
mixture was stirred at rt for 4.5 h. The product was reduced in vacuo and azeotroped 
with pentane (3 x 2 mL) to give a yellow solid. The solid was washed with hexane (3 x 
2 mL) and dried to give [Ir(cod)(IPr)(HF2)] (12a) (384 mg, 93%) as a yellow solid. 
1
H 
NMR (300 MHz, C6D6): δ 11.32 (d, 1H, 
1
JFH = 395.0, F-HF), 7.27 (t, 2H, 
3
JHH = 7.7, p-
ArH), 7.17 (d, 4H, 
3
JHH = 7.7, m-ArH), 6.49 (s, 2H, N-(CH)2-N), 4.67 – 4.57 (m, 2H, 
cod-CH), 3.04 (sept., 4H, 
3
JHH = 6.8, CH(CH3)2), 2.91 – 2.82 (m, 2H, cod-CH), 1.75 – 
1.58 (m, 4H, cod-CH2), 1.50 (d, 12H, 
3
JHH = 6.7, CH3), 1.25 – 1.15 (m, 4H, cod-CH2), 
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1.02 (d, 12H, 
3
JHH = 6.8, CH3); 
1
H NMR (500 MHz, 200K, CD2Cl2): δ 11.73 (app. dd, 
1H, 
1
JFH = 395.0, 
1
JFH = 40.0, Ir-F-HF). 
19
F NMR
 
(282 MHz, C6D6): δ -185.2 (br. d, 
1
JHF = 395, Ir-F-HF), -236.2 (br s., Ir-F-HF). 
19
F NMR
 
(470 MHz, 200K, CD2Cl2): δ -
177.9 (dd, 
1
JHF = 395, 
2
JFF = 120, Ir-F-HF), - 238.9 (dd, 
2
JFF = 120, 
1
JHF = 40, Ir-F-HF). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 183.7 (Ir-Ccarbene), 146.8 (ArC), 136.0 (ArC), 130.3 
(ArCH), 124.1 (N-(CH)2-N), 123.9 (ArCH), 84.7 (d, 
2
JFC = 2, cod-CH), 45.0 (d, 
2
JFC = 
4, cod-CH), 34.3 (cod-CH2), 29.1 (CH(CH3)2), 28.4 (cod-CH2), 26.4 (CH3), 22.9 (CH3). 
FTIR (ATR) ν = 2623.19(s, br, HF2), 1807.30 (w, HF2), 1215.15(s) cm
-1
. Anal. Calcd. 
for C35H49F2IrN2 (MW 727.99): C, 57.74; H, 6.78; N, 3.85. Found: C, 57.90; H, 6.83; 
N, 3.80. 
 
[Ir(cod)(I
i
Pr)(HF2)] 12b 
A Schlenk tube was charged with [Ir(cod)
i
Pr)(OH)] (8b) (50.0 mg, 0.107 mmol) 
in THF (1 mL). NEt3.3HF (11.8 µL, 0.071 mmol) was added under Ar and the reaction 
mixture was stirred at rt for 4.5 h. The reaction mixture was reduced in vacuo and 
azeotroped with hexane (2 x 2 mL) to give a yellow solid. The solid was washed with 
pentane (2 x 2 mL) and dried to give [Ir(cod)(I
i
Pr)(HF2)] (12b) (43.0 mg, 82%) as a 
yellow solid. 
1
H NMR (500 MHz, C6D6): δ 12.22 – 11.32 (br s, 1H, Ir-F-HF), 6.25 (s, 
2H, N-(CH)2-N), 5.68 (sept., 2H, 
3
JHH = 6.8, CH(CH3)2), 4.98 – 4.92 (m, 2H, cod-CH), 
2.95 – 2.87 (m, 2H, cod-CH), 2.87 – 2.11 (m, 4H, cod-CH2), 1.61 – 1.49 (m, 4H, cod-
CH2), 1.26 (d, 6H, 
3
JHH = 6.6, CH3), 1.07 (d, 6H, 
3
JHH = 6.8, CH3); 
1
H NMR (500 MHz, 
197.5K, CD2Cl2): δ 11.53 (dd, 
1
JFH = 403.0, 
1
JFH = 44.8, Ir-F-HF); 
19
F NMR
 
(470 MHz, 
C6D6): δ -187.5 (br, Ir-F-HF), -243.5 (br, Ir-F-HF). 
19
F NMR
 
(470 MHz, 197.5K, 
CD2Cl2): δ -184.3 (dd, 
1
JHF = 403, 
2
JFF = 99, Ir-F-HF), -246.5 (app. dd, 
2
JFF = 95, 
1
JHF = 
45, Ir-F-HF). 
13
C{
1
H} NMR (MHz, C6D6): δ 178.1 (Ir-Ccarbene), 116.6 (N-(CH)2-N), 
85.0 (cod-CH), 52.7 (cod-CH), 44.9 (CH(CH3)2), 34.5 (cod-CH2), 29.1 (cod-CH2), 24.1 
(CH3), 23.1 (CH3). FTIR (ATR) ν = 2546.04 (s, br, HF2), 1869.02 (s, br HF2), 1215.15 
(s) cm
-1
. Anal. Calcd. for C17H29F2IrN2 (MW 491.64): C, 41.53; H, 5.95; N, 5.70. 
Found: C, 41.62; H, 5.87; N, 5.78. 
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[Rh(cod)(IPr)(HF2)] 13a 
A Schlenk tube was charged with [Rh(cod)(IPr)(OH)] (10a) (400 mg, 0.65 mmol) 
in THF (2 mL). NEt3.3HF (72 µL, 0.43 mmol) was added under Ar and the reaction 
mixture was stirred at rt for 4.5 h. The product was reduced in vacuo and azeotroped 
with hexane (3 x 2 mL) to give a yellow solid. The solid was washed with pentane (3 x 
1 mL) and dried to give [Rh(cod)(IPr)(HF2)] (13a) (375 mg, 90%) as a yellow solid. 
1
H 
NMR (400 MHz, C6D6): δ 12.4 (d, 1H, 
1
JFH = 350.0, Rh-F-HF), 7.31 (t, 2H, 
3
JHH = 7.7, 
p-ArH), 7.22 (d, 4H, 
3
JHH = 7.7, m-ArH), 6.49 (s, 2H, N-(CH)2-N), 4.94 – 4.84 (m, 2H, 
cod-CH), 3.09 – 2.93 (m, 6H, CH(CH3)2, cod-CH), 1.83 – 1.68 (m, 4H, cod-CH2), 1.51 
(d, 12H, 
3
JHH = 6.7, CH3), 1.45 – 1.25 (m, 4H, cod-CH2), 1.02 (d, 12H, 
3
JHH = 6.9, 
CH3); 
1
H NMR (500 MHz, 200K, CD2Cl2): δ 12.89 (app. dd, 
1
JFH = 350.0, 
1
JFH = 25.0, 
Rh-F-HF); 
19
F{
1
H} NMR
 
(470 MHz, C6D6): δ -181.5 (br., Rh-F-HF), -255.7 (br, Rh-F-
HF). 
19
F NMR
 
(470 MHz, 200 K, CD2Cl2): δ -173.1 (dd, 
1
JFH = 350, 
2
JFF = 150, Rh-
FHF), -253.6 (app. dd, 
2
JFF = 150, 
1
JFH = 50, Rh-F-HF). 
13
C{
1
H} NMR (100 MHz, 
C6D6): δ 186.3 (d, 
1
JRhC = 52, Rh-Ccarbene), 147.1 (ArC), 136.3 (ArC), 130.3 (ArCH), 
124.4 (N-(CH)2-N), 124.1 (ArCH), 97.9 (d, 
1
JRhC = 8, cod-CH), 62.3 (d, 
1
JRhC = 15, cod-
CH), 33.3 (cod-CH2), 29.0 (CH(CH3)2), 27.9 (cod-CH2), 26.5 (CH3), 23.0 (CH3). FTIR 
(ATR) ν = 2530.61 (s, br, HF2), 1890.24 (s, br, HF2) 758.02 (s) cm
-1
. Anal. Calcd. for 
C35H49F2N2Rh (MW 638.68): C, 65.82; H, 7.73; N, 4.39. Found: C, 66.0; H, 7.85; N, 
4.26. 
 
[Ir(cod)(I
i
Pr)(F)] 14 
A vial was charged with [Ir(cod)(I
i
Pr)(OH)] (8b) (82.0 mg, 0.17 mmol) in toluene 
(1 mL). TMSCF3 (31 µL, 0.21 mmol) was added and the reaction mixture was stirred at 
rt for 2 h. Once complete, the mixture was reduced in vacuo and azeotroped with 
hexane (2 x 1 mL) and washed with hexane (2 x 1 mL). The product was dried in vacuo 
to give [Ir(cod)(I
i
Pr)(OSiMe3)] (14) (88.4 mg, 96%) as a yellow solid. 
1
H NMR (300 
MHz, C6D6): δ 6.19 (s, 2H, N-(CH)2-N), 5.76 (sept., 2H, 
3
JHH = 6.8, N-CH(CH3)2), 4.86 
Chapter 6: Fluorinated Organometallics 
 
176 
 
– 4.75 (m, 2H, cod-CH), 2.89 – 2.77 (m, 2H, cod-CH), 2.49 – 2.20 (m, 4H, cod-CH2), 
1.86 – 1.66 (m, 4H, cod-CH2), 1.20 (d, 6H, 
3
JHH = 6.7, CHCH3), 1.11 (d, 6H, 
3
JHH = 6.8, 
CHCH3), 0.27 (s, 9H, Si-CH3). 
13
C{
1
H} NMR (75 MHz, C6D6): δ 180.6 (Ir-Ccarbene), 
115.9 (N-(CH)2-N), 83.6 (cod-CH), 51.9 (cod-CH), 44.5 (N-CH(CH3)2), 34.8 (cod-
CH2), 29.9 (cod-CH2), 23.6 (CHCH3), 5.0 (Si-CH3). Anal. Calcd. for C20H37IrN2OSi 
(MW 541.82): C, 44.33; H, 6.88; N, 5.09. Found: C, 44.25; H, 6.70; N, 5.09. 
 
[Ir(cod)(I
i
Pr)(CF3)] 15a 
A Schlenk tube was charged with AgF (78.0 mg, 0.61 mmol) and acetonitrile (2 
mL), in the dark and cooled under Ar to -40 °C. TMSCF3 (245 µL, 1.64 mmol) was 
added and after 15 mins the reaction mixture was warmed to rt, where it was stirred for 
30 mins. [Ir(cod)(I
i
Pr)Cl] (6b) (200 mg, 0.410 mmol) was added and the reaction 
mixture was stirred for 16 h. Upon completion, the solvent was removed in vacuo, the 
product dissolved in THF (2 mL) and filtered through a tightly packed celite column to 
give a red solution. The solvent was removed in vacuo and the resultant solid was 
washed with a cold mixture of pentane/Et2O (2:1, 3 x 1 mL). The product was dried in 
vacuo to give [Ir(cod)(I
i
Pr)(CF3)] (15a) (160 mg, 75%) as a red solid. 
1
H NMR (500 
MHz, C6D6): δ 6.21 (s, 2H, N-(CH)2-N), 5.46 (sept., 2H, 
3
JHH = 6.8, N-CH(CH3)2), 4.91 
– 4.86 (m, 2H, cod-CH), 3.64 – 3.58 (m, 2H, cod-CH), 2.26 – 2.08 (m, 4H, cod-CH2), 
1.84 – 1.76 (m, 4H, cod-CH2), 1.16 (d, 6H, 
3
JHH = 6.7, CHCH3), 1.04 (d, 6H, 
3
JHH = 6.8, 
CHCH3). 
19
F{
1
H} NMR (470 MHz, C6D6): δ -25.8 (s). 
13
C{
1
H} NMR (125 MHz, 
C6D6): δ 180.2 (q, 
3
JFC = 5, Ir-Ccarbene), 146.3 (q, 
1
JFC = 346, CF3), 116.3 (N-(CH)2-N), 
75.2 (app. q, 
3
JFC = 1, cod-CH), 71.6 (q, 
3
JFC = 2, cod-CH), 52.5 (cod-CH2), 31.8 (cod-
CH2), 31.5 (N-CH(CH3)2), 23.7 (CH3), 22.8 (q, 
6
JFC = 1, CH3). Anal. Calcd. for 
C18H28F3IrN2 (MW 521.65): C, 41.45; H, 5.41; N, 5.37. Found: C, 41.31; H, 5.32; N, 
5.60. MS (+ve EI) for C18H28F3IrN2 (MW: 521.65, Exact mass calcd. 522.18); m/z 
522.1 (100, M
+
, 
193
Ir), 520.1 (64, M
+
, 
191
Ir); HRMS: 520.18601 (520.1805 for 
C18H28F3
191
IrN2). 
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[Ir(cod)(ICy)(CF3)] 15c 
A Schlenk tube was charged with AgF (14 mg, 0.11 mmol) and MeCN (1 mL) in 
the dark. TMSCF3 (44 µL, 0.30 mmol) was added under Ar at -40 °C. After 15 mins the 
reaction mixture was warmed to rt, where it was stirred for 30 mins. [Ir(cod)(ICy)Cl] 
(6c) (42 mg, 0.074 mmol) was added and the reaction mixture was stirred at rt for 16 h. 
Upon completion, the solvent was removed in vacuo, the product dissolved in THF (2 
mL) and filtered through celite to give a red solution. The solvent was removed in vacuo 
and the resultant solid was washed with a cold mixture of pentane/Et2O (3:1, 3 x 1 mL). 
The product was dried in vacuo to give [Ir(cod)(ICy)(CF3)] (15c) (35 mg, 79%) as a red 
solid. 
1
H NMR (500 MHz, C6D6): δ 6.34 (s, 2H, N-(CH)2-N), 5.19 (tt, 2H, 
3
JHH = 11.8, 
3
JHH = 3.6, N-CH(ICy)), 4.94 – 4.81 (m, 2H, cod-CH), 3.72 – 3.61 (m, 2H, cod-CH), 
2.33 (br. d, 2H, 
3
JHH = 12.0, ICy-CH2), 2.27 – 2.10 (m, 4H, cod-CH2), 1.91 – 1.73 (m, 
6H, cod-CH2, ICy-CH2), 1.70 – 1.54 (m, 4H, ICy-CH2), 1.48 (br. d, 2H, 
3
JHH = 13.0, 
ICy-CH2), 1.44 – 1.30 (m, 4H, ICy-CH2), 1.23 (qd, 2H, 
3
JHH = 12.5, 
3
JHH = 3.5 ICy-
CH2), 1.11 (qd, 2H, 
3
JHH = 12.0, 
3
JHH = 3.5 ICy-CH2), 0.98 – 0.88 (m, 2H, ICy-CH2). 
19
F{
1
H} NMR (470 MHz, C6D6): δ -26.0 (s). 
13
C{
1
H} NMR (125 MHz, C6D6): δ 180.4 
(q, 
3
JFC = 5, Ir-Ccarbene), 146.1 (q, 
1
JFC = 347, CF3), 116.9 (N-(CH)2-N), 74.9 (cod-CH), 
71.6 (q, 
3
JFC = 2, cod-CH), 60.4 (N-CH(ICy)), 35.2 (ICy-CH2), 33.6 (q, 
6
JFC = 1, ICy-
CH2), 32.1 (cod-CH2), 31.6 (cod-CH2), 26.3 (ICy-CH2), 25.9 (ICy-CH2), 25.6 (ICy-
CH2). Anal. Calcd. for C24H36F3IrN2 (MW 601.77): C, 47.90; H, 6.03; N, 4.66. Found: 
C, 47.85; H, 5.95; N, 4.75. 
 
[Rh(cod)(ICy)(CF3)] 16c 
A Schlenk tube was charged with AgF (40 mg, 0.31 mmol) and MeCN (1 mL) in 
the dark and TMSCF3 (110 µL, 0.730 mmol) was added under Ar to -40 °C. After 15 
mins the reaction mixture was warmed to rt, where it was stirred for 30 mins. 
[Rh(cod)(ICy)Cl] (9b) (100 mg, 0.21 mmol) was added and the reaction mixture was 
stirred for 16 h. Upon completion, the reaction mixture was filtered on celite and 
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concentrated in vacuo. The resultant solid was dissolved in hexane and filtered on celite. 
The eluent was concentrated in vacuo to give [Rh(cod)(ICy)(CF3)] (16c) (57 mg, 53%) 
as a yellow solid. 
1
H NMR (400 MHz, C6D6): δ 6.36 (s, 2H, N-(CH)2-N), 5.34 (tt, 2H, 
3
JHH = 12.0, 
3
JHH = 7.3, N-CH(ICy)), 5.27 – 5.18 (m, 2H, cod-CH), 4.16 – 4.08 (m, 2H, 
cod-CH), 2.40 (br. d, 2H, 
3
JHH = 12.2, ICy-CH2), 2.36 – 2.20 (m, 4H, cod-CH2), 2.05 – 
1.95 (m, 4H, cod-CH2), 1.84 (br. d, 2H, 
3
JHH = 12.2, ICy-CH2), 1.70 – 1.57 (m, 4H, ICy-
CH2), 1.47 – 1.38 (m, 4H, ICy-CH2), 1.25 (qd, 2H, 
3
JHH = 12.6, 
3
JHH = 3.6, ICy-CH2), 
1.14 (qd, 2H, 
3
JHH = 12.4, 
3
JHH = 3.8, ICy-CH2), 1.02 – 0.90 (m, 4H, ICy-CH2). 
19
F{
1
H} 
NMR (376 MHz, C6D6): δ -21.7 (d, 
2
JRhF = 27 Hz. 
13
C{
1
H} NMR (125 MHz, C6D6): δ 
185.6 (m, Rh-Ccarbene), 117.0 (N-(CH)2-N), 87.7 (d, 
3
JFC = 9, cod-CH), 86.0 (d, 
3
JFC = 7, 
cod-CH), 60.8 (N-CH(ICy)), 35.2 (ICy-CH2), 33.8 (ICy-CH2), 31.3 (cod-CH2), 31.2 
(cod-CH2), 26.4 (ICy-CH2), 26.0 (ICy-CH2), 25.7 (ICy-CH2). Anal. Calcd. for 
C24H36F3N2Rh (MW 512.47): C, 56.25; H, 7.08; N, 5.47. Found: C, 56.37; H, 7.15; N, 
5.64. *(CF3 not observed by 
13
C{
1
H} NMR) 
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7.  CONCLUSIONS 
The initial aims of this project were to identify and execute robust synthetic 
methods for the preparation of Rh(I)-hydroxide complexes and to explore their 
reactivity, with a fundamental focus on their catalytic capabilities. The Rh(I)-NHC 
hydroxides proved to be very active catalysts in the conjugate addition of arylboronic 
acids to α,β-unsaturated ketones, challenging the state of the art catalysts which employ 
very electron deficient ancillary ligands. Rh(I)-hydroxides were also active catalysts in 
the hydrosilylation of terminal alkenes, boasting high activities. However, selectivity 
proved to be a key issue, with dehydrogenative silylation being very competitive with 
hydrosilylation. We were able to exploit this unwanted side reaction, and demonstrated 
remarkable shifts in selectivity towards dehydrogenative silylation, by optimising the 
ratio of the starting materials.  
When we extended the methodology of metal-NHC hydroxides to include iridium, 
the focus was on reactivity as opposed to catalysis. Having established general 
procedures for the preparation of a family of [Ir(cod)(NHC)(OH)] complexes, we tested 
the reactivity of the motif towards a number of organic substrates. Reactivity was 
confined to the hydroxyl moiety and the Ir-hydroxide deprotonated a number of Si-H, 
O-H, N-H and C-H bonds to afford a wide array of new iridium complexes. The bond 
activation reactions were very straight-forward and atom economical, generating only 
the desired product and H2O in each case. Following this study, we examined the 
reactivity of these new Ir(I)-alkoxides and Ir(I)-amides towards carbon dioxide. CO2 
was found to insert into several Ir-N and Ir-O bonds under very mild conditions. In the 
case of Ir(I)-NHC hydroxide, insertion of CO2 led to the unique [{Ir(I)}2(µ-κ
1
O:κ2O,O-
CO3)] complex, both in solution and in the solid state. Kinetic and theoretical 
calculations were performed,confiming the facile nature of the CO2 insertion reaction 
via an associative transition state, providing valuable mechanistic insight into the CO2 
fixation reaction. 
As a final study, we used the Rh-NHC and Ir-NHC scaffolds to prepare 
fluorinated organometallic complexes. General routes for the preparation of Ir and Rh 
fluoride, bifluoride and trifluoromethyl complexes have been reported and access to 
these complexes allowed us to investigate the relationships between these interesting 
species.
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